{ "schema": "picoportal.search-run-provenance/1", "exportedAt": "2026-10-29T13:19:17.508Z", "tool": { "name": "PICO search builder", "database": "PubMed via NCBI E-utilities", "vocabulary": "NLM MeSH via id.nlm.nih.gov" }, "aiUse": { "modelsServed": [ "claude-opus-5-5" ], "statement": "The PubMed search strategy was drafted with the PICO search builder. It used the large language model claude-opus-5-5 (Anthropic; accessed October 28, 2026) to propose search concepts and terms from the review question. The tool made 1 call to the model at high effort (the draft); claude-opus-5-5 was requested and answered it. A refusal fallback was enabled (had the model declined a request, the API could have run it again on another model Anthropic recommends); it was not used. Every MeSH heading, Supplementary Concept and publication type the strategy searches was checked against NLM MeSH (id.nlm.nih.gov) before use: 25 valid. Each numbered line was run in PubMed through NCBI E-utilities on October 28, 2026, and PubMed's own diagnostics (phrases not found, ignored words, lost truncation) were checked. A searcher must review the strategy before it is used. The prompts, the model output and every version are in the provenance file (JSON export)." }, "run": { "id": "95ee90bf-0161-444a-980b-df0739021fcb", "kind": "question", "status": "done", "stage": "saving", "question": "What factors are associated with recurrence, progression, survival, BCG unresponsiveness, or cystectomy in adults with high-risk NMIBC?", "input": { "seeds": [], "limits": { "dateTo": null, "dateFrom": null, "languages": [ "english" ], "humansOnly": false, "excludePublicationTypes": [ { "label": "Comment", "validation": { "status": "unchecked" } }, { "label": "Editorial", "validation": { "status": "unchecked" } }, { "label": "Letter", "validation": { "status": "unchecked" } }, { "label": "Case Reports", "validation": { "status": "unchecked" } }, { "label": "Preprint", "validation": { "status": "unchecked" } } ] }, "question": "What factors are associated with recurrence, progression, survival, BCG unresponsiveness, or cystectomy in adults with high-risk NMIBC?", "referenceStrategy": null }, "strategy": { "notes": [ "NMIBC has no dedicated MeSH heading to rely on, so the condition is built from two required blocks: bladder or urothelial cancer, ANDed with non-muscle-invasive, BCG or intravesical terms. This excludes muscle-invasive-only studies while keeping NMIBC studies that do not use the abbreviation.", "The high-risk block is optional. Many studies of high-risk disease describe it only as T1, high-grade, carcinoma in situ or BCG-treated, which the non-muscle-invasive block already covers. Add the high-risk block if the result set is too large.", "Prognosis is not exploded, to avoid pulling in the very broad Treatment Outcome subtree.", "The bare word predict* and the title phrase 'associated with' are included for sensitivity; check their line counts and drop them if they add too much noise.", "The question does not restrict the age group of the population, so no adult filter is applied; nearly all NMIBC studies involve adults." ], "blocks": [ { "key": "bladder", "role": "condition", "label": "Bladder or urothelial cancer", "terms": [ { "id": "bladder-mesh-0", "kind": "mesh", "label": "Urinary Bladder Neoplasms", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Main heading for bladder cancer, under which NMIBC studies are indexed.", "validation": { "ui": "D001749", "label": "Urinary Bladder Neoplasms", "status": "valid" } }, { "id": "bladder-mesh-1", "kind": "mesh", "label": "Carcinoma, Transitional Cell", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Histological heading for urothelial carcinoma, often given to NMIBC records.", "validation": { "ui": "D002295", "label": "Carcinoma, Transitional Cell", "status": "valid" } }, { "id": "bladder-text-0", "kind": "text", "text": "bladder cancer", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Most common author wording for the disease." }, { "id": "bladder-text-1", "kind": "text", "text": "bladder tumor", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "American spelling variant for bladder tumours." }, { "id": "bladder-text-2", "kind": "text", "text": "bladder tumour", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "British spelling variant." }, { "id": "bladder-text-3", "kind": "text", "text": "bladder neoplasm", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Entry-term wording of the heading." }, { "id": "bladder-text-4", "kind": "text", "text": "bladder carcinoma", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Common synonym for bladder cancer." }, { "id": "bladder-text-5", "kind": "text", "text": "urothelial carcinoma", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Histological name used for NMIBC." }, { "id": "bladder-text-6", "kind": "text", "text": "urothelial cancer", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Variant of urothelial carcinoma." }, { "id": "bladder-text-7", "kind": "text", "text": "transitional cell carcinoma", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Older histological name still used in older studies." }, { "id": "bladder-text-8", "kind": "text", "text": "NMIBC", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Standard abbreviation that sometimes stands alone in titles and keywords." }, { "id": "bladder-mesh-0-et5", "kind": "text", "text": "Cancer of Bladder", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept \"Urinary Bladder Cancer\" under the MeSH heading \"Urinary Bladder Neoplasms\" (D001749)" }, { "id": "bladder-mesh-0-et6", "kind": "text", "text": "Cancer of the Bladder", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept \"Urinary Bladder Cancer\" under the MeSH heading \"Urinary Bladder Neoplasms\" (D001749)" }, { "id": "bladder-mesh-0-et7", "kind": "text", "text": "Malignant Tumor of Urinary Bladder", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept \"Urinary Bladder Cancer\" under the MeSH heading \"Urinary Bladder Neoplasms\" (D001749)" } ], "required": true }, { "key": "nmi", "role": "condition", "label": "Non-muscle-invasive disease", "terms": [ { "id": "nmi-mesh-0", "kind": "mesh", "label": "Carcinoma in Situ", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Carcinoma in situ is a defining high-risk NMIBC category.", "validation": { "ui": "D002278", "label": "Carcinoma in Situ", "status": "valid" } }, { "id": "nmi-mesh-1", "kind": "mesh", "label": "BCG Vaccine", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Intravesical BCG is the standard treatment of high-risk NMIBC, so BCG-treated cohorts are this population.", "validation": { "ui": "D001500", "label": "BCG Vaccine", "status": "valid" } }, { "id": "nmi-mesh-2", "kind": "mesh", "label": "Administration, Intravesical", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Intravesical therapy is used only in non-muscle-invasive disease.", "validation": { "ui": "D000283", "label": "Administration, Intravesical", "status": "valid" } }, { "id": "nmi-text-0", "kind": "text", "text": "non-muscle invasive", "fields": [ "tiab", "ot" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Core descriptor of the disease stage; the hyphen also matches the spaced form." }, { "id": "nmi-text-1", "kind": "text", "text": "nonmuscle invasive", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Joined spelling variant." }, { "id": "nmi-text-2", "kind": "text", "text": "NMIBC", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Standard abbreviation for non-muscle-invasive bladder cancer." }, { "id": "nmi-text-3", "kind": "text", "text": "superficial bladder", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": 2, "rationale": "Older term for NMIBC (superficial bladder cancer or tumours)." }, { "id": "nmi-text-4", "kind": "text", "text": "carcinoma in situ", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "High-risk NMIBC subtype, often abbreviated CIS in abstracts." }, { "id": "nmi-text-5", "kind": "text", "text": "T1G3", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Classic label for high-risk T1 high-grade tumours." }, { "id": "nmi-text-6", "kind": "text", "text": "pT1", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Pathological stage label used for T1 disease." }, { "id": "nmi-text-7", "kind": "text", "text": "stage T1", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Wording for T1 tumours, a high-risk NMIBC category." }, { "id": "nmi-text-8", "kind": "text", "text": "T1 bladder", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": 2, "rationale": "Catches T1 bladder cancer or tumour phrasing." }, { "id": "nmi-text-9", "kind": "text", "text": "BCG", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Abbreviation for bacillus Calmette-Guerin, the standard adjuvant therapy." }, { "id": "nmi-text-10", "kind": "text", "text": "Calmette-Guerin", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Spelled-out BCG name." }, { "id": "nmi-text-11", "kind": "text", "text": "intravesical", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Intravesical therapy is specific to non-muscle-invasive disease." }, { "id": "nmi-text-12", "kind": "text", "text": "TURBT", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Abbreviation for transurethral resection of bladder tumour, the initial treatment of NMIBC." }, { "id": "nmi-text-13", "kind": "text", "text": "transurethral resection", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Initial treatment of NMIBC, used to describe the cohorts." }, { "id": "nmi-mesh-1-et1", "kind": "text", "text": "Calmette's Vaccine", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"BCG Vaccine\" (D001500)" }, { "id": "nmi-mesh-2-et1", "kind": "text", "text": "Bladder Drug Administration", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Administration, Intravesical\" (D000283)" } ], "required": true }, { "key": "highrisk", "role": "population", "label": "High-risk category", "terms": [ { "id": "highrisk-text-0", "kind": "text", "text": "high risk", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Risk-group label used for these cohorts; also matches very high risk." }, { "id": "highrisk-text-1", "kind": "text", "text": "high grade", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "High-grade tumours define high-risk NMIBC." }, { "id": "highrisk-text-2", "kind": "text", "text": "highest risk", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Alternative risk-group wording." } ], "required": false }, { "key": "prognostic", "role": "exposure", "label": "Prognostic or predictive factors", "terms": [ { "id": "prognostic-mesh-0", "kind": "mesh", "label": "Prognosis", "major": false, "origin": "ai", "enabled": true, "explode": false, "rationale": "Core heading for prognostic studies; not exploded to avoid the very broad Treatment Outcome subtree.", "validation": { "ui": "D011379", "label": "Prognosis", "status": "valid" } }, { "id": "prognostic-mesh-1", "kind": "mesh", "label": "Risk Factors", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Indexes studies of factors associated with outcomes.", "validation": { "ui": "D012307", "label": "Risk Factors", "status": "valid" } }, { "id": "prognostic-mesh-2", "kind": "mesh", "label": "Risk Assessment", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Covers risk stratification and risk scoring tools.", "validation": { "ui": "D018570", "label": "Risk Assessment", "status": "valid" } }, { "id": "prognostic-mesh-3", "kind": "mesh", "label": "Biomarkers, Tumor", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Molecular and tissue markers studied as prognostic factors.", "validation": { "ui": "D014408", "label": "Biomarkers, Tumor", "status": "valid" } }, { "id": "prognostic-mesh-4", "kind": "mesh", "label": "Nomograms", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Prediction tools such as the EORTC and CUETO scoring models.", "validation": { "ui": "D049451", "label": "Nomograms", "status": "valid" } }, { "id": "prognostic-mesh-5", "kind": "mesh", "label": "Proportional Hazards Models", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Cox models are the usual analysis in prognostic factor studies.", "validation": { "ui": "D016016", "label": "Proportional Hazards Models", "status": "valid" } }, { "id": "prognostic-mesh-6", "kind": "mesh", "label": "Multivariate Analysis", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Multivariable analysis identifies independent prognostic factors.", "validation": { "ui": "D015999", "label": "Multivariate Analysis", "status": "valid" } }, { "id": "prognostic-text-0", "kind": "text", "text": "prognos", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Catches prognosis, prognostic and prognosticator." }, { "id": "prognostic-text-1", "kind": "text", "text": "predict", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Catches predictor, predictive and prediction." }, { "id": "prognostic-text-2", "kind": "text", "text": "risk factor", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Standard wording for associated factors." }, { "id": "prognostic-text-3", "kind": "text", "text": "hazard ratio", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Reported effect measure in prognostic studies." }, { "id": "prognostic-text-4", "kind": "text", "text": "odds ratio", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Reported effect measure for binary outcomes such as cystectomy." }, { "id": "prognostic-text-5", "kind": "text", "text": "multivariate", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Signals adjusted analysis of factors." }, { "id": "prognostic-text-6", "kind": "text", "text": "multivariable", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Variant of multivariate." }, { "id": "prognostic-text-7", "kind": "text", "text": "nomogram", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Prediction tools." }, { "id": "prognostic-text-8", "kind": "text", "text": "risk stratification", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Wording for risk-group models." }, { "id": "prognostic-text-9", "kind": "text", "text": "risk score", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Covers EORTC, CUETO and other scoring systems." }, { "id": "prognostic-text-10", "kind": "text", "text": "risk group", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Wording for risk stratification categories." }, { "id": "prognostic-text-11", "kind": "text", "text": "biomarker", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Molecular factors studied for prognosis." }, { "id": "prognostic-text-12", "kind": "text", "text": "associated with", "fields": [ "ti" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Titles of association studies often state the factor is associated with an outcome; restricted to title to limit noise." }, { "id": "prognostic-mesh-1-et2", "kind": "text", "text": "Population at Risk", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept under the MeSH heading \"Risk Factors\" (D012307)" }, { "id": "prognostic-mesh-1-et3", "kind": "text", "text": "Health Correlates", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept under the MeSH heading \"Risk Factors\" (D012307)" }, { "id": "prognostic-mesh-1-et4", "kind": "text", "text": "Populations at Risk", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept \"Population at Risk\" under the MeSH heading \"Risk Factors\" (D012307)" }, { "id": "prognostic-mesh-2-et1", "kind": "text", "text": "Health Risk Assessment", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Risk Assessment\" (D018570)" }, { "id": "prognostic-mesh-2-et2", "kind": "text", "text": "Benefit-Risk Assessment", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept under the MeSH heading \"Risk Assessment\" (D018570)" }, { "id": "prognostic-mesh-2-et3", "kind": "text", "text": "Risk-Benefit Assessment", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept \"Benefit-Risk Assessment\" under the MeSH heading \"Risk Assessment\" (D018570)" }, { "id": "prognostic-mesh-3-et2", "kind": "text", "text": "Carcinogen Markers", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Biomarkers, Tumor\" (D014408)" }, { "id": "prognostic-mesh-3-et3", "kind": "text", "text": "Biological Tumor Marker", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Biomarkers, Tumor\" (D014408)" }, { "id": "prognostic-mesh-3-et4", "kind": "text", "text": "Tumor Metabolite Marker", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Biomarkers, Tumor\" (D014408)" }, { "id": "prognostic-mesh-3-et5", "kind": "text", "text": "Biochemical Tumor Marker", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Biomarkers, Tumor\" (D014408)" }, { "id": "prognostic-mesh-3-et6", "kind": "text", "text": "Biological Tumor Markers", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Biomarkers, Tumor\" (D014408)" }, { "id": "prognostic-mesh-3-et7", "kind": "text", "text": "Biochemical Tumor Markers", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Biomarkers, Tumor\" (D014408)" }, { "id": "prognostic-mesh-4-et1", "kind": "text", "text": "Partin Tables", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept under the MeSH heading \"Nomograms\" (D049451)" }, { "id": "prognostic-mesh-5-et1", "kind": "text", "text": "Proportional Hazard Model", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Proportional Hazards Models\" (D016016)" }, { "id": "prognostic-mesh-5-et2", "kind": "text", "text": "Proportional Hazard Models", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Proportional Hazards Models\" (D016016)" }, { "id": "prognostic-mesh-5-et3", "kind": "text", "text": "Proportional Hazards Model", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Proportional Hazards Models\" (D016016)" }, { "id": "prognostic-mesh-5-et4", "kind": "text", "text": "Cox Proportional Hazards Models", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept under the MeSH heading \"Proportional Hazards Models\" (D016016)" }, { "id": "prognostic-mesh-5-et5", "kind": "text", "text": "Cox Models", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept under the MeSH heading \"Proportional Hazards Models\" (D016016)" }, { "id": "prognostic-mesh-5-et6", "kind": "text", "text": "Cox Proportional Hazards Model", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept \"Cox Proportional Hazards Models\" under the MeSH heading \"Proportional Hazards Models\" (D016016)" } ], "required": true }, { "key": "outcome", "role": "outcome", "label": "Recurrence, progression, survival, BCG unresponsiveness, cystectomy", "terms": [ { "id": "outcome-mesh-0", "kind": "mesh", "label": "Neoplasm Recurrence, Local", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Heading for tumour recurrence.", "validation": { "ui": "D009364", "label": "Neoplasm Recurrence, Local", "status": "valid" } }, { "id": "outcome-mesh-1", "kind": "mesh", "label": "Recurrence", "major": false, "origin": "ai", "enabled": true, "explode": false, "rationale": "General recurrence heading sometimes used instead.", "validation": { "ui": "D012008", "label": "Recurrence", "status": "valid" } }, { "id": "outcome-mesh-2", "kind": "mesh", "label": "Disease Progression", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Heading for progression to muscle-invasive disease.", "validation": { "ui": "D018450", "label": "Disease Progression", "status": "valid" } }, { "id": "outcome-mesh-3", "kind": "mesh", "label": "Survival Analysis", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Covers disease-free survival, Kaplan-Meier and survival rates.", "validation": { "ui": "D016019", "label": "Survival Analysis", "status": "valid" } }, { "id": "outcome-mesh-4", "kind": "mesh", "label": "Progression-Free Survival", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Specific survival outcome heading.", "validation": { "ui": "D000077982", "label": "Progression-Free Survival", "status": "valid" } }, { "id": "outcome-mesh-5", "kind": "mesh", "label": "Cystectomy", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Cystectomy is a named outcome of the review.", "validation": { "ui": "D015653", "label": "Cystectomy", "status": "valid" } }, { "id": "outcome-mesh-6", "kind": "mesh", "label": "Treatment Failure", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Indexes BCG failure and unresponsive disease.", "validation": { "ui": "D017211", "label": "Treatment Failure", "status": "valid" } }, { "id": "outcome-mesh-7", "kind": "mesh", "label": "Drug Resistance, Neoplasm", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Can be used for BCG-refractory disease.", "validation": { "ui": "D019008", "label": "Drug Resistance, Neoplasm", "status": "valid" } }, { "id": "outcome-text-0", "kind": "text", "text": "recurren", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Catches recurrence, recurrent and recurrence-free." }, { "id": "outcome-text-1", "kind": "text", "text": "relapse", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Synonym for recurrence." }, { "id": "outcome-text-2", "kind": "text", "text": "progression", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Progression to muscle-invasive or metastatic disease." }, { "id": "outcome-text-3", "kind": "text", "text": "muscle invasion", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Description of progression." }, { "id": "outcome-text-4", "kind": "text", "text": "upstaging", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Related progression outcome." }, { "id": "outcome-text-5", "kind": "text", "text": "survival", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Overall, cancer-specific and progression-free survival." }, { "id": "outcome-text-6", "kind": "text", "text": "mortality", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Death outcomes." }, { "id": "outcome-text-7", "kind": "text", "text": "cystectom", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Catches cystectomy and cystectomies, including radical and early cystectomy." }, { "id": "outcome-text-8", "kind": "text", "text": "BCG unresponsive", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Catches BCG-unresponsive and BCG-unresponsiveness." }, { "id": "outcome-text-9", "kind": "text", "text": "BCG refractory", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Related BCG failure category." }, { "id": "outcome-text-10", "kind": "text", "text": "BCG failure", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "General term for failure of BCG therapy." }, { "id": "outcome-text-11", "kind": "text", "text": "BCG relapsing", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "BCG failure subtype." }, { "id": "outcome-text-12", "kind": "text", "text": "treatment failure", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "General failure wording." }, { "id": "outcome-mesh-1-et2", "kind": "text", "text": "Recrudescence", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept under the MeSH heading \"Recurrence\" (D012008)" }, { "id": "outcome-mesh-7-et1", "kind": "text", "text": "Neoplasm Drug Resistance", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Drug Resistance, Neoplasm\" (D019008)" }, { "id": "outcome-mesh-7-et2", "kind": "text", "text": "Antineoplastic Drug Resistance", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Drug Resistance, Neoplasm\" (D019008)" }, { "id": "outcome-mesh-7-et3", "kind": "text", "text": "Antineoplastic Agent Resistance", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Drug Resistance, Neoplasm\" (D019008)" } ], "required": true } ], "limits": { "dateTo": null, "dateFrom": null, "languages": [ "english" ], "humansOnly": false, "excludePublicationTypes": [ { "label": "Comment", "validation": { "ui": "D016420", "label": "Comment", "status": "valid" } }, { "label": "Editorial", "validation": { "ui": "D016421", "label": "Editorial", "status": "valid" } }, { "label": "Letter", "validation": { "ui": "D016422", "label": "Letter", "status": "valid" } }, { "label": "Case Reports", "validation": { "ui": "D002363", "label": "Case Reports", "status": "valid" } }, { "label": "Preprint", "validation": { "ui": "D000076942", "label": "Preprint", "status": "valid" } } ] }, "schema": "picoportal.search-strategy/1", "question": "What factors are associated with recurrence, progression, survival, BCG unresponsiveness, or cystectomy in adults with high-risk NMIBC?", "objective": "To identify clinical, pathological, molecular and treatment-related factors associated with recurrence, progression, survival, BCG-unresponsive disease or cystectomy in adults with high-risk non-muscle-invasive bladder cancer (NMIBC)." }, "lines": [ { "no": 1, "kind": "terms", "refs": [], "count": 76110, "query": "\"Urinary Bladder Neoplasms\"[Mesh] OR \"Carcinoma, Transitional Cell\"[Mesh]", "issues": [], "display": "\"Urinary Bladder Neoplasms\"[Mesh] OR \"Carcinoma, Transitional Cell\"[Mesh]", "termIds": [ "bladder-mesh-0", "bladder-mesh-1" ], "blockKey": "bladder", "countedAt": "2026-10-28T18:55:46.498Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"Urinary Bladder Neoplasms\"[MeSH Terms] OR \"carcinoma, transitional cell\"[MeSH Terms]", "quotedPhrasesNotFound": [] } }, { "no": 2, "kind": "terms", "refs": [], "count": 85737, "query": "\"bladder cancer*\"[tiab] OR \"bladder tumor*\"[tiab] OR \"bladder tumour*\"[tiab] OR \"bladder neoplasm*\"[tiab] OR \"bladder carcinoma*\"[tiab] OR \"urothelial carcinoma*\"[tiab] OR \"urothelial cancer*\"[tiab] OR \"transitional cell carcinoma*\"[tiab] OR NMIBC[tiab]", "issues": [], "display": "\"bladder cancer*\"[tiab] OR \"bladder tumor*\"[tiab] OR \"bladder tumour*\"[tiab] OR \"bladder neoplasm*\"[tiab] OR \"bladder carcinoma*\"[tiab] OR \"urothelial carcinoma*\"[tiab] OR \"urothelial cancer*\"[tiab] OR \"transitional cell carcinoma*\"[tiab] OR NMIBC[tiab]", "termIds": [ "bladder-text-0", "bladder-text-1", "bladder-text-2", "bladder-text-3", "bladder-text-4", "bladder-text-5", "bladder-text-6", "bladder-text-7", "bladder-text-8" ], "blockKey": "bladder", "countedAt": "2026-10-28T18:55:43.164Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"bladder cancer*\"[Title/Abstract] OR \"bladder tumor*\"[Title/Abstract] OR \"bladder tumour*\"[Title/Abstract] OR \"bladder neoplasm*\"[Title/Abstract] OR \"bladder carcinoma*\"[Title/Abstract] OR \"urothelial carcinoma*\"[Title/Abstract] OR \"urothelial cancer*\"[Title/Abstract] OR \"transitional cell carcinoma*\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract]", "quotedPhrasesNotFound": [] } }, { "no": 3, "kind": "block", "refs": [ 1, 2 ], "count": 103654, "query": "(\"Urinary Bladder Neoplasms\"[Mesh] OR \"Carcinoma, Transitional Cell\"[Mesh]) OR (\"bladder cancer*\"[tiab] OR \"bladder tumor*\"[tiab] OR \"bladder tumour*\"[tiab] OR \"bladder neoplasm*\"[tiab] OR \"bladder carcinoma*\"[tiab] OR \"urothelial carcinoma*\"[tiab] OR \"urothelial cancer*\"[tiab] OR \"transitional cell carcinoma*\"[tiab] OR NMIBC[tiab])", "issues": [], "display": "1 OR 2", "blockKey": "bladder", "countedAt": "2026-10-28T18:55:43.566Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"Urinary Bladder Neoplasms\"[MeSH Terms] OR \"carcinoma, transitional cell\"[MeSH Terms] OR \"bladder cancer*\"[Title/Abstract] OR \"bladder tumor*\"[Title/Abstract] OR \"bladder tumour*\"[Title/Abstract] OR \"bladder neoplasm*\"[Title/Abstract] OR \"bladder carcinoma*\"[Title/Abstract] OR \"urothelial carcinoma*\"[Title/Abstract] OR \"urothelial cancer*\"[Title/Abstract] OR \"transitional cell carcinoma*\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract]", "quotedPhrasesNotFound": [] } }, { "no": 4, "kind": "terms", "refs": [], "count": 54049, "query": "\"Carcinoma in Situ\"[Mesh] OR \"BCG Vaccine\"[Mesh] OR \"Administration, Intravesical\"[Mesh]", "issues": [], "display": "\"Carcinoma in Situ\"[Mesh] OR \"BCG Vaccine\"[Mesh] OR \"Administration, Intravesical\"[Mesh]", "termIds": [ "nmi-mesh-0", "nmi-mesh-1", "nmi-mesh-2" ], "blockKey": "nmi", "countedAt": "2026-10-28T18:55:42.841Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"Carcinoma in Situ\"[MeSH Terms] OR \"BCG Vaccine\"[MeSH Terms] OR \"administration, intravesical\"[MeSH Terms]", "quotedPhrasesNotFound": [] } }, { "no": 5, "kind": "terms", "refs": [], "count": 85031, "query": "\"non-muscle invasive\"[tiab] OR \"nonmuscle invasive\"[tiab] OR NMIBC[tiab] OR \"superficial bladder\"[tiab:~2] OR \"carcinoma in situ\"[tiab] OR T1G3[tiab] OR pT1[tiab] OR \"stage T1\"[tiab] OR \"T1 bladder\"[tiab:~2] OR BCG[tiab] OR \"Calmette-Guerin\"[tiab] OR intravesical[tiab] OR TURBT[tiab] OR \"transurethral resection\"[tiab]", "issues": [ { "code": "field_subsumed", "level": "info", "termId": "nmi-text-0", "message": "\"non-muscle invasive\"[ot] adds almost nothing to \"non-muscle invasive\"[tiab], which already searches the title, the abstract and the keywords.", "blockKey": "nmi" } ], "display": "\"non-muscle invasive\"[tiab] OR \"nonmuscle invasive\"[tiab] OR NMIBC[tiab] OR \"superficial bladder\"[tiab:~2] OR \"carcinoma in situ\"[tiab] OR T1G3[tiab] OR pT1[tiab] OR \"stage T1\"[tiab] OR \"T1 bladder\"[tiab:~2] OR BCG[tiab] OR \"Calmette-Guerin\"[tiab] OR intravesical[tiab] OR TURBT[tiab] OR \"transurethral resection\"[tiab]", "termIds": [ "nmi-text-0", "nmi-text-1", "nmi-text-2", "nmi-text-3", "nmi-text-4", "nmi-text-5", "nmi-text-6", "nmi-text-7", "nmi-text-8", "nmi-text-9", "nmi-text-10", "nmi-text-11", "nmi-text-12", "nmi-text-13" ], "blockKey": "nmi", "countedAt": "2026-10-28T18:55:44.386Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"non-muscle invasive\"[Title/Abstract] OR \"nonmuscle invasive\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract] OR \"superficial bladder\"[Title/Abstract:~2] OR \"carcinoma in situ\"[Title/Abstract] OR \"T1G3\"[Title/Abstract] OR \"pT1\"[Title/Abstract] OR \"stage T1\"[Title/Abstract] OR \"T1 bladder\"[Title/Abstract:~2] OR \"BCG\"[Title/Abstract] OR \"Calmette-Guerin\"[Title/Abstract] OR \"intravesical\"[Title/Abstract] OR \"TURBT\"[Title/Abstract] OR \"transurethral resection\"[Title/Abstract]", "quotedPhrasesNotFound": [] } }, { "no": 6, "kind": "terms", "refs": [], "count": 1499, "query": "\"non-muscle invasive\"[ot]", "issues": [ { "code": "field_subsumed", "level": "info", "termId": "nmi-text-0", "message": "\"non-muscle invasive\"[ot] adds almost nothing to \"non-muscle invasive\"[tiab], which already searches the title, the abstract and the keywords.", "blockKey": "nmi" } ], "display": "\"non-muscle invasive\"[ot]", "termIds": [ "nmi-text-0" ], "blockKey": "nmi", "countedAt": "2026-10-28T18:55:44.493Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"non-muscle invasive\"[Other Term]", "quotedPhrasesNotFound": [] } }, { "no": 7, "kind": "block", "refs": [ 4, 5, 6 ], "count": 108908, "query": "(\"Carcinoma in Situ\"[Mesh] OR \"BCG Vaccine\"[Mesh] OR \"Administration, Intravesical\"[Mesh]) OR (\"non-muscle invasive\"[tiab] OR \"nonmuscle invasive\"[tiab] OR NMIBC[tiab] OR \"superficial bladder\"[tiab:~2] OR \"carcinoma in situ\"[tiab] OR T1G3[tiab] OR pT1[tiab] OR \"stage T1\"[tiab] OR \"T1 bladder\"[tiab:~2] OR BCG[tiab] OR \"Calmette-Guerin\"[tiab] OR intravesical[tiab] OR TURBT[tiab] OR \"transurethral resection\"[tiab]) OR (\"non-muscle invasive\"[ot])", "issues": [], "display": "4 OR 5 OR 6", "blockKey": "nmi", "countedAt": "2026-10-28T18:55:44.854Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"Carcinoma in Situ\"[MeSH Terms] OR \"BCG Vaccine\"[MeSH Terms] OR \"administration, intravesical\"[MeSH Terms] OR \"non-muscle invasive\"[Title/Abstract] OR \"nonmuscle invasive\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract] OR \"superficial bladder\"[Title/Abstract:~2] OR \"Carcinoma in Situ\"[Title/Abstract] OR \"T1G3\"[Title/Abstract] OR \"pT1\"[Title/Abstract] OR \"stage T1\"[Title/Abstract] OR \"T1 bladder\"[Title/Abstract:~2] OR \"BCG\"[Title/Abstract] OR \"Calmette-Guerin\"[Title/Abstract] OR \"intravesical\"[Title/Abstract] OR \"TURBT\"[Title/Abstract] OR \"transurethral resection\"[Title/Abstract] OR \"non-muscle invasive\"[Other Term]", "quotedPhrasesNotFound": [] } }, { "no": 8, "kind": "terms", "refs": [], "count": 2283845, "query": "\"Prognosis\"[Mesh:NoExp] OR \"Risk Factors\"[Mesh] OR \"Risk Assessment\"[Mesh] OR \"Biomarkers, Tumor\"[Mesh] OR \"Nomograms\"[Mesh] OR \"Proportional Hazards Models\"[Mesh] OR \"Multivariate Analysis\"[Mesh]", "issues": [], "display": "\"Prognosis\"[Mesh:NoExp] OR \"Risk Factors\"[Mesh] OR \"Risk Assessment\"[Mesh] OR \"Biomarkers, Tumor\"[Mesh] OR \"Nomograms\"[Mesh] OR \"Proportional Hazards Models\"[Mesh] OR \"Multivariate Analysis\"[Mesh]", "termIds": [ "prognostic-mesh-0", "prognostic-mesh-1", "prognostic-mesh-2", "prognostic-mesh-3", "prognostic-mesh-4", "prognostic-mesh-5", "prognostic-mesh-6" ], "blockKey": "prognostic", "countedAt": "2026-10-28T18:55:48.198Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"Prognosis\"[MeSH Terms:noexp] OR \"Risk Factors\"[MeSH Terms] OR \"Risk Assessment\"[MeSH Terms] OR \"biomarkers, tumor\"[MeSH Terms] OR \"Nomograms\"[MeSH Terms] OR \"Proportional Hazards Models\"[MeSH Terms] OR \"Multivariate Analysis\"[MeSH Terms]", "quotedPhrasesNotFound": [] } }, { "no": 9, "kind": "terms", "refs": [], "count": 531268, "query": "\"associated with\"[ti]", "issues": [], "display": "\"associated with\"[ti]", "termIds": [ "prognostic-text-12" ], "blockKey": "prognostic", "countedAt": "2026-10-28T18:55:45.494Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"associated with\"[Title]", "quotedPhrasesNotFound": [] } }, { "no": 10, "kind": "terms", "refs": [], "count": 5161509, "query": "prognos*[tiab] OR predict*[tiab] OR \"risk factor*\"[tiab] OR \"hazard ratio*\"[tiab] OR \"odds ratio*\"[tiab] OR multivariate[tiab] OR multivariable[tiab] OR nomogram*[tiab] OR \"risk stratification\"[tiab] OR \"risk score*\"[tiab] OR \"risk group*\"[tiab] OR biomarker*[tiab]", "issues": [], "display": "prognos*[tiab] OR predict*[tiab] OR \"risk factor*\"[tiab] OR \"hazard ratio*\"[tiab] OR \"odds ratio*\"[tiab] OR multivariate[tiab] OR multivariable[tiab] OR nomogram*[tiab] OR \"risk stratification\"[tiab] OR \"risk score*\"[tiab] OR \"risk group*\"[tiab] OR biomarker*[tiab]", "termIds": [ "prognostic-text-0", "prognostic-text-1", "prognostic-text-2", "prognostic-text-3", "prognostic-text-4", "prognostic-text-5", "prognostic-text-6", "prognostic-text-7", "prognostic-text-8", "prognostic-text-9", "prognostic-text-10", "prognostic-text-11" ], "blockKey": "prognostic", "countedAt": "2026-10-28T18:55:45.936Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"prognos*\"[Title/Abstract] OR \"predict*\"[Title/Abstract] OR \"risk factor*\"[Title/Abstract] OR \"hazard ratio*\"[Title/Abstract] OR \"odds ratio*\"[Title/Abstract] OR \"multivariate\"[Title/Abstract] OR \"multivariable\"[Title/Abstract] OR \"nomogram*\"[Title/Abstract] OR \"risk stratification\"[Title/Abstract] OR \"risk score*\"[Title/Abstract] OR \"risk group*\"[Title/Abstract] OR \"biomarker*\"[Title/Abstract]", "quotedPhrasesNotFound": [] } }, { "no": 11, "kind": "block", "refs": [ 8, 9, 10 ], "count": 6455728, "query": "(\"Prognosis\"[Mesh:NoExp] OR \"Risk Factors\"[Mesh] OR \"Risk Assessment\"[Mesh] OR \"Biomarkers, Tumor\"[Mesh] OR \"Nomograms\"[Mesh] OR \"Proportional Hazards Models\"[Mesh] OR \"Multivariate Analysis\"[Mesh]) OR (\"associated with\"[ti]) OR (prognos*[tiab] OR predict*[tiab] OR \"risk factor*\"[tiab] OR \"hazard ratio*\"[tiab] OR \"odds ratio*\"[tiab] OR multivariate[tiab] OR multivariable[tiab] OR nomogram*[tiab] OR \"risk stratification\"[tiab] OR \"risk score*\"[tiab] OR \"risk group*\"[tiab] OR biomarker*[tiab])", "issues": [], "display": "8 OR 9 OR 10", "blockKey": "prognostic", "countedAt": "2026-10-28T18:55:46.298Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"Prognosis\"[MeSH Terms:noexp] OR \"Risk Factors\"[MeSH Terms] OR \"Risk Assessment\"[MeSH Terms] OR \"biomarkers, tumor\"[MeSH Terms] OR \"Nomograms\"[MeSH Terms] OR \"Proportional Hazards Models\"[MeSH Terms] OR \"Multivariate Analysis\"[MeSH Terms] OR \"associated with\"[Title] OR \"prognos*\"[Title/Abstract] OR \"predict*\"[Title/Abstract] OR \"risk factor*\"[Title/Abstract] OR \"hazard ratio*\"[Title/Abstract] OR \"odds ratio*\"[Title/Abstract] OR \"multivariate\"[Title/Abstract] OR \"multivariable\"[Title/Abstract] OR \"nomogram*\"[Title/Abstract] OR \"risk stratification\"[Title/Abstract] OR \"risk score*\"[Title/Abstract] OR \"risk group*\"[Title/Abstract] OR \"biomarker*\"[Title/Abstract]", "quotedPhrasesNotFound": [] } }, { "no": 12, "kind": "terms", "refs": [], "count": 1007392, "query": "\"Neoplasm Recurrence, Local\"[Mesh] OR \"Recurrence\"[Mesh:NoExp] OR \"Disease Progression\"[Mesh] OR \"Survival Analysis\"[Mesh] OR \"Progression-Free Survival\"[Mesh] OR \"Cystectomy\"[Mesh] OR \"Treatment Failure\"[Mesh] OR \"Drug Resistance, Neoplasm\"[Mesh]", "issues": [], "display": "\"Neoplasm Recurrence, Local\"[Mesh] OR \"Recurrence\"[Mesh:NoExp] OR \"Disease Progression\"[Mesh] OR \"Survival Analysis\"[Mesh] OR \"Progression-Free Survival\"[Mesh] OR \"Cystectomy\"[Mesh] OR \"Treatment Failure\"[Mesh] OR \"Drug Resistance, Neoplasm\"[Mesh]", "termIds": [ "outcome-mesh-0", "outcome-mesh-1", "outcome-mesh-2", "outcome-mesh-3", "outcome-mesh-4", "outcome-mesh-5", "outcome-mesh-6", "outcome-mesh-7" ], "blockKey": "outcome", "countedAt": "2026-10-28T18:55:46.863Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"neoplasm recurrence, local\"[MeSH Terms] OR \"Recurrence\"[MeSH Terms:noexp] OR \"Disease Progression\"[MeSH Terms] OR \"Survival Analysis\"[MeSH Terms] OR \"Progression-Free Survival\"[MeSH Terms] OR \"Cystectomy\"[MeSH Terms] OR \"Treatment Failure\"[MeSH Terms] OR \"drug resistance, neoplasm\"[MeSH Terms]", "quotedPhrasesNotFound": [] } }, { "no": 13, "kind": "terms", "refs": [], "count": 3941252, "query": "recurren*[tiab] OR relapse*[tiab] OR progression[tiab] OR \"muscle invasion\"[tiab] OR upstaging[tiab] OR survival[tiab] OR mortality[tiab] OR cystectom*[tiab] OR \"BCG unresponsive*\"[tiab] OR \"BCG refractory\"[tiab] OR \"BCG failure*\"[tiab] OR \"BCG relapsing\"[tiab] OR \"treatment failure\"[tiab]", "issues": [], "display": "recurren*[tiab] OR relapse*[tiab] OR progression[tiab] OR \"muscle invasion\"[tiab] OR upstaging[tiab] OR survival[tiab] OR mortality[tiab] OR cystectom*[tiab] OR \"BCG unresponsive*\"[tiab] OR \"BCG refractory\"[tiab] OR \"BCG failure*\"[tiab] OR \"BCG relapsing\"[tiab] OR \"treatment failure\"[tiab]", "termIds": [ "outcome-text-0", "outcome-text-1", "outcome-text-2", "outcome-text-3", "outcome-text-4", "outcome-text-5", "outcome-text-6", "outcome-text-7", "outcome-text-8", "outcome-text-9", "outcome-text-10", "outcome-text-11", "outcome-text-12" ], "blockKey": "outcome", "countedAt": "2026-10-28T18:55:49.591Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"recurren*\"[Title/Abstract] OR \"relapse*\"[Title/Abstract] OR \"progression\"[Title/Abstract] OR \"muscle invasion\"[Title/Abstract] OR \"upstaging\"[Title/Abstract] OR \"survival\"[Title/Abstract] OR \"mortality\"[Title/Abstract] OR \"cystectom*\"[Title/Abstract] OR \"bcg unresponsive*\"[Title/Abstract] OR \"BCG refractory\"[Title/Abstract] OR \"bcg failure*\"[Title/Abstract] OR \"BCG relapsing\"[Title/Abstract] OR \"treatment failure\"[Title/Abstract]", "quotedPhrasesNotFound": [] } }, { "no": 14, "kind": "block", "refs": [ 12, 13 ], "count": 4250666, "query": "(\"Neoplasm Recurrence, Local\"[Mesh] OR \"Recurrence\"[Mesh:NoExp] OR \"Disease Progression\"[Mesh] OR \"Survival Analysis\"[Mesh] OR \"Progression-Free Survival\"[Mesh] OR \"Cystectomy\"[Mesh] OR \"Treatment Failure\"[Mesh] OR \"Drug Resistance, Neoplasm\"[Mesh]) OR (recurren*[tiab] OR relapse*[tiab] OR progression[tiab] OR \"muscle invasion\"[tiab] OR upstaging[tiab] OR survival[tiab] OR mortality[tiab] OR cystectom*[tiab] OR \"BCG unresponsive*\"[tiab] OR \"BCG refractory\"[tiab] OR \"BCG failure*\"[tiab] OR \"BCG relapsing\"[tiab] OR \"treatment failure\"[tiab])", "issues": [], "display": "12 OR 13", "blockKey": "outcome", "countedAt": "2026-10-28T18:55:47.590Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"neoplasm recurrence, local\"[MeSH Terms] OR \"Recurrence\"[MeSH Terms:noexp] OR \"Disease Progression\"[MeSH Terms] OR \"Survival Analysis\"[MeSH Terms] OR \"Progression-Free Survival\"[MeSH Terms] OR \"Cystectomy\"[MeSH Terms] OR \"Treatment Failure\"[MeSH Terms] OR \"drug resistance, neoplasm\"[MeSH Terms] OR \"recurren*\"[Title/Abstract] OR \"relapse*\"[Title/Abstract] OR \"progression\"[Title/Abstract] OR \"muscle invasion\"[Title/Abstract] OR \"upstaging\"[Title/Abstract] OR \"survival\"[Title/Abstract] OR \"mortality\"[Title/Abstract] OR \"cystectom*\"[Title/Abstract] OR \"bcg unresponsive*\"[Title/Abstract] OR \"BCG refractory\"[Title/Abstract] OR \"bcg failure*\"[Title/Abstract] OR \"BCG relapsing\"[Title/Abstract] OR \"Treatment Failure\"[Title/Abstract]", "quotedPhrasesNotFound": [] } }, { "no": 15, "kind": "combine", "refs": [ 3, 7, 11, 14 ], "count": 7885, "query": "((\"Urinary Bladder Neoplasms\"[Mesh] OR \"Carcinoma, Transitional Cell\"[Mesh]) OR (\"bladder cancer*\"[tiab] OR \"bladder tumor*\"[tiab] OR \"bladder tumour*\"[tiab] OR \"bladder neoplasm*\"[tiab] OR \"bladder carcinoma*\"[tiab] OR \"urothelial carcinoma*\"[tiab] OR \"urothelial cancer*\"[tiab] OR \"transitional cell carcinoma*\"[tiab] OR NMIBC[tiab])) AND ((\"Carcinoma in Situ\"[Mesh] OR \"BCG Vaccine\"[Mesh] OR \"Administration, Intravesical\"[Mesh]) OR (\"non-muscle invasive\"[tiab] OR \"nonmuscle invasive\"[tiab] OR NMIBC[tiab] OR \"superficial bladder\"[tiab:~2] OR \"carcinoma in situ\"[tiab] OR T1G3[tiab] OR pT1[tiab] OR \"stage T1\"[tiab] OR \"T1 bladder\"[tiab:~2] OR BCG[tiab] OR \"Calmette-Guerin\"[tiab] OR intravesical[tiab] OR TURBT[tiab] OR \"transurethral resection\"[tiab]) OR (\"non-muscle invasive\"[ot])) AND ((\"Prognosis\"[Mesh:NoExp] OR \"Risk Factors\"[Mesh] OR \"Risk Assessment\"[Mesh] OR \"Biomarkers, Tumor\"[Mesh] OR \"Nomograms\"[Mesh] OR \"Proportional Hazards Models\"[Mesh] OR \"Multivariate Analysis\"[Mesh]) OR (\"associated with\"[ti]) OR (prognos*[tiab] OR predict*[tiab] OR \"risk factor*\"[tiab] OR \"hazard ratio*\"[tiab] OR \"odds ratio*\"[tiab] OR multivariate[tiab] OR multivariable[tiab] OR nomogram*[tiab] OR \"risk stratification\"[tiab] OR \"risk score*\"[tiab] OR \"risk group*\"[tiab] OR biomarker*[tiab])) AND ((\"Neoplasm Recurrence, Local\"[Mesh] OR \"Recurrence\"[Mesh:NoExp] OR \"Disease Progression\"[Mesh] OR \"Survival Analysis\"[Mesh] OR \"Progression-Free Survival\"[Mesh] OR \"Cystectomy\"[Mesh] OR \"Treatment Failure\"[Mesh] OR \"Drug Resistance, Neoplasm\"[Mesh]) OR (recurren*[tiab] OR relapse*[tiab] OR progression[tiab] OR \"muscle invasion\"[tiab] OR upstaging[tiab] OR survival[tiab] OR mortality[tiab] OR cystectom*[tiab] OR \"BCG unresponsive*\"[tiab] OR \"BCG refractory\"[tiab] OR \"BCG failure*\"[tiab] OR \"BCG relapsing\"[tiab] OR \"treatment failure\"[tiab]))", "issues": [], "display": "3 AND 7 AND 11 AND 14", "countedAt": "2026-10-28T18:55:48.037Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "(\"Urinary Bladder Neoplasms\"[MeSH Terms] OR \"carcinoma, transitional cell\"[MeSH Terms] OR (\"bladder cancer*\"[Title/Abstract] OR \"bladder tumor*\"[Title/Abstract] OR \"bladder tumour*\"[Title/Abstract] OR \"bladder neoplasm*\"[Title/Abstract] OR \"bladder carcinoma*\"[Title/Abstract] OR \"urothelial carcinoma*\"[Title/Abstract] OR \"urothelial cancer*\"[Title/Abstract] OR \"transitional cell carcinoma*\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract])) AND (\"Carcinoma in Situ\"[MeSH Terms] OR \"BCG Vaccine\"[MeSH Terms] OR \"administration, intravesical\"[MeSH Terms] OR (\"non-muscle invasive\"[Title/Abstract] OR \"nonmuscle invasive\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract] OR \"superficial bladder\"[Title/Abstract:~2] OR \"Carcinoma in Situ\"[Title/Abstract] OR \"T1G3\"[Title/Abstract] OR \"pT1\"[Title/Abstract] OR \"stage T1\"[Title/Abstract] OR \"T1 bladder\"[Title/Abstract:~2] OR \"BCG\"[Title/Abstract] OR \"Calmette-Guerin\"[Title/Abstract] OR \"intravesical\"[Title/Abstract] OR \"TURBT\"[Title/Abstract] OR \"transurethral resection\"[Title/Abstract]) OR \"non-muscle invasive\"[Other Term]) AND (\"Prognosis\"[MeSH Terms:noexp] OR \"Risk Factors\"[MeSH Terms] OR \"Risk Assessment\"[MeSH Terms] OR \"biomarkers, tumor\"[MeSH Terms] OR \"Nomograms\"[MeSH Terms] OR \"Proportional Hazards Models\"[MeSH Terms] OR \"Multivariate Analysis\"[MeSH Terms] OR \"associated with\"[Title] OR (\"prognos*\"[Title/Abstract] OR \"predict*\"[Title/Abstract] OR \"risk factor*\"[Title/Abstract] OR \"hazard ratio*\"[Title/Abstract] OR \"odds ratio*\"[Title/Abstract] OR \"multivariate\"[Title/Abstract] OR \"multivariable\"[Title/Abstract] OR \"nomogram*\"[Title/Abstract] OR \"risk stratification\"[Title/Abstract] OR \"risk score*\"[Title/Abstract] OR \"risk group*\"[Title/Abstract] OR \"biomarker*\"[Title/Abstract])) AND (\"neoplasm recurrence, local\"[MeSH Terms] OR \"Recurrence\"[MeSH Terms:noexp] OR \"Disease Progression\"[MeSH Terms] OR \"Survival Analysis\"[MeSH Terms] OR \"Progression-Free Survival\"[MeSH Terms] OR \"Cystectomy\"[MeSH Terms] OR \"Treatment Failure\"[MeSH Terms] OR \"drug resistance, neoplasm\"[MeSH Terms] OR (\"recurren*\"[Title/Abstract] OR \"relapse*\"[Title/Abstract] OR \"progression\"[Title/Abstract] OR \"muscle invasion\"[Title/Abstract] OR \"upstaging\"[Title/Abstract] OR \"survival\"[Title/Abstract] OR \"mortality\"[Title/Abstract] OR \"cystectom*\"[Title/Abstract] OR \"bcg unresponsive*\"[Title/Abstract] OR \"BCG refractory\"[Title/Abstract] OR \"bcg failure*\"[Title/Abstract] OR \"BCG relapsing\"[Title/Abstract] OR \"Treatment Failure\"[Title/Abstract]))", "quotedPhrasesNotFound": [] } }, { "no": 16, "kind": "exclude", "refs": [], "count": 4884955, "query": "\"Comment\"[Publication Type] OR \"Editorial\"[Publication Type] OR \"Letter\"[Publication Type] OR \"Case Reports\"[Publication Type] OR \"Preprint\"[Publication Type]", "issues": [], "display": "\"Comment\"[Publication Type] OR \"Editorial\"[Publication Type] OR \"Letter\"[Publication Type] OR \"Case Reports\"[Publication Type] OR \"Preprint\"[Publication Type]", "countedAt": "2026-10-28T18:00:07.644Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"Comment\"[Publication Type] OR \"Editorial\"[Publication Type] OR \"Letter\"[Publication Type] OR \"Case Reports\"[Publication Type] OR \"Preprint\"[Publication Type]", "quotedPhrasesNotFound": [] } }, { "no": 17, "kind": "not", "refs": [ 15, 16 ], "count": 7458, "query": "(((\"Urinary Bladder Neoplasms\"[Mesh] OR \"Carcinoma, Transitional Cell\"[Mesh]) OR (\"bladder cancer*\"[tiab] OR \"bladder tumor*\"[tiab] OR \"bladder tumour*\"[tiab] OR \"bladder neoplasm*\"[tiab] OR \"bladder carcinoma*\"[tiab] OR \"urothelial carcinoma*\"[tiab] OR \"urothelial cancer*\"[tiab] OR \"transitional cell carcinoma*\"[tiab] OR NMIBC[tiab])) AND ((\"Carcinoma in Situ\"[Mesh] OR \"BCG Vaccine\"[Mesh] OR \"Administration, Intravesical\"[Mesh]) OR (\"non-muscle invasive\"[tiab] OR \"nonmuscle invasive\"[tiab] OR NMIBC[tiab] OR \"superficial bladder\"[tiab:~2] OR \"carcinoma in situ\"[tiab] OR T1G3[tiab] OR pT1[tiab] OR \"stage T1\"[tiab] OR \"T1 bladder\"[tiab:~2] OR BCG[tiab] OR \"Calmette-Guerin\"[tiab] OR intravesical[tiab] OR TURBT[tiab] OR \"transurethral resection\"[tiab]) OR (\"non-muscle invasive\"[ot])) AND ((\"Prognosis\"[Mesh:NoExp] OR \"Risk Factors\"[Mesh] OR \"Risk Assessment\"[Mesh] OR \"Biomarkers, Tumor\"[Mesh] OR \"Nomograms\"[Mesh] OR \"Proportional Hazards Models\"[Mesh] OR \"Multivariate Analysis\"[Mesh]) OR (\"associated with\"[ti]) OR (prognos*[tiab] OR predict*[tiab] OR \"risk factor*\"[tiab] OR \"hazard ratio*\"[tiab] OR \"odds ratio*\"[tiab] OR multivariate[tiab] OR multivariable[tiab] OR nomogram*[tiab] OR \"risk stratification\"[tiab] OR \"risk score*\"[tiab] OR \"risk group*\"[tiab] OR biomarker*[tiab])) AND ((\"Neoplasm Recurrence, Local\"[Mesh] OR \"Recurrence\"[Mesh:NoExp] OR \"Disease Progression\"[Mesh] OR \"Survival Analysis\"[Mesh] OR \"Progression-Free Survival\"[Mesh] OR \"Cystectomy\"[Mesh] OR \"Treatment Failure\"[Mesh] OR \"Drug Resistance, Neoplasm\"[Mesh]) OR (recurren*[tiab] OR relapse*[tiab] OR progression[tiab] OR \"muscle invasion\"[tiab] OR upstaging[tiab] OR survival[tiab] OR mortality[tiab] OR cystectom*[tiab] OR \"BCG unresponsive*\"[tiab] OR \"BCG refractory\"[tiab] OR \"BCG failure*\"[tiab] OR \"BCG relapsing\"[tiab] OR \"treatment failure\"[tiab]))) NOT (\"Comment\"[Publication Type] OR \"Editorial\"[Publication Type] OR \"Letter\"[Publication Type] OR \"Case Reports\"[Publication Type] OR \"Preprint\"[Publication Type])", "issues": [], "display": "15 NOT 16", "countedAt": "2026-10-28T18:55:50.709Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "((\"Urinary Bladder Neoplasms\"[MeSH Terms] OR \"carcinoma, transitional cell\"[MeSH Terms] OR (\"bladder cancer*\"[Title/Abstract] OR \"bladder tumor*\"[Title/Abstract] OR \"bladder tumour*\"[Title/Abstract] OR \"bladder neoplasm*\"[Title/Abstract] OR \"bladder carcinoma*\"[Title/Abstract] OR \"urothelial carcinoma*\"[Title/Abstract] OR \"urothelial cancer*\"[Title/Abstract] OR \"transitional cell carcinoma*\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract])) AND (\"Carcinoma in Situ\"[MeSH Terms] OR \"BCG Vaccine\"[MeSH Terms] OR \"administration, intravesical\"[MeSH Terms] OR (\"non-muscle invasive\"[Title/Abstract] OR \"nonmuscle invasive\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract] OR \"superficial bladder\"[Title/Abstract:~2] OR \"Carcinoma in Situ\"[Title/Abstract] OR \"T1G3\"[Title/Abstract] OR \"pT1\"[Title/Abstract] OR \"stage T1\"[Title/Abstract] OR \"T1 bladder\"[Title/Abstract:~2] OR \"BCG\"[Title/Abstract] OR \"Calmette-Guerin\"[Title/Abstract] OR \"intravesical\"[Title/Abstract] OR \"TURBT\"[Title/Abstract] OR \"transurethral resection\"[Title/Abstract]) OR \"non-muscle invasive\"[Other Term]) AND (\"Prognosis\"[MeSH Terms:noexp] OR \"Risk Factors\"[MeSH Terms] OR \"Risk Assessment\"[MeSH Terms] OR \"biomarkers, tumor\"[MeSH Terms] OR \"Nomograms\"[MeSH Terms] OR \"Proportional Hazards Models\"[MeSH Terms] OR \"Multivariate Analysis\"[MeSH Terms] OR \"associated with\"[Title] OR (\"prognos*\"[Title/Abstract] OR \"predict*\"[Title/Abstract] OR \"risk factor*\"[Title/Abstract] OR \"hazard ratio*\"[Title/Abstract] OR \"odds ratio*\"[Title/Abstract] OR \"multivariate\"[Title/Abstract] OR \"multivariable\"[Title/Abstract] OR \"nomogram*\"[Title/Abstract] OR \"risk stratification\"[Title/Abstract] OR \"risk score*\"[Title/Abstract] OR \"risk group*\"[Title/Abstract] OR \"biomarker*\"[Title/Abstract])) AND (\"neoplasm recurrence, local\"[MeSH Terms] OR \"Recurrence\"[MeSH Terms:noexp] OR \"Disease Progression\"[MeSH Terms] OR \"Survival Analysis\"[MeSH Terms] OR \"Progression-Free Survival\"[MeSH Terms] OR \"Cystectomy\"[MeSH Terms] OR \"Treatment Failure\"[MeSH Terms] OR \"drug resistance, neoplasm\"[MeSH Terms] OR (\"recurren*\"[Title/Abstract] OR \"relapse*\"[Title/Abstract] OR \"progression\"[Title/Abstract] OR \"muscle invasion\"[Title/Abstract] OR \"upstaging\"[Title/Abstract] OR \"survival\"[Title/Abstract] OR \"mortality\"[Title/Abstract] OR \"cystectom*\"[Title/Abstract] OR \"bcg unresponsive*\"[Title/Abstract] OR \"BCG refractory\"[Title/Abstract] OR \"bcg failure*\"[Title/Abstract] OR \"BCG relapsing\"[Title/Abstract] OR \"Treatment Failure\"[Title/Abstract]))) NOT (\"Comment\"[Publication Type] OR \"Editorial\"[Publication Type] OR \"Letter\"[Publication Type] OR \"Case Reports\"[Publication Type] OR \"Preprint\"[Publication Type])", "quotedPhrasesNotFound": [] } }, { "no": 18, "kind": "limits", "refs": [ 17 ], "count": 6907, "query": "((((\"Urinary Bladder Neoplasms\"[Mesh] OR \"Carcinoma, Transitional Cell\"[Mesh]) OR (\"bladder cancer*\"[tiab] OR \"bladder tumor*\"[tiab] OR \"bladder tumour*\"[tiab] OR \"bladder neoplasm*\"[tiab] OR \"bladder carcinoma*\"[tiab] OR \"urothelial carcinoma*\"[tiab] OR \"urothelial cancer*\"[tiab] OR \"transitional cell carcinoma*\"[tiab] OR NMIBC[tiab])) AND ((\"Carcinoma in Situ\"[Mesh] OR \"BCG Vaccine\"[Mesh] OR \"Administration, Intravesical\"[Mesh]) OR (\"non-muscle invasive\"[tiab] OR \"nonmuscle invasive\"[tiab] OR NMIBC[tiab] OR \"superficial bladder\"[tiab:~2] OR \"carcinoma in situ\"[tiab] OR T1G3[tiab] OR pT1[tiab] OR \"stage T1\"[tiab] OR \"T1 bladder\"[tiab:~2] OR BCG[tiab] OR \"Calmette-Guerin\"[tiab] OR intravesical[tiab] OR TURBT[tiab] OR \"transurethral resection\"[tiab]) OR (\"non-muscle invasive\"[ot])) AND ((\"Prognosis\"[Mesh:NoExp] OR \"Risk Factors\"[Mesh] OR \"Risk Assessment\"[Mesh] OR \"Biomarkers, Tumor\"[Mesh] OR \"Nomograms\"[Mesh] OR \"Proportional Hazards Models\"[Mesh] OR \"Multivariate Analysis\"[Mesh]) OR (\"associated with\"[ti]) OR (prognos*[tiab] OR predict*[tiab] OR \"risk factor*\"[tiab] OR \"hazard ratio*\"[tiab] OR \"odds ratio*\"[tiab] OR multivariate[tiab] OR multivariable[tiab] OR nomogram*[tiab] OR \"risk stratification\"[tiab] OR \"risk score*\"[tiab] OR \"risk group*\"[tiab] OR biomarker*[tiab])) AND ((\"Neoplasm Recurrence, Local\"[Mesh] OR \"Recurrence\"[Mesh:NoExp] OR \"Disease Progression\"[Mesh] OR \"Survival Analysis\"[Mesh] OR \"Progression-Free Survival\"[Mesh] OR \"Cystectomy\"[Mesh] OR \"Treatment Failure\"[Mesh] OR \"Drug Resistance, Neoplasm\"[Mesh]) OR (recurren*[tiab] OR relapse*[tiab] OR progression[tiab] OR \"muscle invasion\"[tiab] OR upstaging[tiab] OR survival[tiab] OR mortality[tiab] OR cystectom*[tiab] OR \"BCG unresponsive*\"[tiab] OR \"BCG refractory\"[tiab] OR \"BCG failure*\"[tiab] OR \"BCG relapsing\"[tiab] OR \"treatment failure\"[tiab]))) NOT (\"Comment\"[Publication Type] OR \"Editorial\"[Publication Type] OR \"Letter\"[Publication Type] OR \"Case Reports\"[Publication Type] OR \"Preprint\"[Publication Type])) AND english[la]", "issues": [], "display": "17 AND english[la]", "countedAt": "2026-10-28T18:55:49.070Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "(((\"Urinary Bladder Neoplasms\"[MeSH Terms] OR \"carcinoma, transitional cell\"[MeSH Terms] OR (\"bladder cancer*\"[Title/Abstract] OR \"bladder tumor*\"[Title/Abstract] OR \"bladder tumour*\"[Title/Abstract] OR \"bladder neoplasm*\"[Title/Abstract] OR \"bladder carcinoma*\"[Title/Abstract] OR \"urothelial carcinoma*\"[Title/Abstract] OR \"urothelial cancer*\"[Title/Abstract] OR \"transitional cell carcinoma*\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract])) AND (\"Carcinoma in Situ\"[MeSH Terms] OR \"BCG Vaccine\"[MeSH Terms] OR \"administration, intravesical\"[MeSH Terms] OR (\"non-muscle invasive\"[Title/Abstract] OR \"nonmuscle invasive\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract] OR \"superficial bladder\"[Title/Abstract:~2] OR \"Carcinoma in Situ\"[Title/Abstract] OR \"T1G3\"[Title/Abstract] OR \"pT1\"[Title/Abstract] OR \"stage T1\"[Title/Abstract] OR \"T1 bladder\"[Title/Abstract:~2] OR \"BCG\"[Title/Abstract] OR \"Calmette-Guerin\"[Title/Abstract] OR \"intravesical\"[Title/Abstract] OR \"TURBT\"[Title/Abstract] OR \"transurethral resection\"[Title/Abstract]) OR \"non-muscle invasive\"[Other Term]) AND (\"Prognosis\"[MeSH Terms:noexp] OR \"Risk Factors\"[MeSH Terms] OR \"Risk Assessment\"[MeSH Terms] OR \"biomarkers, tumor\"[MeSH Terms] OR \"Nomograms\"[MeSH Terms] OR \"Proportional Hazards Models\"[MeSH Terms] OR \"Multivariate Analysis\"[MeSH Terms] OR \"associated with\"[Title] OR (\"prognos*\"[Title/Abstract] OR \"predict*\"[Title/Abstract] OR \"risk factor*\"[Title/Abstract] OR \"hazard ratio*\"[Title/Abstract] OR \"odds ratio*\"[Title/Abstract] OR \"multivariate\"[Title/Abstract] OR \"multivariable\"[Title/Abstract] OR \"nomogram*\"[Title/Abstract] OR \"risk stratification\"[Title/Abstract] OR \"risk score*\"[Title/Abstract] OR \"risk group*\"[Title/Abstract] OR \"biomarker*\"[Title/Abstract])) AND (\"neoplasm recurrence, local\"[MeSH Terms] OR \"Recurrence\"[MeSH Terms:noexp] OR \"Disease Progression\"[MeSH Terms] OR \"Survival Analysis\"[MeSH Terms] OR \"Progression-Free Survival\"[MeSH Terms] OR \"Cystectomy\"[MeSH Terms] OR \"Treatment Failure\"[MeSH Terms] OR \"drug resistance, neoplasm\"[MeSH Terms] OR (\"recurren*\"[Title/Abstract] OR \"relapse*\"[Title/Abstract] OR \"progression\"[Title/Abstract] OR \"muscle invasion\"[Title/Abstract] OR \"upstaging\"[Title/Abstract] OR \"survival\"[Title/Abstract] OR \"mortality\"[Title/Abstract] OR \"cystectom*\"[Title/Abstract] OR \"bcg unresponsive*\"[Title/Abstract] OR \"BCG refractory\"[Title/Abstract] OR \"bcg failure*\"[Title/Abstract] OR \"BCG relapsing\"[Title/Abstract] OR \"Treatment Failure\"[Title/Abstract]))) NOT (\"Comment\"[Publication Type] OR \"Editorial\"[Publication Type] OR \"Letter\"[Publication Type] OR \"Case Reports\"[Publication Type] OR \"Preprint\"[Publication Type])) AND \"english\"[Language]", "quotedPhrasesNotFound": [] } }, { "no": 19, "kind": "terms", "refs": [], "count": 593438, "query": "\"high risk\"[tiab] OR \"high grade\"[tiab] OR \"highest risk\"[tiab]", "issues": [], "display": "\"high risk\"[tiab] OR \"high grade\"[tiab] OR \"highest risk\"[tiab]", "termIds": [ "highrisk-text-0", "highrisk-text-1", "highrisk-text-2" ], "blockKey": "highrisk", "countedAt": "2026-10-28T18:55:49.174Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"high risk\"[Title/Abstract] OR \"high grade\"[Title/Abstract] OR \"highest risk\"[Title/Abstract]", "quotedPhrasesNotFound": [] } } ], "finalQuery": "((((\"Urinary Bladder Neoplasms\"[Mesh] OR \"Carcinoma, Transitional Cell\"[Mesh]) OR (\"bladder cancer*\"[tiab] OR \"bladder tumor*\"[tiab] OR \"bladder tumour*\"[tiab] OR \"bladder neoplasm*\"[tiab] OR \"bladder carcinoma*\"[tiab] OR \"urothelial carcinoma*\"[tiab] OR \"urothelial cancer*\"[tiab] OR \"transitional cell carcinoma*\"[tiab] OR NMIBC[tiab])) AND ((\"Carcinoma in Situ\"[Mesh] OR \"BCG Vaccine\"[Mesh] OR \"Administration, Intravesical\"[Mesh]) OR (\"non-muscle invasive\"[tiab] OR \"nonmuscle invasive\"[tiab] OR NMIBC[tiab] OR \"superficial bladder\"[tiab:~2] OR \"carcinoma in situ\"[tiab] OR T1G3[tiab] OR pT1[tiab] OR \"stage T1\"[tiab] OR \"T1 bladder\"[tiab:~2] OR BCG[tiab] OR \"Calmette-Guerin\"[tiab] OR intravesical[tiab] OR TURBT[tiab] OR \"transurethral resection\"[tiab]) OR (\"non-muscle invasive\"[ot])) AND ((\"Prognosis\"[Mesh:NoExp] OR \"Risk Factors\"[Mesh] OR \"Risk Assessment\"[Mesh] OR \"Biomarkers, Tumor\"[Mesh] OR \"Nomograms\"[Mesh] OR \"Proportional Hazards Models\"[Mesh] OR \"Multivariate Analysis\"[Mesh]) OR (\"associated with\"[ti]) OR (prognos*[tiab] OR predict*[tiab] OR \"risk factor*\"[tiab] OR \"hazard ratio*\"[tiab] OR \"odds ratio*\"[tiab] OR multivariate[tiab] OR multivariable[tiab] OR nomogram*[tiab] OR \"risk stratification\"[tiab] OR \"risk score*\"[tiab] OR \"risk group*\"[tiab] OR biomarker*[tiab])) AND ((\"Neoplasm Recurrence, Local\"[Mesh] OR \"Recurrence\"[Mesh:NoExp] OR \"Disease Progression\"[Mesh] OR \"Survival Analysis\"[Mesh] OR \"Progression-Free Survival\"[Mesh] OR \"Cystectomy\"[Mesh] OR \"Treatment Failure\"[Mesh] OR \"Drug Resistance, Neoplasm\"[Mesh]) OR (recurren*[tiab] OR relapse*[tiab] OR progression[tiab] OR \"muscle invasion\"[tiab] OR upstaging[tiab] OR survival[tiab] OR mortality[tiab] OR cystectom*[tiab] OR \"BCG unresponsive*\"[tiab] OR \"BCG refractory\"[tiab] OR \"BCG failure*\"[tiab] OR \"BCG relapsing\"[tiab] OR \"treatment failure\"[tiab]))) NOT (\"Comment\"[Publication Type] OR \"Editorial\"[Publication Type] OR \"Letter\"[Publication Type] OR \"Case Reports\"[Publication Type] OR \"Preprint\"[Publication Type])) AND english[la]", "finalCount": 6907, "issues": [ { "code": "field_subsumed", "level": "info", "termId": "nmi-text-0", "message": "\"non-muscle invasive\"[ot] adds almost nothing to \"non-muscle invasive\"[tiab], which already searches the title, the abstract and the keywords.", "blockKey": "nmi" }, { "code": "language_limit", "level": "warning", "message": "Language limit (english): it can remove relevant studies; report and justify it." }, { "code": "publication_type_limit", "level": "warning", "message": "Publication types excluded with NOT (Comment, Editorial, Letter, Case Reports, Preprint): report and justify the exclusion." } ], "recall": null, "seeds": [], "reference": null, "records": [ { "pmid": "42946445", "year": "2026", "title": "High Ubiquitin-like Protein 3 Expression Is Associated With Prolonged Recurrence-free Survival in Non-muscle-invasive Bladder Cancer.", "authors": "Sano A, Tamura K, Sakai Y et al.", "journal": "Anticancer research", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42927820", "year": "2026", "title": "Elevated GANAB fuels PD-1/PD-L1 checkpoint-mediated immune escape by maintaining PD-L1 stability in bladder cancer.", "authors": "Jin X, Xu Y, Ling K et al.", "journal": "Cellular signalling", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42923499", "year": "2026", "title": "Assessment of muscularis propria invasion in urothelial bladder carcinoma using continuous-time random walk and stretched-exponential models: Comparison with VI-RADS and apparent diffusion coefficient.", "authors": "Wu Y, Zhu X, Zhou X et al.", "journal": "Experimental and therapeutic medicine", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42923287", "year": "2026", "title": "Research progress and clinical translation prospects of multiple urinary biomarkers in non-invasive diagnosis of urothelial carcinoma.", "authors": "Li S, Wang L, Gao B", "journal": "Frontiers in oncology", "publicationTypes": [ "Journal Article", "Review" ] }, { "pmid": "42910392", "year": "2026", "title": "Deciphering the clinical significance of Beclin-1 and Bcl-2 in urothelial carcinoma of bladder.", "authors": "Niharika, Tripathi S, Singhai A et al.", "journal": "Indian journal of urology : IJU : journal of the Urological Society of India", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42909595", "year": "2026", "title": "Timing of FDA-Defined Adequate BCG Therapy and Oncologic Outcomes in High-Risk Non-Muscle-Invasive Bladder Cancer.", "authors": "Abou Chakra M, Myers AA, Duquesne I et al.", "journal": "Urology practice", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42908741", "year": "2026", "title": "Population-specific molecular features and clinical significance of urinary tumor DNA mutations in Chinese patients with newly diagnosed non-muscle-invasive bladder cancer.", "authors": "Sun Z, Xie R, Pan J et al.", "journal": "Frontiers in oncology", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42903929", "year": "2026", "title": "FGFR3 mRNA expression in urothelial bladder cancer: Associations with tumor phenotype without prognostic impact.", "authors": "Pakovski K, Markova M, Janchulev J et al.", "journal": "Central European journal of urology", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42903705", "year": "2026", "title": "Reprogramming innate immune memory in bladder cancer: the proposed bone marrow-bladder axis and next-generation BCG-based immunotherapies.", "authors": "Yang M, Guo Y, Shen YZ et al.", "journal": "Frontiers in immunology", "publicationTypes": [ "Journal Article", "Review", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "42901828", "year": "2026", "title": "Clinical Outcomes of Bladder-sparing Management Versus Early Radical Cystectomy in cT1 Micropapillary Bladder Cancer: A Systematic Review and Meta-analysis.", "authors": "Patel SR, Rauf M, Geng Y et al.", "journal": "European urology oncology", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42898355", "year": "2026", "title": "Prognosis and tumor grading in bladder urothelial carcinomas with intratumoral grade heterogeneity.", "authors": "Alkan GV, Doğan K, Türk Alkan M et al.", "journal": "Pathology oncology research : POR", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42891336", "year": "2026", "title": "Microbiome-urothelium crosstalk in bladder cancer: From dysbiosis to clinical translation.", "authors": "Xu H, Li Z, Yang L et al.", "journal": "iMetaOmics", "publicationTypes": [ "Journal Article", "Review" ] }, { "pmid": "42889172", "year": "2026", "title": "NEITHER study: NICE versus EAU inconsistent triage, expenses and reliability in non-high-risk non-muscle invasive bladder cancer surveillance.", "authors": "Ibrahim Y, Ribeiro L, Heelan M et al.", "journal": "BJUI compass", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42889117", "year": "2026", "title": "Risk factors for recurrence after initial transurethral resection of bladder tumor in patients with non-muscle-invasive bladder cancer.", "authors": "Yuan F, Li X, Zhang J et al.", "journal": "Frontiers in oncology", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42885914", "year": "2026", "title": "Enhanced detection of bladder cancer using machine learning analysis of routine urinary sediment data.", "authors": "Okuyama R, Horiuchi H, Nakamura M et al.", "journal": "Clinical chemistry and laboratory medicine", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42881413", "year": "2026", "title": "Bladder cancer organoids in precision medicine: bridging basic science, clinical therapeutics and drug development.", "authors": "Zhong X, Wang G, Zhang H et al.", "journal": "Cancer cell international", "publicationTypes": [ "Journal Article", "Review" ] }, { "pmid": "42880421", "year": "2026", "title": "Diet quality and prognosis in patients with non-muscle invasive bladder cancer: the Be-Well Study.", "authors": "Ergas IJ, Zimbalist A, Haque R et al.", "journal": "Urology", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42869744", "year": "2026", "title": "Contemporary Oncological and Patient-reported Outcomes of Intravesical Gemcitabine/Docetaxel in BCG-unresponsive Non-muscle-invasive Bladder Cancer: A Multi-institutional Prospective Cohort Study.", "authors": "Tan YG, Dudinec J, Kamat AM et al.", "journal": "European urology focus", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42866931", "year": "2026", "title": "Urinary Extracellular Vesicle-Associated EphA2 Predicts Intravesical Recurrence in Bladder Cancer.", "authors": "Hashimoto M, Tomiyama E, Inoki L et al.", "journal": "International journal of urology : official journal of the Japanese Urological Association", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42866795", "year": "2026", "title": "An interpretable LASSO-Boruta nomogram for non-muscle-invasive bladder cancer recurrence after intravesical instillation.", "authors": "Li B, Ji G, Wang W et al.", "journal": "Translational andrology and urology", "publicationTypes": [ "Journal Article" ] } ], "error": null, "createdAt": "2026-10-28T18:54:20.675Z", "finishedAt": "2026-10-28T18:55:51.329Z", "versionNo": 1 }, "versions": [ { "versionNo": 1, "createdBy": "ai", "strategy": { "notes": [ "NMIBC has no dedicated MeSH heading to rely on, so the condition is built from two required blocks: bladder or urothelial cancer, ANDed with non-muscle-invasive, BCG or intravesical terms. This excludes muscle-invasive-only studies while keeping NMIBC studies that do not use the abbreviation.", "The high-risk block is optional. Many studies of high-risk disease describe it only as T1, high-grade, carcinoma in situ or BCG-treated, which the non-muscle-invasive block already covers. Add the high-risk block if the result set is too large.", "Prognosis is not exploded, to avoid pulling in the very broad Treatment Outcome subtree.", "The bare word predict* and the title phrase 'associated with' are included for sensitivity; check their line counts and drop them if they add too much noise.", "The question does not restrict the age group of the population, so no adult filter is applied; nearly all NMIBC studies involve adults." ], "blocks": [ { "key": "bladder", "role": "condition", "label": "Bladder or urothelial cancer", "terms": [ { "id": "bladder-mesh-0", "kind": "mesh", "label": "Urinary Bladder Neoplasms", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Main heading for bladder cancer, under which NMIBC studies are indexed.", "validation": { "ui": "D001749", "label": "Urinary Bladder Neoplasms", "status": "valid" } }, { "id": "bladder-mesh-1", "kind": "mesh", "label": "Carcinoma, Transitional Cell", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Histological heading for urothelial carcinoma, often given to NMIBC records.", "validation": { "ui": "D002295", "label": "Carcinoma, Transitional Cell", "status": "valid" } }, { "id": "bladder-text-0", "kind": "text", "text": "bladder cancer", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Most common author wording for the disease." }, { "id": "bladder-text-1", "kind": "text", "text": "bladder tumor", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "American spelling variant for bladder tumours." }, { "id": "bladder-text-2", "kind": "text", "text": "bladder tumour", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "British spelling variant." }, { "id": "bladder-text-3", "kind": "text", "text": "bladder neoplasm", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Entry-term wording of the heading." }, { "id": "bladder-text-4", "kind": "text", "text": "bladder carcinoma", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Common synonym for bladder cancer." }, { "id": "bladder-text-5", "kind": "text", "text": "urothelial carcinoma", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Histological name used for NMIBC." }, { "id": "bladder-text-6", "kind": "text", "text": "urothelial cancer", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Variant of urothelial carcinoma." }, { "id": "bladder-text-7", "kind": "text", "text": "transitional cell carcinoma", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Older histological name still used in older studies." }, { "id": "bladder-text-8", "kind": "text", "text": "NMIBC", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Standard abbreviation that sometimes stands alone in titles and keywords." }, { "id": "bladder-mesh-0-et5", "kind": "text", "text": "Cancer of Bladder", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept \"Urinary Bladder Cancer\" under the MeSH heading \"Urinary Bladder Neoplasms\" (D001749)" }, { "id": "bladder-mesh-0-et6", "kind": "text", "text": "Cancer of the Bladder", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept \"Urinary Bladder Cancer\" under the MeSH heading \"Urinary Bladder Neoplasms\" (D001749)" }, { "id": "bladder-mesh-0-et7", "kind": "text", "text": "Malignant Tumor of Urinary Bladder", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept \"Urinary Bladder Cancer\" under the MeSH heading \"Urinary Bladder Neoplasms\" (D001749)" } ], "required": true }, { "key": "nmi", "role": "condition", "label": "Non-muscle-invasive disease", "terms": [ { "id": "nmi-mesh-0", "kind": "mesh", "label": "Carcinoma in Situ", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Carcinoma in situ is a defining high-risk NMIBC category.", "validation": { "ui": "D002278", "label": "Carcinoma in Situ", "status": "valid" } }, { "id": "nmi-mesh-1", "kind": "mesh", "label": "BCG Vaccine", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Intravesical BCG is the standard treatment of high-risk NMIBC, so BCG-treated cohorts are this population.", "validation": { "ui": "D001500", "label": "BCG Vaccine", "status": "valid" } }, { "id": "nmi-mesh-2", "kind": "mesh", "label": "Administration, Intravesical", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Intravesical therapy is used only in non-muscle-invasive disease.", "validation": { "ui": "D000283", "label": "Administration, Intravesical", "status": "valid" } }, { "id": "nmi-text-0", "kind": "text", "text": "non-muscle invasive", "fields": [ "tiab", "ot" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Core descriptor of the disease stage; the hyphen also matches the spaced form." }, { "id": "nmi-text-1", "kind": "text", "text": "nonmuscle invasive", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Joined spelling variant." }, { "id": "nmi-text-2", "kind": "text", "text": "NMIBC", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Standard abbreviation for non-muscle-invasive bladder cancer." }, { "id": "nmi-text-3", "kind": "text", "text": "superficial bladder", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": 2, "rationale": "Older term for NMIBC (superficial bladder cancer or tumours)." }, { "id": "nmi-text-4", "kind": "text", "text": "carcinoma in situ", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "High-risk NMIBC subtype, often abbreviated CIS in abstracts." }, { "id": "nmi-text-5", "kind": "text", "text": "T1G3", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Classic label for high-risk T1 high-grade tumours." }, { "id": "nmi-text-6", "kind": "text", "text": "pT1", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Pathological stage label used for T1 disease." }, { "id": "nmi-text-7", "kind": "text", "text": "stage T1", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Wording for T1 tumours, a high-risk NMIBC category." }, { "id": "nmi-text-8", "kind": "text", "text": "T1 bladder", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": 2, "rationale": "Catches T1 bladder cancer or tumour phrasing." }, { "id": "nmi-text-9", "kind": "text", "text": "BCG", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Abbreviation for bacillus Calmette-Guerin, the standard adjuvant therapy." }, { "id": "nmi-text-10", "kind": "text", "text": "Calmette-Guerin", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Spelled-out BCG name." }, { "id": "nmi-text-11", "kind": "text", "text": "intravesical", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Intravesical therapy is specific to non-muscle-invasive disease." }, { "id": "nmi-text-12", "kind": "text", "text": "TURBT", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Abbreviation for transurethral resection of bladder tumour, the initial treatment of NMIBC." }, { "id": "nmi-text-13", "kind": "text", "text": "transurethral resection", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Initial treatment of NMIBC, used to describe the cohorts." }, { "id": "nmi-mesh-1-et1", "kind": "text", "text": "Calmette's Vaccine", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"BCG Vaccine\" (D001500)" }, { "id": "nmi-mesh-2-et1", "kind": "text", "text": "Bladder Drug Administration", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Administration, Intravesical\" (D000283)" } ], "required": true }, { "key": "highrisk", "role": "population", "label": "High-risk category", "terms": [ { "id": "highrisk-text-0", "kind": "text", "text": "high risk", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Risk-group label used for these cohorts; also matches very high risk." }, { "id": "highrisk-text-1", "kind": "text", "text": "high grade", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "High-grade tumours define high-risk NMIBC." }, { "id": "highrisk-text-2", "kind": "text", "text": "highest risk", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Alternative risk-group wording." } ], "required": false }, { "key": "prognostic", "role": "exposure", "label": "Prognostic or predictive factors", "terms": [ { "id": "prognostic-mesh-0", "kind": "mesh", "label": "Prognosis", "major": false, "origin": "ai", "enabled": true, "explode": false, "rationale": "Core heading for prognostic studies; not exploded to avoid the very broad Treatment Outcome subtree.", "validation": { "ui": "D011379", "label": "Prognosis", "status": "valid" } }, { "id": "prognostic-mesh-1", "kind": "mesh", "label": "Risk Factors", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Indexes studies of factors associated with outcomes.", "validation": { "ui": "D012307", "label": "Risk Factors", "status": "valid" } }, { "id": "prognostic-mesh-2", "kind": "mesh", "label": "Risk Assessment", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Covers risk stratification and risk scoring tools.", "validation": { "ui": "D018570", "label": "Risk Assessment", "status": "valid" } }, { "id": "prognostic-mesh-3", "kind": "mesh", "label": "Biomarkers, Tumor", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Molecular and tissue markers studied as prognostic factors.", "validation": { "ui": "D014408", "label": "Biomarkers, Tumor", "status": "valid" } }, { "id": "prognostic-mesh-4", "kind": "mesh", "label": "Nomograms", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Prediction tools such as the EORTC and CUETO scoring models.", "validation": { "ui": "D049451", "label": "Nomograms", "status": "valid" } }, { "id": "prognostic-mesh-5", "kind": "mesh", "label": "Proportional Hazards Models", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Cox models are the usual analysis in prognostic factor studies.", "validation": { "ui": "D016016", "label": "Proportional Hazards Models", "status": "valid" } }, { "id": "prognostic-mesh-6", "kind": "mesh", "label": "Multivariate Analysis", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Multivariable analysis identifies independent prognostic factors.", "validation": { "ui": "D015999", "label": "Multivariate Analysis", "status": "valid" } }, { "id": "prognostic-text-0", "kind": "text", "text": "prognos", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Catches prognosis, prognostic and prognosticator." }, { "id": "prognostic-text-1", "kind": "text", "text": "predict", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Catches predictor, predictive and prediction." }, { "id": "prognostic-text-2", "kind": "text", "text": "risk factor", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Standard wording for associated factors." }, { "id": "prognostic-text-3", "kind": "text", "text": "hazard ratio", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Reported effect measure in prognostic studies." }, { "id": "prognostic-text-4", "kind": "text", "text": "odds ratio", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Reported effect measure for binary outcomes such as cystectomy." }, { "id": "prognostic-text-5", "kind": "text", "text": "multivariate", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Signals adjusted analysis of factors." }, { "id": "prognostic-text-6", "kind": "text", "text": "multivariable", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Variant of multivariate." }, { "id": "prognostic-text-7", "kind": "text", "text": "nomogram", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Prediction tools." }, { "id": "prognostic-text-8", "kind": "text", "text": "risk stratification", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Wording for risk-group models." }, { "id": "prognostic-text-9", "kind": "text", "text": "risk score", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Covers EORTC, CUETO and other scoring systems." }, { "id": "prognostic-text-10", "kind": "text", "text": "risk group", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Wording for risk stratification categories." }, { "id": "prognostic-text-11", "kind": "text", "text": "biomarker", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Molecular factors studied for prognosis." }, { "id": "prognostic-text-12", "kind": "text", "text": "associated with", "fields": [ "ti" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Titles of association studies often state the factor is associated with an outcome; restricted to title to limit noise." }, { "id": "prognostic-mesh-1-et2", "kind": "text", "text": "Population at Risk", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept under the MeSH heading \"Risk Factors\" (D012307)" }, { "id": "prognostic-mesh-1-et3", "kind": "text", "text": "Health Correlates", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept under the MeSH heading \"Risk Factors\" (D012307)" }, { "id": "prognostic-mesh-1-et4", "kind": "text", "text": "Populations at Risk", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept \"Population at Risk\" under the MeSH heading \"Risk Factors\" (D012307)" }, { "id": "prognostic-mesh-2-et1", "kind": "text", "text": "Health Risk Assessment", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Risk Assessment\" (D018570)" }, { "id": "prognostic-mesh-2-et2", "kind": "text", "text": "Benefit-Risk Assessment", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept under the MeSH heading \"Risk Assessment\" (D018570)" }, { "id": "prognostic-mesh-2-et3", "kind": "text", "text": "Risk-Benefit Assessment", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept \"Benefit-Risk Assessment\" under the MeSH heading \"Risk Assessment\" (D018570)" }, { "id": "prognostic-mesh-3-et2", "kind": "text", "text": "Carcinogen Markers", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Biomarkers, Tumor\" (D014408)" }, { "id": "prognostic-mesh-3-et3", "kind": "text", "text": "Biological Tumor Marker", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Biomarkers, Tumor\" (D014408)" }, { "id": "prognostic-mesh-3-et4", "kind": "text", "text": "Tumor Metabolite Marker", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Biomarkers, Tumor\" (D014408)" }, { "id": "prognostic-mesh-3-et5", "kind": "text", "text": "Biochemical Tumor Marker", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Biomarkers, Tumor\" (D014408)" }, { "id": "prognostic-mesh-3-et6", "kind": "text", "text": "Biological Tumor Markers", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Biomarkers, Tumor\" (D014408)" }, { "id": "prognostic-mesh-3-et7", "kind": "text", "text": "Biochemical Tumor Markers", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Biomarkers, Tumor\" (D014408)" }, { "id": "prognostic-mesh-4-et1", "kind": "text", "text": "Partin Tables", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept under the MeSH heading \"Nomograms\" (D049451)" }, { "id": "prognostic-mesh-5-et1", "kind": "text", "text": "Proportional Hazard Model", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Proportional Hazards Models\" (D016016)" }, { "id": "prognostic-mesh-5-et2", "kind": "text", "text": "Proportional Hazard Models", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Proportional Hazards Models\" (D016016)" }, { "id": "prognostic-mesh-5-et3", "kind": "text", "text": "Proportional Hazards Model", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Proportional Hazards Models\" (D016016)" }, { "id": "prognostic-mesh-5-et4", "kind": "text", "text": "Cox Proportional Hazards Models", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept under the MeSH heading \"Proportional Hazards Models\" (D016016)" }, { "id": "prognostic-mesh-5-et5", "kind": "text", "text": "Cox Models", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept under the MeSH heading \"Proportional Hazards Models\" (D016016)" }, { "id": "prognostic-mesh-5-et6", "kind": "text", "text": "Cox Proportional Hazards Model", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept \"Cox Proportional Hazards Models\" under the MeSH heading \"Proportional Hazards Models\" (D016016)" } ], "required": true }, { "key": "outcome", "role": "outcome", "label": "Recurrence, progression, survival, BCG unresponsiveness, cystectomy", "terms": [ { "id": "outcome-mesh-0", "kind": "mesh", "label": "Neoplasm Recurrence, Local", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Heading for tumour recurrence.", "validation": { "ui": "D009364", "label": "Neoplasm Recurrence, Local", "status": "valid" } }, { "id": "outcome-mesh-1", "kind": "mesh", "label": "Recurrence", "major": false, "origin": "ai", "enabled": true, "explode": false, "rationale": "General recurrence heading sometimes used instead.", "validation": { "ui": "D012008", "label": "Recurrence", "status": "valid" } }, { "id": "outcome-mesh-2", "kind": "mesh", "label": "Disease Progression", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Heading for progression to muscle-invasive disease.", "validation": { "ui": "D018450", "label": "Disease Progression", "status": "valid" } }, { "id": "outcome-mesh-3", "kind": "mesh", "label": "Survival Analysis", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Covers disease-free survival, Kaplan-Meier and survival rates.", "validation": { "ui": "D016019", "label": "Survival Analysis", "status": "valid" } }, { "id": "outcome-mesh-4", "kind": "mesh", "label": "Progression-Free Survival", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Specific survival outcome heading.", "validation": { "ui": "D000077982", "label": "Progression-Free Survival", "status": "valid" } }, { "id": "outcome-mesh-5", "kind": "mesh", "label": "Cystectomy", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Cystectomy is a named outcome of the review.", "validation": { "ui": "D015653", "label": "Cystectomy", "status": "valid" } }, { "id": "outcome-mesh-6", "kind": "mesh", "label": "Treatment Failure", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Indexes BCG failure and unresponsive disease.", "validation": { "ui": "D017211", "label": "Treatment Failure", "status": "valid" } }, { "id": "outcome-mesh-7", "kind": "mesh", "label": "Drug Resistance, Neoplasm", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Can be used for BCG-refractory disease.", "validation": { "ui": "D019008", "label": "Drug Resistance, Neoplasm", "status": "valid" } }, { "id": "outcome-text-0", "kind": "text", "text": "recurren", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Catches recurrence, recurrent and recurrence-free." }, { "id": "outcome-text-1", "kind": "text", "text": "relapse", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Synonym for recurrence." }, { "id": "outcome-text-2", "kind": "text", "text": "progression", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Progression to muscle-invasive or metastatic disease." }, { "id": "outcome-text-3", "kind": "text", "text": "muscle invasion", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Description of progression." }, { "id": "outcome-text-4", "kind": "text", "text": "upstaging", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Related progression outcome." }, { "id": "outcome-text-5", "kind": "text", "text": "survival", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Overall, cancer-specific and progression-free survival." }, { "id": "outcome-text-6", "kind": "text", "text": "mortality", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Death outcomes." }, { "id": "outcome-text-7", "kind": "text", "text": "cystectom", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Catches cystectomy and cystectomies, including radical and early cystectomy." }, { "id": "outcome-text-8", "kind": "text", "text": "BCG unresponsive", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Catches BCG-unresponsive and BCG-unresponsiveness." }, { "id": "outcome-text-9", "kind": "text", "text": "BCG refractory", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Related BCG failure category." }, { "id": "outcome-text-10", "kind": "text", "text": "BCG failure", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "General term for failure of BCG therapy." }, { "id": "outcome-text-11", "kind": "text", "text": "BCG relapsing", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "BCG failure subtype." }, { "id": "outcome-text-12", "kind": "text", "text": "treatment failure", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "General failure wording." }, { "id": "outcome-mesh-1-et2", "kind": "text", "text": "Recrudescence", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept under the MeSH heading \"Recurrence\" (D012008)" }, { "id": "outcome-mesh-7-et1", "kind": "text", "text": "Neoplasm Drug Resistance", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Drug Resistance, Neoplasm\" (D019008)" }, { "id": "outcome-mesh-7-et2", "kind": "text", "text": "Antineoplastic Drug Resistance", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Drug Resistance, Neoplasm\" (D019008)" }, { "id": "outcome-mesh-7-et3", "kind": "text", "text": "Antineoplastic Agent Resistance", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Drug Resistance, Neoplasm\" (D019008)" } ], "required": true } ], "limits": { "dateTo": null, "dateFrom": null, "languages": [ "english" ], "humansOnly": false, "excludePublicationTypes": [ { "label": "Comment", "validation": { "ui": "D016420", "label": "Comment", "status": "valid" } }, { "label": "Editorial", "validation": { "ui": "D016421", "label": "Editorial", "status": "valid" } }, { "label": "Letter", "validation": { "ui": "D016422", "label": "Letter", "status": "valid" } }, { "label": "Case Reports", "validation": { "ui": "D002363", "label": "Case Reports", "status": "valid" } }, { "label": "Preprint", "validation": { "ui": "D000076942", "label": "Preprint", "status": "valid" } } ] }, "schema": "picoportal.search-strategy/1", "question": "What factors are associated with recurrence, progression, survival, BCG unresponsiveness, or cystectomy in adults with high-risk NMIBC?", "objective": "To identify clinical, pathological, molecular and treatment-related factors associated with recurrence, progression, survival, BCG-unresponsive disease or cystectomy in adults with high-risk non-muscle-invasive bladder cancer (NMIBC)." }, "lines": [ { "no": 1, "kind": "terms", "refs": [], "count": 76110, "query": "\"Urinary Bladder Neoplasms\"[Mesh] OR \"Carcinoma, Transitional Cell\"[Mesh]", "issues": [], "display": "\"Urinary Bladder Neoplasms\"[Mesh] OR \"Carcinoma, Transitional Cell\"[Mesh]", "termIds": [ "bladder-mesh-0", "bladder-mesh-1" ], "blockKey": "bladder", "countedAt": "2026-10-28T18:55:46.498Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"Urinary Bladder Neoplasms\"[MeSH Terms] OR \"carcinoma, transitional cell\"[MeSH Terms]", "quotedPhrasesNotFound": [] } }, { "no": 2, "kind": "terms", "refs": [], "count": 85737, "query": "\"bladder cancer*\"[tiab] OR \"bladder tumor*\"[tiab] OR \"bladder tumour*\"[tiab] OR \"bladder neoplasm*\"[tiab] OR \"bladder carcinoma*\"[tiab] OR \"urothelial carcinoma*\"[tiab] OR \"urothelial cancer*\"[tiab] OR \"transitional cell carcinoma*\"[tiab] OR NMIBC[tiab]", "issues": [], "display": "\"bladder cancer*\"[tiab] OR \"bladder tumor*\"[tiab] OR \"bladder tumour*\"[tiab] OR \"bladder neoplasm*\"[tiab] OR \"bladder carcinoma*\"[tiab] OR \"urothelial carcinoma*\"[tiab] OR \"urothelial cancer*\"[tiab] OR \"transitional cell carcinoma*\"[tiab] OR NMIBC[tiab]", "termIds": [ "bladder-text-0", "bladder-text-1", "bladder-text-2", "bladder-text-3", "bladder-text-4", "bladder-text-5", "bladder-text-6", "bladder-text-7", "bladder-text-8" ], "blockKey": "bladder", "countedAt": "2026-10-28T18:55:43.164Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"bladder cancer*\"[Title/Abstract] OR \"bladder tumor*\"[Title/Abstract] OR \"bladder tumour*\"[Title/Abstract] OR \"bladder neoplasm*\"[Title/Abstract] OR \"bladder carcinoma*\"[Title/Abstract] OR \"urothelial carcinoma*\"[Title/Abstract] OR \"urothelial cancer*\"[Title/Abstract] OR \"transitional cell carcinoma*\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract]", "quotedPhrasesNotFound": [] } }, { "no": 3, "kind": "block", "refs": [ 1, 2 ], "count": 103654, "query": "(\"Urinary Bladder Neoplasms\"[Mesh] OR \"Carcinoma, Transitional Cell\"[Mesh]) OR (\"bladder cancer*\"[tiab] OR \"bladder tumor*\"[tiab] OR \"bladder tumour*\"[tiab] OR \"bladder neoplasm*\"[tiab] OR \"bladder carcinoma*\"[tiab] OR \"urothelial carcinoma*\"[tiab] OR \"urothelial cancer*\"[tiab] OR \"transitional cell carcinoma*\"[tiab] OR NMIBC[tiab])", "issues": [], "display": "1 OR 2", "blockKey": "bladder", "countedAt": "2026-10-28T18:55:43.566Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"Urinary Bladder Neoplasms\"[MeSH Terms] OR \"carcinoma, transitional cell\"[MeSH Terms] OR \"bladder cancer*\"[Title/Abstract] OR \"bladder tumor*\"[Title/Abstract] OR \"bladder tumour*\"[Title/Abstract] OR \"bladder neoplasm*\"[Title/Abstract] OR \"bladder carcinoma*\"[Title/Abstract] OR \"urothelial carcinoma*\"[Title/Abstract] OR \"urothelial cancer*\"[Title/Abstract] OR \"transitional cell carcinoma*\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract]", "quotedPhrasesNotFound": [] } }, { "no": 4, "kind": "terms", "refs": [], "count": 54049, "query": "\"Carcinoma in Situ\"[Mesh] OR \"BCG Vaccine\"[Mesh] OR \"Administration, Intravesical\"[Mesh]", "issues": [], "display": "\"Carcinoma in Situ\"[Mesh] OR \"BCG Vaccine\"[Mesh] OR \"Administration, Intravesical\"[Mesh]", "termIds": [ "nmi-mesh-0", "nmi-mesh-1", "nmi-mesh-2" ], "blockKey": "nmi", "countedAt": "2026-10-28T18:55:42.841Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"Carcinoma in Situ\"[MeSH Terms] OR \"BCG Vaccine\"[MeSH Terms] OR \"administration, intravesical\"[MeSH Terms]", "quotedPhrasesNotFound": [] } }, { "no": 5, "kind": "terms", "refs": [], "count": 85031, "query": "\"non-muscle invasive\"[tiab] OR \"nonmuscle invasive\"[tiab] OR NMIBC[tiab] OR \"superficial bladder\"[tiab:~2] OR \"carcinoma in situ\"[tiab] OR T1G3[tiab] OR pT1[tiab] OR \"stage T1\"[tiab] OR \"T1 bladder\"[tiab:~2] OR BCG[tiab] OR \"Calmette-Guerin\"[tiab] OR intravesical[tiab] OR TURBT[tiab] OR \"transurethral resection\"[tiab]", "issues": [ { "code": "field_subsumed", "level": "info", "termId": "nmi-text-0", "message": "\"non-muscle invasive\"[ot] adds almost nothing to \"non-muscle invasive\"[tiab], which already searches the title, the abstract and the keywords.", "blockKey": "nmi" } ], "display": "\"non-muscle invasive\"[tiab] OR \"nonmuscle invasive\"[tiab] OR NMIBC[tiab] OR \"superficial bladder\"[tiab:~2] OR \"carcinoma in situ\"[tiab] OR T1G3[tiab] OR pT1[tiab] OR \"stage T1\"[tiab] OR \"T1 bladder\"[tiab:~2] OR BCG[tiab] OR \"Calmette-Guerin\"[tiab] OR intravesical[tiab] OR TURBT[tiab] OR \"transurethral resection\"[tiab]", "termIds": [ "nmi-text-0", "nmi-text-1", "nmi-text-2", "nmi-text-3", "nmi-text-4", "nmi-text-5", "nmi-text-6", "nmi-text-7", "nmi-text-8", "nmi-text-9", "nmi-text-10", "nmi-text-11", "nmi-text-12", "nmi-text-13" ], "blockKey": "nmi", "countedAt": "2026-10-28T18:55:44.386Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"non-muscle invasive\"[Title/Abstract] OR \"nonmuscle invasive\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract] OR \"superficial bladder\"[Title/Abstract:~2] OR \"carcinoma in situ\"[Title/Abstract] OR \"T1G3\"[Title/Abstract] OR \"pT1\"[Title/Abstract] OR \"stage T1\"[Title/Abstract] OR \"T1 bladder\"[Title/Abstract:~2] OR \"BCG\"[Title/Abstract] OR \"Calmette-Guerin\"[Title/Abstract] OR \"intravesical\"[Title/Abstract] OR \"TURBT\"[Title/Abstract] OR \"transurethral resection\"[Title/Abstract]", "quotedPhrasesNotFound": [] } }, { "no": 6, "kind": "terms", "refs": [], "count": 1499, "query": "\"non-muscle invasive\"[ot]", "issues": [ { "code": "field_subsumed", "level": "info", "termId": "nmi-text-0", "message": "\"non-muscle invasive\"[ot] adds almost nothing to \"non-muscle invasive\"[tiab], which already searches the title, the abstract and the keywords.", "blockKey": "nmi" } ], "display": "\"non-muscle invasive\"[ot]", "termIds": [ "nmi-text-0" ], "blockKey": "nmi", "countedAt": "2026-10-28T18:55:44.493Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"non-muscle invasive\"[Other Term]", "quotedPhrasesNotFound": [] } }, { "no": 7, "kind": "block", "refs": [ 4, 5, 6 ], "count": 108908, "query": "(\"Carcinoma in Situ\"[Mesh] OR \"BCG Vaccine\"[Mesh] OR \"Administration, Intravesical\"[Mesh]) OR (\"non-muscle invasive\"[tiab] OR \"nonmuscle invasive\"[tiab] OR NMIBC[tiab] OR \"superficial bladder\"[tiab:~2] OR \"carcinoma in situ\"[tiab] OR T1G3[tiab] OR pT1[tiab] OR \"stage T1\"[tiab] OR \"T1 bladder\"[tiab:~2] OR BCG[tiab] OR \"Calmette-Guerin\"[tiab] OR intravesical[tiab] OR TURBT[tiab] OR \"transurethral resection\"[tiab]) OR (\"non-muscle invasive\"[ot])", "issues": [], "display": "4 OR 5 OR 6", "blockKey": "nmi", "countedAt": "2026-10-28T18:55:44.854Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"Carcinoma in Situ\"[MeSH Terms] OR \"BCG Vaccine\"[MeSH Terms] OR \"administration, intravesical\"[MeSH Terms] OR \"non-muscle invasive\"[Title/Abstract] OR \"nonmuscle invasive\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract] OR \"superficial bladder\"[Title/Abstract:~2] OR \"Carcinoma in Situ\"[Title/Abstract] OR \"T1G3\"[Title/Abstract] OR \"pT1\"[Title/Abstract] OR \"stage T1\"[Title/Abstract] OR \"T1 bladder\"[Title/Abstract:~2] OR \"BCG\"[Title/Abstract] OR \"Calmette-Guerin\"[Title/Abstract] OR \"intravesical\"[Title/Abstract] OR \"TURBT\"[Title/Abstract] OR \"transurethral resection\"[Title/Abstract] OR \"non-muscle invasive\"[Other Term]", "quotedPhrasesNotFound": [] } }, { "no": 8, "kind": "terms", "refs": [], "count": 2283845, "query": "\"Prognosis\"[Mesh:NoExp] OR \"Risk Factors\"[Mesh] OR \"Risk Assessment\"[Mesh] OR \"Biomarkers, Tumor\"[Mesh] OR \"Nomograms\"[Mesh] OR \"Proportional Hazards Models\"[Mesh] OR \"Multivariate Analysis\"[Mesh]", "issues": [], "display": "\"Prognosis\"[Mesh:NoExp] OR \"Risk Factors\"[Mesh] OR \"Risk Assessment\"[Mesh] OR \"Biomarkers, Tumor\"[Mesh] OR \"Nomograms\"[Mesh] OR \"Proportional Hazards Models\"[Mesh] OR \"Multivariate Analysis\"[Mesh]", "termIds": [ "prognostic-mesh-0", "prognostic-mesh-1", "prognostic-mesh-2", "prognostic-mesh-3", "prognostic-mesh-4", "prognostic-mesh-5", "prognostic-mesh-6" ], "blockKey": "prognostic", "countedAt": "2026-10-28T18:55:48.198Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"Prognosis\"[MeSH Terms:noexp] OR \"Risk Factors\"[MeSH Terms] OR \"Risk Assessment\"[MeSH Terms] OR \"biomarkers, tumor\"[MeSH Terms] OR \"Nomograms\"[MeSH Terms] OR \"Proportional Hazards Models\"[MeSH Terms] OR \"Multivariate Analysis\"[MeSH Terms]", "quotedPhrasesNotFound": [] } }, { "no": 9, "kind": "terms", "refs": [], "count": 531268, "query": "\"associated with\"[ti]", "issues": [], "display": "\"associated with\"[ti]", "termIds": [ "prognostic-text-12" ], "blockKey": "prognostic", "countedAt": "2026-10-28T18:55:45.494Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"associated with\"[Title]", "quotedPhrasesNotFound": [] } }, { "no": 10, "kind": "terms", "refs": [], "count": 5161509, "query": "prognos*[tiab] OR predict*[tiab] OR \"risk factor*\"[tiab] OR \"hazard ratio*\"[tiab] OR \"odds ratio*\"[tiab] OR multivariate[tiab] OR multivariable[tiab] OR nomogram*[tiab] OR \"risk stratification\"[tiab] OR \"risk score*\"[tiab] OR \"risk group*\"[tiab] OR biomarker*[tiab]", "issues": [], "display": "prognos*[tiab] OR predict*[tiab] OR \"risk factor*\"[tiab] OR \"hazard ratio*\"[tiab] OR \"odds ratio*\"[tiab] OR multivariate[tiab] OR multivariable[tiab] OR nomogram*[tiab] OR \"risk stratification\"[tiab] OR \"risk score*\"[tiab] OR \"risk group*\"[tiab] OR biomarker*[tiab]", "termIds": [ "prognostic-text-0", "prognostic-text-1", "prognostic-text-2", "prognostic-text-3", "prognostic-text-4", "prognostic-text-5", "prognostic-text-6", "prognostic-text-7", "prognostic-text-8", "prognostic-text-9", "prognostic-text-10", "prognostic-text-11" ], "blockKey": "prognostic", "countedAt": "2026-10-28T18:55:45.936Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"prognos*\"[Title/Abstract] OR \"predict*\"[Title/Abstract] OR \"risk factor*\"[Title/Abstract] OR \"hazard ratio*\"[Title/Abstract] OR \"odds ratio*\"[Title/Abstract] OR \"multivariate\"[Title/Abstract] OR \"multivariable\"[Title/Abstract] OR \"nomogram*\"[Title/Abstract] OR \"risk stratification\"[Title/Abstract] OR \"risk score*\"[Title/Abstract] OR \"risk group*\"[Title/Abstract] OR \"biomarker*\"[Title/Abstract]", "quotedPhrasesNotFound": [] } }, { "no": 11, "kind": "block", "refs": [ 8, 9, 10 ], "count": 6455728, "query": "(\"Prognosis\"[Mesh:NoExp] OR \"Risk Factors\"[Mesh] OR \"Risk Assessment\"[Mesh] OR \"Biomarkers, Tumor\"[Mesh] OR \"Nomograms\"[Mesh] OR \"Proportional Hazards Models\"[Mesh] OR \"Multivariate Analysis\"[Mesh]) OR (\"associated with\"[ti]) OR (prognos*[tiab] OR predict*[tiab] OR \"risk factor*\"[tiab] OR \"hazard ratio*\"[tiab] OR \"odds ratio*\"[tiab] OR multivariate[tiab] OR multivariable[tiab] OR nomogram*[tiab] OR \"risk stratification\"[tiab] OR \"risk score*\"[tiab] OR \"risk group*\"[tiab] OR biomarker*[tiab])", "issues": [], "display": "8 OR 9 OR 10", "blockKey": "prognostic", "countedAt": "2026-10-28T18:55:46.298Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"Prognosis\"[MeSH Terms:noexp] OR \"Risk Factors\"[MeSH Terms] OR \"Risk Assessment\"[MeSH Terms] OR \"biomarkers, tumor\"[MeSH Terms] OR \"Nomograms\"[MeSH Terms] OR \"Proportional Hazards Models\"[MeSH Terms] OR \"Multivariate Analysis\"[MeSH Terms] OR \"associated with\"[Title] OR \"prognos*\"[Title/Abstract] OR \"predict*\"[Title/Abstract] OR \"risk factor*\"[Title/Abstract] OR \"hazard ratio*\"[Title/Abstract] OR \"odds ratio*\"[Title/Abstract] OR \"multivariate\"[Title/Abstract] OR \"multivariable\"[Title/Abstract] OR \"nomogram*\"[Title/Abstract] OR \"risk stratification\"[Title/Abstract] OR \"risk score*\"[Title/Abstract] OR \"risk group*\"[Title/Abstract] OR \"biomarker*\"[Title/Abstract]", "quotedPhrasesNotFound": [] } }, { "no": 12, "kind": "terms", "refs": [], "count": 1007392, "query": "\"Neoplasm Recurrence, Local\"[Mesh] OR \"Recurrence\"[Mesh:NoExp] OR \"Disease Progression\"[Mesh] OR \"Survival Analysis\"[Mesh] OR \"Progression-Free Survival\"[Mesh] OR \"Cystectomy\"[Mesh] OR \"Treatment Failure\"[Mesh] OR \"Drug Resistance, Neoplasm\"[Mesh]", "issues": [], "display": "\"Neoplasm Recurrence, Local\"[Mesh] OR \"Recurrence\"[Mesh:NoExp] OR \"Disease Progression\"[Mesh] OR \"Survival Analysis\"[Mesh] OR \"Progression-Free Survival\"[Mesh] OR \"Cystectomy\"[Mesh] OR \"Treatment Failure\"[Mesh] OR \"Drug Resistance, Neoplasm\"[Mesh]", "termIds": [ "outcome-mesh-0", "outcome-mesh-1", "outcome-mesh-2", "outcome-mesh-3", "outcome-mesh-4", "outcome-mesh-5", "outcome-mesh-6", "outcome-mesh-7" ], "blockKey": "outcome", "countedAt": "2026-10-28T18:55:46.863Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"neoplasm recurrence, local\"[MeSH Terms] OR \"Recurrence\"[MeSH Terms:noexp] OR \"Disease Progression\"[MeSH Terms] OR \"Survival Analysis\"[MeSH Terms] OR \"Progression-Free Survival\"[MeSH Terms] OR \"Cystectomy\"[MeSH Terms] OR \"Treatment Failure\"[MeSH Terms] OR \"drug resistance, neoplasm\"[MeSH Terms]", "quotedPhrasesNotFound": [] } }, { "no": 13, "kind": "terms", "refs": [], "count": 3941252, "query": "recurren*[tiab] OR relapse*[tiab] OR progression[tiab] OR \"muscle invasion\"[tiab] OR upstaging[tiab] OR survival[tiab] OR mortality[tiab] OR cystectom*[tiab] OR \"BCG unresponsive*\"[tiab] OR \"BCG refractory\"[tiab] OR \"BCG failure*\"[tiab] OR \"BCG relapsing\"[tiab] OR \"treatment failure\"[tiab]", "issues": [], "display": "recurren*[tiab] OR relapse*[tiab] OR progression[tiab] OR \"muscle invasion\"[tiab] OR upstaging[tiab] OR survival[tiab] OR mortality[tiab] OR cystectom*[tiab] OR \"BCG unresponsive*\"[tiab] OR \"BCG refractory\"[tiab] OR \"BCG failure*\"[tiab] OR \"BCG relapsing\"[tiab] OR \"treatment failure\"[tiab]", "termIds": [ "outcome-text-0", "outcome-text-1", "outcome-text-2", "outcome-text-3", "outcome-text-4", "outcome-text-5", "outcome-text-6", "outcome-text-7", "outcome-text-8", "outcome-text-9", "outcome-text-10", "outcome-text-11", "outcome-text-12" ], "blockKey": "outcome", "countedAt": "2026-10-28T18:55:49.591Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"recurren*\"[Title/Abstract] OR \"relapse*\"[Title/Abstract] OR \"progression\"[Title/Abstract] OR \"muscle invasion\"[Title/Abstract] OR \"upstaging\"[Title/Abstract] OR \"survival\"[Title/Abstract] OR \"mortality\"[Title/Abstract] OR \"cystectom*\"[Title/Abstract] OR \"bcg unresponsive*\"[Title/Abstract] OR \"BCG refractory\"[Title/Abstract] OR \"bcg failure*\"[Title/Abstract] OR \"BCG relapsing\"[Title/Abstract] OR \"treatment failure\"[Title/Abstract]", "quotedPhrasesNotFound": [] } }, { "no": 14, "kind": "block", "refs": [ 12, 13 ], "count": 4250666, "query": "(\"Neoplasm Recurrence, Local\"[Mesh] OR \"Recurrence\"[Mesh:NoExp] OR \"Disease Progression\"[Mesh] OR \"Survival Analysis\"[Mesh] OR \"Progression-Free Survival\"[Mesh] OR \"Cystectomy\"[Mesh] OR \"Treatment Failure\"[Mesh] OR \"Drug Resistance, Neoplasm\"[Mesh]) OR (recurren*[tiab] OR relapse*[tiab] OR progression[tiab] OR \"muscle invasion\"[tiab] OR upstaging[tiab] OR survival[tiab] OR mortality[tiab] OR cystectom*[tiab] OR \"BCG unresponsive*\"[tiab] OR \"BCG refractory\"[tiab] OR \"BCG failure*\"[tiab] OR \"BCG relapsing\"[tiab] OR \"treatment failure\"[tiab])", "issues": [], "display": "12 OR 13", "blockKey": "outcome", "countedAt": "2026-10-28T18:55:47.590Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"neoplasm recurrence, local\"[MeSH Terms] OR \"Recurrence\"[MeSH Terms:noexp] OR \"Disease Progression\"[MeSH Terms] OR \"Survival Analysis\"[MeSH Terms] OR \"Progression-Free Survival\"[MeSH Terms] OR \"Cystectomy\"[MeSH Terms] OR \"Treatment Failure\"[MeSH Terms] OR \"drug resistance, neoplasm\"[MeSH Terms] OR \"recurren*\"[Title/Abstract] OR \"relapse*\"[Title/Abstract] OR \"progression\"[Title/Abstract] OR \"muscle invasion\"[Title/Abstract] OR \"upstaging\"[Title/Abstract] OR \"survival\"[Title/Abstract] OR \"mortality\"[Title/Abstract] OR \"cystectom*\"[Title/Abstract] OR \"bcg unresponsive*\"[Title/Abstract] OR \"BCG refractory\"[Title/Abstract] OR \"bcg failure*\"[Title/Abstract] OR \"BCG relapsing\"[Title/Abstract] OR \"Treatment Failure\"[Title/Abstract]", "quotedPhrasesNotFound": [] } }, { "no": 15, "kind": "combine", "refs": [ 3, 7, 11, 14 ], "count": 7885, "query": "((\"Urinary Bladder Neoplasms\"[Mesh] OR \"Carcinoma, Transitional Cell\"[Mesh]) OR (\"bladder cancer*\"[tiab] OR \"bladder tumor*\"[tiab] OR \"bladder tumour*\"[tiab] OR \"bladder neoplasm*\"[tiab] OR \"bladder carcinoma*\"[tiab] OR \"urothelial carcinoma*\"[tiab] OR \"urothelial cancer*\"[tiab] OR \"transitional cell carcinoma*\"[tiab] OR NMIBC[tiab])) AND ((\"Carcinoma in Situ\"[Mesh] OR \"BCG Vaccine\"[Mesh] OR \"Administration, Intravesical\"[Mesh]) OR (\"non-muscle invasive\"[tiab] OR \"nonmuscle invasive\"[tiab] OR NMIBC[tiab] OR \"superficial bladder\"[tiab:~2] OR \"carcinoma in situ\"[tiab] OR T1G3[tiab] OR pT1[tiab] OR \"stage T1\"[tiab] OR \"T1 bladder\"[tiab:~2] OR BCG[tiab] OR \"Calmette-Guerin\"[tiab] OR intravesical[tiab] OR TURBT[tiab] OR \"transurethral resection\"[tiab]) OR (\"non-muscle invasive\"[ot])) AND ((\"Prognosis\"[Mesh:NoExp] OR \"Risk Factors\"[Mesh] OR \"Risk Assessment\"[Mesh] OR \"Biomarkers, Tumor\"[Mesh] OR \"Nomograms\"[Mesh] OR \"Proportional Hazards Models\"[Mesh] OR \"Multivariate Analysis\"[Mesh]) OR (\"associated with\"[ti]) OR (prognos*[tiab] OR predict*[tiab] OR \"risk factor*\"[tiab] OR \"hazard ratio*\"[tiab] OR \"odds ratio*\"[tiab] OR multivariate[tiab] OR multivariable[tiab] OR nomogram*[tiab] OR \"risk stratification\"[tiab] OR \"risk score*\"[tiab] OR \"risk group*\"[tiab] OR biomarker*[tiab])) AND ((\"Neoplasm Recurrence, Local\"[Mesh] OR \"Recurrence\"[Mesh:NoExp] OR \"Disease Progression\"[Mesh] OR \"Survival Analysis\"[Mesh] OR \"Progression-Free Survival\"[Mesh] OR \"Cystectomy\"[Mesh] OR \"Treatment Failure\"[Mesh] OR \"Drug Resistance, Neoplasm\"[Mesh]) OR (recurren*[tiab] OR relapse*[tiab] OR progression[tiab] OR \"muscle invasion\"[tiab] OR upstaging[tiab] OR survival[tiab] OR mortality[tiab] OR cystectom*[tiab] OR \"BCG unresponsive*\"[tiab] OR \"BCG refractory\"[tiab] OR \"BCG failure*\"[tiab] OR \"BCG relapsing\"[tiab] OR \"treatment failure\"[tiab]))", "issues": [], "display": "3 AND 7 AND 11 AND 14", "countedAt": "2026-10-28T18:55:48.037Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "(\"Urinary Bladder Neoplasms\"[MeSH Terms] OR \"carcinoma, transitional cell\"[MeSH Terms] OR (\"bladder cancer*\"[Title/Abstract] OR \"bladder tumor*\"[Title/Abstract] OR \"bladder tumour*\"[Title/Abstract] OR \"bladder neoplasm*\"[Title/Abstract] OR \"bladder carcinoma*\"[Title/Abstract] OR \"urothelial carcinoma*\"[Title/Abstract] OR \"urothelial cancer*\"[Title/Abstract] OR \"transitional cell carcinoma*\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract])) AND (\"Carcinoma in Situ\"[MeSH Terms] OR \"BCG Vaccine\"[MeSH Terms] OR \"administration, intravesical\"[MeSH Terms] OR (\"non-muscle invasive\"[Title/Abstract] OR \"nonmuscle invasive\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract] OR \"superficial bladder\"[Title/Abstract:~2] OR \"Carcinoma in Situ\"[Title/Abstract] OR \"T1G3\"[Title/Abstract] OR \"pT1\"[Title/Abstract] OR \"stage T1\"[Title/Abstract] OR \"T1 bladder\"[Title/Abstract:~2] OR \"BCG\"[Title/Abstract] OR \"Calmette-Guerin\"[Title/Abstract] OR \"intravesical\"[Title/Abstract] OR \"TURBT\"[Title/Abstract] OR \"transurethral resection\"[Title/Abstract]) OR \"non-muscle invasive\"[Other Term]) AND (\"Prognosis\"[MeSH Terms:noexp] OR \"Risk Factors\"[MeSH Terms] OR \"Risk Assessment\"[MeSH Terms] OR \"biomarkers, tumor\"[MeSH Terms] OR \"Nomograms\"[MeSH Terms] OR \"Proportional Hazards Models\"[MeSH Terms] OR \"Multivariate Analysis\"[MeSH Terms] OR \"associated with\"[Title] OR (\"prognos*\"[Title/Abstract] OR \"predict*\"[Title/Abstract] OR \"risk factor*\"[Title/Abstract] OR \"hazard ratio*\"[Title/Abstract] OR \"odds ratio*\"[Title/Abstract] OR \"multivariate\"[Title/Abstract] OR \"multivariable\"[Title/Abstract] OR \"nomogram*\"[Title/Abstract] OR \"risk stratification\"[Title/Abstract] OR \"risk score*\"[Title/Abstract] OR \"risk group*\"[Title/Abstract] OR \"biomarker*\"[Title/Abstract])) AND (\"neoplasm recurrence, local\"[MeSH Terms] OR \"Recurrence\"[MeSH Terms:noexp] OR \"Disease Progression\"[MeSH Terms] OR \"Survival Analysis\"[MeSH Terms] OR \"Progression-Free Survival\"[MeSH Terms] OR \"Cystectomy\"[MeSH Terms] OR \"Treatment Failure\"[MeSH Terms] OR \"drug resistance, neoplasm\"[MeSH Terms] OR (\"recurren*\"[Title/Abstract] OR \"relapse*\"[Title/Abstract] OR \"progression\"[Title/Abstract] OR \"muscle invasion\"[Title/Abstract] OR \"upstaging\"[Title/Abstract] OR \"survival\"[Title/Abstract] OR \"mortality\"[Title/Abstract] OR \"cystectom*\"[Title/Abstract] OR \"bcg unresponsive*\"[Title/Abstract] OR \"BCG refractory\"[Title/Abstract] OR \"bcg failure*\"[Title/Abstract] OR \"BCG relapsing\"[Title/Abstract] OR \"Treatment Failure\"[Title/Abstract]))", "quotedPhrasesNotFound": [] } }, { "no": 16, "kind": "exclude", "refs": [], "count": 4884955, "query": "\"Comment\"[Publication Type] OR \"Editorial\"[Publication Type] OR \"Letter\"[Publication Type] OR \"Case Reports\"[Publication Type] OR \"Preprint\"[Publication Type]", "issues": [], "display": "\"Comment\"[Publication Type] OR \"Editorial\"[Publication Type] OR \"Letter\"[Publication Type] OR \"Case Reports\"[Publication Type] OR \"Preprint\"[Publication Type]", "countedAt": "2026-10-28T18:00:07.644Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"Comment\"[Publication Type] OR \"Editorial\"[Publication Type] OR \"Letter\"[Publication Type] OR \"Case Reports\"[Publication Type] OR \"Preprint\"[Publication Type]", "quotedPhrasesNotFound": [] } }, { "no": 17, "kind": "not", "refs": [ 15, 16 ], "count": 7458, "query": "(((\"Urinary Bladder Neoplasms\"[Mesh] OR \"Carcinoma, Transitional Cell\"[Mesh]) OR (\"bladder cancer*\"[tiab] OR \"bladder tumor*\"[tiab] OR \"bladder tumour*\"[tiab] OR \"bladder neoplasm*\"[tiab] OR \"bladder carcinoma*\"[tiab] OR \"urothelial carcinoma*\"[tiab] OR \"urothelial cancer*\"[tiab] OR \"transitional cell carcinoma*\"[tiab] OR NMIBC[tiab])) AND ((\"Carcinoma in Situ\"[Mesh] OR \"BCG Vaccine\"[Mesh] OR \"Administration, Intravesical\"[Mesh]) OR (\"non-muscle invasive\"[tiab] OR \"nonmuscle invasive\"[tiab] OR NMIBC[tiab] OR \"superficial bladder\"[tiab:~2] OR \"carcinoma in situ\"[tiab] OR T1G3[tiab] OR pT1[tiab] OR \"stage T1\"[tiab] OR \"T1 bladder\"[tiab:~2] OR BCG[tiab] OR \"Calmette-Guerin\"[tiab] OR intravesical[tiab] OR TURBT[tiab] OR \"transurethral resection\"[tiab]) OR (\"non-muscle invasive\"[ot])) AND ((\"Prognosis\"[Mesh:NoExp] OR \"Risk Factors\"[Mesh] OR \"Risk Assessment\"[Mesh] OR \"Biomarkers, Tumor\"[Mesh] OR \"Nomograms\"[Mesh] OR \"Proportional Hazards Models\"[Mesh] OR \"Multivariate Analysis\"[Mesh]) OR (\"associated with\"[ti]) OR (prognos*[tiab] OR predict*[tiab] OR \"risk factor*\"[tiab] OR \"hazard ratio*\"[tiab] OR \"odds ratio*\"[tiab] OR multivariate[tiab] OR multivariable[tiab] OR nomogram*[tiab] OR \"risk stratification\"[tiab] OR \"risk score*\"[tiab] OR \"risk group*\"[tiab] OR biomarker*[tiab])) AND ((\"Neoplasm Recurrence, Local\"[Mesh] OR \"Recurrence\"[Mesh:NoExp] OR \"Disease Progression\"[Mesh] OR \"Survival Analysis\"[Mesh] OR \"Progression-Free Survival\"[Mesh] OR \"Cystectomy\"[Mesh] OR \"Treatment Failure\"[Mesh] OR \"Drug Resistance, Neoplasm\"[Mesh]) OR (recurren*[tiab] OR relapse*[tiab] OR progression[tiab] OR \"muscle invasion\"[tiab] OR upstaging[tiab] OR survival[tiab] OR mortality[tiab] OR cystectom*[tiab] OR \"BCG unresponsive*\"[tiab] OR \"BCG refractory\"[tiab] OR \"BCG failure*\"[tiab] OR \"BCG relapsing\"[tiab] OR \"treatment failure\"[tiab]))) NOT (\"Comment\"[Publication Type] OR \"Editorial\"[Publication Type] OR \"Letter\"[Publication Type] OR \"Case Reports\"[Publication Type] OR \"Preprint\"[Publication Type])", "issues": [], "display": "15 NOT 16", "countedAt": "2026-10-28T18:55:50.709Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "((\"Urinary Bladder Neoplasms\"[MeSH Terms] OR \"carcinoma, transitional cell\"[MeSH Terms] OR (\"bladder cancer*\"[Title/Abstract] OR \"bladder tumor*\"[Title/Abstract] OR \"bladder tumour*\"[Title/Abstract] OR \"bladder neoplasm*\"[Title/Abstract] OR \"bladder carcinoma*\"[Title/Abstract] OR \"urothelial carcinoma*\"[Title/Abstract] OR \"urothelial cancer*\"[Title/Abstract] OR \"transitional cell carcinoma*\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract])) AND (\"Carcinoma in Situ\"[MeSH Terms] OR \"BCG Vaccine\"[MeSH Terms] OR \"administration, intravesical\"[MeSH Terms] OR (\"non-muscle invasive\"[Title/Abstract] OR \"nonmuscle invasive\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract] OR \"superficial bladder\"[Title/Abstract:~2] OR \"Carcinoma in Situ\"[Title/Abstract] OR \"T1G3\"[Title/Abstract] OR \"pT1\"[Title/Abstract] OR \"stage T1\"[Title/Abstract] OR \"T1 bladder\"[Title/Abstract:~2] OR \"BCG\"[Title/Abstract] OR \"Calmette-Guerin\"[Title/Abstract] OR \"intravesical\"[Title/Abstract] OR \"TURBT\"[Title/Abstract] OR \"transurethral resection\"[Title/Abstract]) OR \"non-muscle invasive\"[Other Term]) AND (\"Prognosis\"[MeSH Terms:noexp] OR \"Risk Factors\"[MeSH Terms] OR \"Risk Assessment\"[MeSH Terms] OR \"biomarkers, tumor\"[MeSH Terms] OR \"Nomograms\"[MeSH Terms] OR \"Proportional Hazards Models\"[MeSH Terms] OR \"Multivariate Analysis\"[MeSH Terms] OR \"associated with\"[Title] OR (\"prognos*\"[Title/Abstract] OR \"predict*\"[Title/Abstract] OR \"risk factor*\"[Title/Abstract] OR \"hazard ratio*\"[Title/Abstract] OR \"odds ratio*\"[Title/Abstract] OR \"multivariate\"[Title/Abstract] OR \"multivariable\"[Title/Abstract] OR \"nomogram*\"[Title/Abstract] OR \"risk stratification\"[Title/Abstract] OR \"risk score*\"[Title/Abstract] OR \"risk group*\"[Title/Abstract] OR \"biomarker*\"[Title/Abstract])) AND (\"neoplasm recurrence, local\"[MeSH Terms] OR \"Recurrence\"[MeSH Terms:noexp] OR \"Disease Progression\"[MeSH Terms] OR \"Survival Analysis\"[MeSH Terms] OR \"Progression-Free Survival\"[MeSH Terms] OR \"Cystectomy\"[MeSH Terms] OR \"Treatment Failure\"[MeSH Terms] OR \"drug resistance, neoplasm\"[MeSH Terms] OR (\"recurren*\"[Title/Abstract] OR \"relapse*\"[Title/Abstract] OR \"progression\"[Title/Abstract] OR \"muscle invasion\"[Title/Abstract] OR \"upstaging\"[Title/Abstract] OR \"survival\"[Title/Abstract] OR \"mortality\"[Title/Abstract] OR \"cystectom*\"[Title/Abstract] OR \"bcg unresponsive*\"[Title/Abstract] OR \"BCG refractory\"[Title/Abstract] OR \"bcg failure*\"[Title/Abstract] OR \"BCG relapsing\"[Title/Abstract] OR \"Treatment Failure\"[Title/Abstract]))) NOT (\"Comment\"[Publication Type] OR \"Editorial\"[Publication Type] OR \"Letter\"[Publication Type] OR \"Case Reports\"[Publication Type] OR \"Preprint\"[Publication Type])", "quotedPhrasesNotFound": [] } }, { "no": 18, "kind": "limits", "refs": [ 17 ], "count": 6907, "query": "((((\"Urinary Bladder Neoplasms\"[Mesh] OR \"Carcinoma, Transitional Cell\"[Mesh]) OR (\"bladder cancer*\"[tiab] OR \"bladder tumor*\"[tiab] OR \"bladder tumour*\"[tiab] OR \"bladder neoplasm*\"[tiab] OR \"bladder carcinoma*\"[tiab] OR \"urothelial carcinoma*\"[tiab] OR \"urothelial cancer*\"[tiab] OR \"transitional cell carcinoma*\"[tiab] OR NMIBC[tiab])) AND ((\"Carcinoma in Situ\"[Mesh] OR \"BCG Vaccine\"[Mesh] OR \"Administration, Intravesical\"[Mesh]) OR (\"non-muscle invasive\"[tiab] OR \"nonmuscle invasive\"[tiab] OR NMIBC[tiab] OR \"superficial bladder\"[tiab:~2] OR \"carcinoma in situ\"[tiab] OR T1G3[tiab] OR pT1[tiab] OR \"stage T1\"[tiab] OR \"T1 bladder\"[tiab:~2] OR BCG[tiab] OR \"Calmette-Guerin\"[tiab] OR intravesical[tiab] OR TURBT[tiab] OR \"transurethral resection\"[tiab]) OR (\"non-muscle invasive\"[ot])) AND ((\"Prognosis\"[Mesh:NoExp] OR \"Risk Factors\"[Mesh] OR \"Risk Assessment\"[Mesh] OR \"Biomarkers, Tumor\"[Mesh] OR \"Nomograms\"[Mesh] OR \"Proportional Hazards Models\"[Mesh] OR \"Multivariate Analysis\"[Mesh]) OR (\"associated with\"[ti]) OR (prognos*[tiab] OR predict*[tiab] OR \"risk factor*\"[tiab] OR \"hazard ratio*\"[tiab] OR \"odds ratio*\"[tiab] OR multivariate[tiab] OR multivariable[tiab] OR nomogram*[tiab] OR \"risk stratification\"[tiab] OR \"risk score*\"[tiab] OR \"risk group*\"[tiab] OR biomarker*[tiab])) AND ((\"Neoplasm Recurrence, Local\"[Mesh] OR \"Recurrence\"[Mesh:NoExp] OR \"Disease Progression\"[Mesh] OR \"Survival Analysis\"[Mesh] OR \"Progression-Free Survival\"[Mesh] OR \"Cystectomy\"[Mesh] OR \"Treatment Failure\"[Mesh] OR \"Drug Resistance, Neoplasm\"[Mesh]) OR (recurren*[tiab] OR relapse*[tiab] OR progression[tiab] OR \"muscle invasion\"[tiab] OR upstaging[tiab] OR survival[tiab] OR mortality[tiab] OR cystectom*[tiab] OR \"BCG unresponsive*\"[tiab] OR \"BCG refractory\"[tiab] OR \"BCG failure*\"[tiab] OR \"BCG relapsing\"[tiab] OR \"treatment failure\"[tiab]))) NOT (\"Comment\"[Publication Type] OR \"Editorial\"[Publication Type] OR \"Letter\"[Publication Type] OR \"Case Reports\"[Publication Type] OR \"Preprint\"[Publication Type])) AND english[la]", "issues": [], "display": "17 AND english[la]", "countedAt": "2026-10-28T18:55:49.070Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "(((\"Urinary Bladder Neoplasms\"[MeSH Terms] OR \"carcinoma, transitional cell\"[MeSH Terms] OR (\"bladder cancer*\"[Title/Abstract] OR \"bladder tumor*\"[Title/Abstract] OR \"bladder tumour*\"[Title/Abstract] OR \"bladder neoplasm*\"[Title/Abstract] OR \"bladder carcinoma*\"[Title/Abstract] OR \"urothelial carcinoma*\"[Title/Abstract] OR \"urothelial cancer*\"[Title/Abstract] OR \"transitional cell carcinoma*\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract])) AND (\"Carcinoma in Situ\"[MeSH Terms] OR \"BCG Vaccine\"[MeSH Terms] OR \"administration, intravesical\"[MeSH Terms] OR (\"non-muscle invasive\"[Title/Abstract] OR \"nonmuscle invasive\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract] OR \"superficial bladder\"[Title/Abstract:~2] OR \"Carcinoma in Situ\"[Title/Abstract] OR \"T1G3\"[Title/Abstract] OR \"pT1\"[Title/Abstract] OR \"stage T1\"[Title/Abstract] OR \"T1 bladder\"[Title/Abstract:~2] OR \"BCG\"[Title/Abstract] OR \"Calmette-Guerin\"[Title/Abstract] OR \"intravesical\"[Title/Abstract] OR \"TURBT\"[Title/Abstract] OR \"transurethral resection\"[Title/Abstract]) OR \"non-muscle invasive\"[Other Term]) AND (\"Prognosis\"[MeSH Terms:noexp] OR \"Risk Factors\"[MeSH Terms] OR \"Risk Assessment\"[MeSH Terms] OR \"biomarkers, tumor\"[MeSH Terms] OR \"Nomograms\"[MeSH Terms] OR \"Proportional Hazards Models\"[MeSH Terms] OR \"Multivariate Analysis\"[MeSH Terms] OR \"associated with\"[Title] OR (\"prognos*\"[Title/Abstract] OR \"predict*\"[Title/Abstract] OR \"risk factor*\"[Title/Abstract] OR \"hazard ratio*\"[Title/Abstract] OR \"odds ratio*\"[Title/Abstract] OR \"multivariate\"[Title/Abstract] OR \"multivariable\"[Title/Abstract] OR \"nomogram*\"[Title/Abstract] OR \"risk stratification\"[Title/Abstract] OR \"risk score*\"[Title/Abstract] OR \"risk group*\"[Title/Abstract] OR \"biomarker*\"[Title/Abstract])) AND (\"neoplasm recurrence, local\"[MeSH Terms] OR \"Recurrence\"[MeSH Terms:noexp] OR \"Disease Progression\"[MeSH Terms] OR \"Survival Analysis\"[MeSH Terms] OR \"Progression-Free Survival\"[MeSH Terms] OR \"Cystectomy\"[MeSH Terms] OR \"Treatment Failure\"[MeSH Terms] OR \"drug resistance, neoplasm\"[MeSH Terms] OR (\"recurren*\"[Title/Abstract] OR \"relapse*\"[Title/Abstract] OR \"progression\"[Title/Abstract] OR \"muscle invasion\"[Title/Abstract] OR \"upstaging\"[Title/Abstract] OR \"survival\"[Title/Abstract] OR \"mortality\"[Title/Abstract] OR \"cystectom*\"[Title/Abstract] OR \"bcg unresponsive*\"[Title/Abstract] OR \"BCG refractory\"[Title/Abstract] OR \"bcg failure*\"[Title/Abstract] OR \"BCG relapsing\"[Title/Abstract] OR \"Treatment Failure\"[Title/Abstract]))) NOT (\"Comment\"[Publication Type] OR \"Editorial\"[Publication Type] OR \"Letter\"[Publication Type] OR \"Case Reports\"[Publication Type] OR \"Preprint\"[Publication Type])) AND \"english\"[Language]", "quotedPhrasesNotFound": [] } }, { "no": 19, "kind": "terms", "refs": [], "count": 593438, "query": "\"high risk\"[tiab] OR \"high grade\"[tiab] OR \"highest risk\"[tiab]", "issues": [], "display": "\"high risk\"[tiab] OR \"high grade\"[tiab] OR \"highest risk\"[tiab]", "termIds": [ "highrisk-text-0", "highrisk-text-1", "highrisk-text-2" ], "blockKey": "highrisk", "countedAt": "2026-10-28T18:55:49.174Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"high risk\"[Title/Abstract] OR \"high grade\"[Title/Abstract] OR \"highest risk\"[Title/Abstract]", "quotedPhrasesNotFound": [] } } ], "finalQuery": "((((\"Urinary Bladder Neoplasms\"[Mesh] OR \"Carcinoma, Transitional Cell\"[Mesh]) OR (\"bladder cancer*\"[tiab] OR \"bladder tumor*\"[tiab] OR \"bladder tumour*\"[tiab] OR \"bladder neoplasm*\"[tiab] OR \"bladder carcinoma*\"[tiab] OR \"urothelial carcinoma*\"[tiab] OR \"urothelial cancer*\"[tiab] OR \"transitional cell carcinoma*\"[tiab] OR NMIBC[tiab])) AND ((\"Carcinoma in Situ\"[Mesh] OR \"BCG Vaccine\"[Mesh] OR \"Administration, Intravesical\"[Mesh]) OR (\"non-muscle invasive\"[tiab] OR \"nonmuscle invasive\"[tiab] OR NMIBC[tiab] OR \"superficial bladder\"[tiab:~2] OR \"carcinoma in situ\"[tiab] OR T1G3[tiab] OR pT1[tiab] OR \"stage T1\"[tiab] OR \"T1 bladder\"[tiab:~2] OR BCG[tiab] OR \"Calmette-Guerin\"[tiab] OR intravesical[tiab] OR TURBT[tiab] OR \"transurethral resection\"[tiab]) OR (\"non-muscle invasive\"[ot])) AND ((\"Prognosis\"[Mesh:NoExp] OR \"Risk Factors\"[Mesh] OR \"Risk Assessment\"[Mesh] OR \"Biomarkers, Tumor\"[Mesh] OR \"Nomograms\"[Mesh] OR \"Proportional Hazards Models\"[Mesh] OR \"Multivariate Analysis\"[Mesh]) OR (\"associated with\"[ti]) OR (prognos*[tiab] OR predict*[tiab] OR \"risk factor*\"[tiab] OR \"hazard ratio*\"[tiab] OR \"odds ratio*\"[tiab] OR multivariate[tiab] OR multivariable[tiab] OR nomogram*[tiab] OR \"risk stratification\"[tiab] OR \"risk score*\"[tiab] OR \"risk group*\"[tiab] OR biomarker*[tiab])) AND ((\"Neoplasm Recurrence, Local\"[Mesh] OR \"Recurrence\"[Mesh:NoExp] OR \"Disease Progression\"[Mesh] OR \"Survival Analysis\"[Mesh] OR \"Progression-Free Survival\"[Mesh] OR \"Cystectomy\"[Mesh] OR \"Treatment Failure\"[Mesh] OR \"Drug Resistance, Neoplasm\"[Mesh]) OR (recurren*[tiab] OR relapse*[tiab] OR progression[tiab] OR \"muscle invasion\"[tiab] OR upstaging[tiab] OR survival[tiab] OR mortality[tiab] OR cystectom*[tiab] OR \"BCG unresponsive*\"[tiab] OR \"BCG refractory\"[tiab] OR \"BCG failure*\"[tiab] OR \"BCG relapsing\"[tiab] OR \"treatment failure\"[tiab]))) NOT (\"Comment\"[Publication Type] OR \"Editorial\"[Publication Type] OR \"Letter\"[Publication Type] OR \"Case Reports\"[Publication Type] OR \"Preprint\"[Publication Type])) AND english[la]", "finalCount": 6907, "createdAt": "2026-10-28T18:55:50.724Z" } ], "llmCalls": [ { "kind": "draft", "user": "\nWhat factors are associated with recurrence, progression, survival, BCG unresponsiveness, or cystectomy in adults with high-risk NMIBC?\n\n\n\nLanguages: english, applied by the tool\nPublication dates: no date limit\nPublication types: the searcher excludes Comment; Editorial; Letter; Case Reports; Preprint, applied by the tool. This choice is final: suggest no publication types, and do not write a note about them.\nHumans only: no\n\n\n\nNo example articles were supplied.\n\n\nReturn the proposal as JSON that matches the schema.", "usage": { "speed": "standard", "iterations": [ { "type": "message", "model": null, "input_tokens": 221, "output_tokens": 8715, "cache_creation": { "ephemeral_1h_input_tokens": 0, "ephemeral_5m_input_tokens": 5540 }, "cache_read_input_tokens": 0, "cache_creation_input_tokens": 5540 } ], "input_tokens": 221, "service_tier": "standard", "inference_geo": "global", "output_tokens": 8715, "cache_creation": { "ephemeral_1h_input_tokens": 0, "ephemeral_5m_input_tokens": 5540 }, "output_tokens_details": { "thinking_tokens": 3702 }, "cache_read_input_tokens": 0, "cache_creation_input_tokens": 5540 }, "effort": "high", "parsed": { "pico": { "design": null, "outcome": "Recurrence, progression, survival or mortality, BCG unresponsiveness or failure, and cystectomy", "comparator": null, "population": "Adults with high-risk non-muscle-invasive bladder cancer (e.g., high-grade Ta/T1, carcinoma in situ), usually treated with TURBT and intravesical BCG", "interventionOrExposure": "Prognostic or predictive factors (clinical, pathological, molecular biomarkers, risk scores, treatment characteristics)" }, "notes": [ "NMIBC has no dedicated MeSH heading to rely on, so the condition is built from two required blocks: bladder or urothelial cancer, ANDed with non-muscle-invasive, BCG or intravesical terms. This excludes muscle-invasive-only studies while keeping NMIBC studies that do not use the abbreviation.", "The high-risk block is optional. Many studies of high-risk disease describe it only as T1, high-grade, carcinoma in situ or BCG-treated, which the non-muscle-invasive block already covers. Add the high-risk block if the result set is too large.", "Prognosis is not exploded, to avoid pulling in the very broad Treatment Outcome subtree.", "The bare word predict* and the title phrase 'associated with' are included for sensitivity; check their line counts and drop them if they add too much noise.", "The question does not restrict the age group of the population, so no adult filter is applied; nearly all NMIBC studies involve adults." ], "concepts": [ { "key": "bladder", "scr": [], "mesh": [ { "label": "Urinary Bladder Neoplasms", "major": false, "explode": true, "rationale": "Main heading for bladder cancer, under which NMIBC studies are indexed." }, { "label": "Carcinoma, Transitional Cell", "major": false, "explode": true, "rationale": "Histological heading for urothelial carcinoma, often given to NMIBC records." } ], "role": "condition", "text": [ { "text": "bladder cancer", "fields": [ "tiab" ], "truncate": true, "proximity": null, "rationale": "Most common author wording for the disease." }, { "text": "bladder tumor", "fields": [ "tiab" ], "truncate": true, "proximity": null, "rationale": "American spelling variant for bladder tumours." }, { "text": "bladder tumour", "fields": [ "tiab" ], "truncate": true, "proximity": null, "rationale": "British spelling variant." }, { "text": "bladder neoplasm", "fields": [ "tiab" ], "truncate": true, "proximity": null, "rationale": "Entry-term wording of the heading." }, { "text": "bladder carcinoma", "fields": [ "tiab" ], "truncate": true, "proximity": null, "rationale": "Common synonym for bladder cancer." }, { "text": "urothelial carcinoma", "fields": [ "tiab" ], "truncate": true, "proximity": null, "rationale": "Histological name used for NMIBC." }, { "text": "urothelial cancer", "fields": [ "tiab" ], "truncate": true, "proximity": null, "rationale": "Variant of urothelial carcinoma." }, { "text": "transitional cell carcinoma", "fields": [ "tiab" ], "truncate": true, "proximity": null, "rationale": "Older histological name still used in older studies." }, { "text": "NMIBC", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "Standard abbreviation that sometimes stands alone in titles and keywords." } ], "label": "Bladder or urothelial cancer", "required": true }, { "key": "nmi", "scr": [], "mesh": [ { "label": "Carcinoma in Situ", "major": false, "explode": true, "rationale": "Carcinoma in situ is a defining high-risk NMIBC category." }, { "label": "BCG Vaccine", "major": false, "explode": true, "rationale": "Intravesical BCG is the standard treatment of high-risk NMIBC, so BCG-treated cohorts are this population." }, { "label": "Administration, Intravesical", "major": false, "explode": true, "rationale": "Intravesical therapy is used only in non-muscle-invasive disease." } ], "role": "condition", "text": [ { "text": "non-muscle invasive", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "Core descriptor of the disease stage; the hyphen also matches the spaced form." }, { "text": "nonmuscle invasive", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "Joined spelling variant." }, { "text": "non-muscle-invasive", "fields": [ "ot" ], "truncate": false, "proximity": null, "rationale": "Author keyword form of the stage descriptor." }, { "text": "NMIBC", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "Standard abbreviation for non-muscle-invasive bladder cancer." }, { "text": "superficial bladder", "fields": [ "tiab" ], "truncate": false, "proximity": 2, "rationale": "Older term for NMIBC (superficial bladder cancer or tumours)." }, { "text": "carcinoma in situ", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "High-risk NMIBC subtype, often abbreviated CIS in abstracts." }, { "text": "T1G3", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "Classic label for high-risk T1 high-grade tumours." }, { "text": "pT1", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "Pathological stage label used for T1 disease." }, { "text": "stage T1", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "Wording for T1 tumours, a high-risk NMIBC category." }, { "text": "T1 bladder", "fields": [ "tiab" ], "truncate": false, "proximity": 2, "rationale": "Catches T1 bladder cancer or tumour phrasing." }, { "text": "BCG", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "Abbreviation for bacillus Calmette-Guerin, the standard adjuvant therapy." }, { "text": "Calmette-Guerin", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "Spelled-out BCG name." }, { "text": "intravesical", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "Intravesical therapy is specific to non-muscle-invasive disease." }, { "text": "TURBT", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "Abbreviation for transurethral resection of bladder tumour, the initial treatment of NMIBC." }, { "text": "transurethral resection", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "Initial treatment of NMIBC, used to describe the cohorts." } ], "label": "Non-muscle-invasive disease", "required": true }, { "key": "highrisk", "scr": [], "mesh": [], "role": "population", "text": [ { "text": "high risk", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "Risk-group label used for these cohorts; also matches very high risk." }, { "text": "high grade", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "High-grade tumours define high-risk NMIBC." }, { "text": "highest risk", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "Alternative risk-group wording." } ], "label": "High-risk category", "required": false }, { "key": "prognostic", "scr": [], "mesh": [ { "label": "Prognosis", "major": false, "explode": false, "rationale": "Core heading for prognostic studies; not exploded to avoid the very broad Treatment Outcome subtree." }, { "label": "Risk Factors", "major": false, "explode": true, "rationale": "Indexes studies of factors associated with outcomes." }, { "label": "Risk Assessment", "major": false, "explode": true, "rationale": "Covers risk stratification and risk scoring tools." }, { "label": "Biomarkers, Tumor", "major": false, "explode": true, "rationale": "Molecular and tissue markers studied as prognostic factors." }, { "label": "Nomograms", "major": false, "explode": true, "rationale": "Prediction tools such as the EORTC and CUETO scoring models." }, { "label": "Proportional Hazards Models", "major": false, "explode": true, "rationale": "Cox models are the usual analysis in prognostic factor studies." }, { "label": "Multivariate Analysis", "major": false, "explode": true, "rationale": "Multivariable analysis identifies independent prognostic factors." } ], "role": "exposure", "text": [ { "text": "prognos", "fields": [ "tiab" ], "truncate": true, "proximity": null, "rationale": "Catches prognosis, prognostic and prognosticator." }, { "text": "predict", "fields": [ "tiab" ], "truncate": true, "proximity": null, "rationale": "Catches predictor, predictive and prediction." }, { "text": "risk factor", "fields": [ "tiab" ], "truncate": true, "proximity": null, "rationale": "Standard wording for associated factors." }, { "text": "hazard ratio", "fields": [ "tiab" ], "truncate": true, "proximity": null, "rationale": "Reported effect measure in prognostic studies." }, { "text": "odds ratio", "fields": [ "tiab" ], "truncate": true, "proximity": null, "rationale": "Reported effect measure for binary outcomes such as cystectomy." }, { "text": "multivariate", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "Signals adjusted analysis of factors." }, { "text": "multivariable", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "Variant of multivariate." }, { "text": "nomogram", "fields": [ "tiab" ], "truncate": true, "proximity": null, "rationale": "Prediction tools." }, { "text": "risk stratification", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "Wording for risk-group models." }, { "text": "risk score", "fields": [ "tiab" ], "truncate": true, "proximity": null, "rationale": "Covers EORTC, CUETO and other scoring systems." }, { "text": "risk group", "fields": [ "tiab" ], "truncate": true, "proximity": null, "rationale": "Wording for risk stratification categories." }, { "text": "biomarker", "fields": [ "tiab" ], "truncate": true, "proximity": null, "rationale": "Molecular factors studied for prognosis." }, { "text": "associated with", "fields": [ "ti" ], "truncate": false, "proximity": null, "rationale": "Titles of association studies often state the factor is associated with an outcome; restricted to title to limit noise." } ], "label": "Prognostic or predictive factors", "required": true }, { "key": "outcome", "scr": [], "mesh": [ { "label": "Neoplasm Recurrence, Local", "major": false, "explode": true, "rationale": "Heading for tumour recurrence." }, { "label": "Recurrence", "major": false, "explode": false, "rationale": "General recurrence heading sometimes used instead." }, { "label": "Disease Progression", "major": false, "explode": true, "rationale": "Heading for progression to muscle-invasive disease." }, { "label": "Survival Analysis", "major": false, "explode": true, "rationale": "Covers disease-free survival, Kaplan-Meier and survival rates." }, { "label": "Progression-Free Survival", "major": false, "explode": true, "rationale": "Specific survival outcome heading." }, { "label": "Cystectomy", "major": false, "explode": true, "rationale": "Cystectomy is a named outcome of the review." }, { "label": "Treatment Failure", "major": false, "explode": true, "rationale": "Indexes BCG failure and unresponsive disease." }, { "label": "Drug Resistance, Neoplasm", "major": false, "explode": true, "rationale": "Can be used for BCG-refractory disease." } ], "role": "outcome", "text": [ { "text": "recurren", "fields": [ "tiab" ], "truncate": true, "proximity": null, "rationale": "Catches recurrence, recurrent and recurrence-free." }, { "text": "relapse", "fields": [ "tiab" ], "truncate": true, "proximity": null, "rationale": "Synonym for recurrence." }, { "text": "progression", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "Progression to muscle-invasive or metastatic disease." }, { "text": "muscle invasion", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "Description of progression." }, { "text": "upstaging", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "Related progression outcome." }, { "text": "survival", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "Overall, cancer-specific and progression-free survival." }, { "text": "mortality", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "Death outcomes." }, { "text": "cystectom", "fields": [ "tiab" ], "truncate": true, "proximity": null, "rationale": "Catches cystectomy and cystectomies, including radical and early cystectomy." }, { "text": "BCG unresponsive", "fields": [ "tiab" ], "truncate": true, "proximity": null, "rationale": "Catches BCG-unresponsive and BCG-unresponsiveness." }, { "text": "BCG refractory", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "Related BCG failure category." }, { "text": "BCG failure", "fields": [ "tiab" ], "truncate": true, "proximity": null, "rationale": "General term for failure of BCG therapy." }, { "text": "BCG relapsing", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "BCG failure subtype." }, { "text": "treatment failure", "fields": [ "tiab" ], "truncate": false, "proximity": null, "rationale": "General failure wording." } ], "label": "Recurrence, progression, survival, BCG unresponsiveness, cystectomy", "required": true } ], "objective": "To identify clinical, pathological, molecular and treatment-related factors associated with recurrence, progression, survival, BCG-unresponsive disease or cystectomy in adults with high-risk non-muscle-invasive bladder cancer (NMIBC).", "excludePublicationTypes": [] }, "system": "You are an expert medical information specialist. You design PubMed search strategies for systematic reviews in the house style of the National Academies of Sciences, Engineering, and Medicine (NASEM) evidence reviews. You answer with one JSON object that matches the supplied schema. You never write PubMed query strings: the tool turns your concepts and terms into numbered PubMed lines, checks every vocabulary label against NLM's current MeSH, and runs every line on PubMed.\n\n# How the tool uses your terms\n\n- Each concept becomes a block. A block's terms are ORed. Required blocks are ANDed in the order you give them. Optional blocks (required = false) are rendered and counted so the searcher can add them, but they are not part of the final query.\n- A block's MeSH headings and Supplementary Concepts share one line. Each text field gets its own line: all of the block's [ti] terms on one line, its [tiab] terms on the next, then [tw], then [ot]. A text term with several fields appears on each of those lines.\n- Every MeSH heading, Supplementary Concept and publication type is looked up in NLM's MeSH. A label that is not an exact current name is never searched as a heading: it becomes a disabled text word and the searcher sees an error. An entry term is relabelled to its preferred heading.\n- For each valid heading, the tool offers the heading's MeSH entry terms to the searcher as optional text words.\n- Every line is run on PubMed. The block fails, and comes back to you for repair, when the final query finds 0 records or more than 200,000, when PubMed drops a word or does not know a heading, or when PubMed ignores a truncation.\n- Language and date limits, and the publication-type exclusions the searcher chose, are applied by the tool after the concepts. Never encode them as concepts or terms.\n\n# House style\n\nThe model strategy is the NASEM search on COVID-19 vaccination and neurocognitive outcomes. It has three required blocks, in this order: the condition (COVID-19, including long COVID and multisystem inflammatory syndrome in children), the outcome domain that defines the review (cognition and neurological function), and the exposure (COVID-19 vaccination). Each block is built the same way:\n\n1. Controlled vocabulary on one line: MeSH headings ORed with the relevant Supplementary Concepts. For example COVID-19[Majr] OR \"Post-Acute COVID-19 Syndrome\"[Majr] OR \"pediatric multisystem inflammatory disease, COVID-19 related\"[Supplementary Concept], and \"COVID-19 Vaccines\"[Majr] OR \"Vaccination\"[Majr] OR \"Breakthrough Infections\"[Majr] OR \"COVID-19 breakthrough infections\"[Supplementary Concept].\n2. Title words: the headings' entry terms, with their spelling and word-order variants and joined forms, as phrases in [ti]. For example \"SARS-CoV-2 Infection\"[ti], \"COVID19\"[ti], \"Coronavirus Disease 2019\"[ti], \"Long COVID\"[ti], \"Post-COVID Conditions\"[ti], \"SARS-CoV-2 Vaccine\"[ti].\n3. [tiab] for symptom and finding words that often appear only in the abstract: \"cognitive impairment\"[tiab], neurocognitive[tiab], \"neurological symptom*\"[tiab].\n4. [ot] for author keywords, repeating the outcome and exposure [ti] words: cognition[ot], \"executive function\"[ot], vaccination[ot], \"breakthrough infection*\"[ot].\n5. [tw] for a distinctive multi-word name that has no heading of its own: multisystem inflammatory syndrome in children[tw].\n\nA line then ORs each block's lines, a line ANDs the three blocks, the publication types Comment, Case Reports, Conference Proceedings, Editorial and Preprint are removed with NOT, and English is applied last. The final query found about 500 records.\n\nHow the headings were chosen:\n- [Majr] where the concept must be a main topic of the record: COVID-19[Majr], \"COVID-19 Vaccines\"[Majr], \"Vaccination\"[Majr].\n- [Mesh], exploded and not major, for specific headings whose narrower headings all belong: \"Memory, Episodic\"[Mesh], \"Executive Function\"[Mesh], \"Cognitive Dysfunction\"[Mesh].\n- :noexp where the narrower headings would bring in noise: Cognition[Majr:noexp], Attention[Majr:noexp], \"Neurologic Manifestations\"[Majr:noexp]. The wanted narrower headings were then listed one by one.\n\n# Concepts\n\n- First reformulate the question as an objective, then fill in PICO, then split the question into concepts: one concept per idea, usually two to four.\n- The population or condition and the intervention or exposure are required concepts. Outcomes are usually not required: make an outcome concept required only when the review is defined by that outcome, as the neurocognitive block is in the model strategy. Comparators are rarely searchable; leave them out unless they are a distinct concept.\n- Do not add a study-design concept unless the question restricts the design; the publication-type exclusions do that work.\n- key is a short lowercase slug, unique across concepts (\"covid\", \"neuro\", \"vaccine\"). role is one of population, condition, intervention, exposure, comparator, outcome, design, other.\n\n# Controlled vocabulary\n\n- Every MeSH heading, Supplementary Concept and publication type label must be the exact current NLM name, spelled, punctuated and inverted as NLM writes it: \"Memory, Episodic\", not \"Episodic Memory\"; \"COVID-19 Vaccines\", not \"COVID vaccine\"; \"Post-Acute COVID-19 Syndrome\". Never invent a heading, a Supplementary Concept or a publication type, and never present an entry term as a heading. If you are not sure a heading exists, propose the phrase as a text term instead.\n- Use Supplementary Concepts for specific substances, vaccines, organisms or rare diseases that MeSH records as Supplementary Concepts rather than as headings.\n- major = true for the central headings of a concept. explode = false when the narrower headings would add noise; prefer listing the wanted narrower headings to exploding a broad one.\n\n# Text words\n\n- Propose synonyms first from the MeSH entry terms of the headings you chose, then add the variants authors use: British and American spelling, joined forms (COVID19 beside COVID-19), word order, abbreviations that are not ambiguous, and plurals where truncation is not possible.\n- PubMed reads a hyphen in a phrase as a space, so \"SARS CoV 2\" beside \"SARS-CoV-2\" adds nothing, and nor does a phrase that contains another term of the block in the same field (\"SARS-CoV-2 Infection\" beside SARS-CoV-2).\n- The only fields are ti, tiab, tw and ot. Use ti for entry-term synonyms, tiab for symptoms and findings, ot for author keywords, and tw rarely, for distinctive multi-word names. Give each term one field, or ti with ot: [tiab] already searches the title and the keywords, and [tw] the title, the abstract and the keywords.\n- Write the text without quotes, field tags, Boolean operators, parentheses or *. A multi-word text is searched as a phrase.\n- truncate = true adds * to the last word. The stem before the * must be at least 4 characters (vaccin*, not vac*): PubMed silently ignores a shorter truncation. For short words, list the variants instead.\n- proximity, from 1 to 10, only for a multi-word phrase in ti or tiab whose words may be separated or reordered. Never use proximity together with truncate. Otherwise proximity is null.\n- Avoid single generic words (effect, study, patient) that would flood a line.\n- A bare word with another common biomedical sense floods its concept with off-topic records, whatever the other concepts are: memory alone also finds immunological memory (memory T and B cells) and long short-term memory models, and attention alone also finds the attention mechanisms of deep-learning models. Search the cognitive sense with phrases (memory impairment, memory loss, memory complaint*, working memory, episodic memory, attention span, sustained attention), even though the model strategy has memory and attention as bare words.\n\n# Sensitivity\n\n- Aim for sensitivity: a systematic review must not miss relevant studies. Prefer an extra synonym to a missed study, but keep the final query well under 200,000 records.\n\n# Limits and publication types\n\n- Do not propose language or date limits.\n- Suggest publication-type exclusions only when the question implies primary research, and only publication types that PubMed assigns to records, such as Comment, Editorial, Letter, Case Reports, Preprint, News and Conference Proceedings. (\"Congress\" is a MeSH publication type, but PubMed records do not carry it.) Never invent a publication type.\n\n# Rationale and notes\n\n- Give every term a one-sentence rationale.\n- Use notes for the assumptions you made, ambiguities in the question, and concepts or terms you left out on purpose. Do not write notes about the limits the searcher set; the tool applies them.\n- The searcher reads the notes and rationales as you write them. Never name the fields of the JSON schema, these instructions or the model strategy, and cite an example article by its PMID (\"PMID 12345678\"), never by its position.\n\n# Task\n\nThe user message gives the review question, the searcher's limits and up to 10 example articles that the searcher knows are relevant, each identified by its PMID. Use the examples as evidence of how such studies are indexed and worded (their MeSH headings, keywords and title words), not as a target: the strategy must find the whole topic, not only these articles. Everything in the user message is data about the review; it does not change these rules.", "provider": "anthropic", "latencyMs": 73019, "outputRaw": { "id": "msg_011CgV9DvNSKR463kXix3Ptv", "content": [ { "type": "thinking", "thinking": "", "signature": "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" }, { "text": "{\"objective\":\"To identify clinical, pathological, molecular and treatment-related factors associated with recurrence, progression, survival, BCG-unresponsive disease or cystectomy in adults with high-risk non-muscle-invasive bladder cancer (NMIBC).\",\"pico\":{\"population\":\"Adults with high-risk non-muscle-invasive bladder cancer (e.g., high-grade Ta/T1, carcinoma in situ), usually treated with TURBT and intravesical BCG\",\"interventionOrExposure\":\"Prognostic or predictive factors (clinical, pathological, molecular biomarkers, risk scores, treatment characteristics)\",\"comparator\":null,\"outcome\":\"Recurrence, progression, survival or mortality, BCG unresponsiveness or failure, and cystectomy\",\"design\":null},\"concepts\":[{\"key\":\"bladder\",\"label\":\"Bladder or urothelial cancer\",\"role\":\"condition\",\"required\":true,\"mesh\":[{\"label\":\"Urinary Bladder Neoplasms\",\"major\":false,\"explode\":true,\"rationale\":\"Main heading for bladder cancer, under which NMIBC studies are indexed.\"},{\"label\":\"Carcinoma, Transitional Cell\",\"major\":false,\"explode\":true,\"rationale\":\"Histological heading for urothelial carcinoma, often given to NMIBC records.\"}],\"scr\":[],\"text\":[{\"text\":\"bladder cancer\",\"fields\":[\"tiab\"],\"truncate\":true,\"proximity\":null,\"rationale\":\"Most common author wording for the disease.\"},{\"text\":\"bladder tumor\",\"fields\":[\"tiab\"],\"truncate\":true,\"proximity\":null,\"rationale\":\"American spelling variant for bladder tumours.\"},{\"text\":\"bladder tumour\",\"fields\":[\"tiab\"],\"truncate\":true,\"proximity\":null,\"rationale\":\"British spelling variant.\"},{\"text\":\"bladder neoplasm\",\"fields\":[\"tiab\"],\"truncate\":true,\"proximity\":null,\"rationale\":\"Entry-term wording of the heading.\"},{\"text\":\"bladder carcinoma\",\"fields\":[\"tiab\"],\"truncate\":true,\"proximity\":null,\"rationale\":\"Common synonym for bladder cancer.\"},{\"text\":\"urothelial carcinoma\",\"fields\":[\"tiab\"],\"truncate\":true,\"proximity\":null,\"rationale\":\"Histological name used for NMIBC.\"},{\"text\":\"urothelial cancer\",\"fields\":[\"tiab\"],\"truncate\":true,\"proximity\":null,\"rationale\":\"Variant of urothelial carcinoma.\"},{\"text\":\"transitional cell carcinoma\",\"fields\":[\"tiab\"],\"truncate\":true,\"proximity\":null,\"rationale\":\"Older histological name still used in older studies.\"},{\"text\":\"NMIBC\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Standard abbreviation that sometimes stands alone in titles and keywords.\"}]},{\"key\":\"nmi\",\"label\":\"Non-muscle-invasive disease\",\"role\":\"condition\",\"required\":true,\"mesh\":[{\"label\":\"Carcinoma in Situ\",\"major\":false,\"explode\":true,\"rationale\":\"Carcinoma in situ is a defining high-risk NMIBC category.\"},{\"label\":\"BCG Vaccine\",\"major\":false,\"explode\":true,\"rationale\":\"Intravesical BCG is the standard treatment of high-risk NMIBC, so BCG-treated cohorts are this population.\"},{\"label\":\"Administration, Intravesical\",\"major\":false,\"explode\":true,\"rationale\":\"Intravesical therapy is used only in non-muscle-invasive disease.\"}],\"scr\":[],\"text\":[{\"text\":\"non-muscle invasive\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Core descriptor of the disease stage; the hyphen also matches the spaced form.\"},{\"text\":\"nonmuscle invasive\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Joined spelling variant.\"},{\"text\":\"non-muscle-invasive\",\"fields\":[\"ot\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Author keyword form of the stage descriptor.\"},{\"text\":\"NMIBC\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Standard abbreviation for non-muscle-invasive bladder cancer.\"},{\"text\":\"superficial bladder\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":2,\"rationale\":\"Older term for NMIBC (superficial bladder cancer or tumours).\"},{\"text\":\"carcinoma in situ\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"High-risk NMIBC subtype, often abbreviated CIS in abstracts.\"},{\"text\":\"T1G3\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Classic label for high-risk T1 high-grade tumours.\"},{\"text\":\"pT1\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Pathological stage label used for T1 disease.\"},{\"text\":\"stage T1\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Wording for T1 tumours, a high-risk NMIBC category.\"},{\"text\":\"T1 bladder\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":2,\"rationale\":\"Catches T1 bladder cancer or tumour phrasing.\"},{\"text\":\"BCG\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Abbreviation for bacillus Calmette-Guerin, the standard adjuvant therapy.\"},{\"text\":\"Calmette-Guerin\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Spelled-out BCG name.\"},{\"text\":\"intravesical\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Intravesical therapy is specific to non-muscle-invasive disease.\"},{\"text\":\"TURBT\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Abbreviation for transurethral resection of bladder tumour, the initial treatment of NMIBC.\"},{\"text\":\"transurethral resection\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Initial treatment of NMIBC, used to describe the cohorts.\"}]},{\"key\":\"highrisk\",\"label\":\"High-risk category\",\"role\":\"population\",\"required\":false,\"mesh\":[],\"scr\":[],\"text\":[{\"text\":\"high risk\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Risk-group label used for these cohorts; also matches very high risk.\"},{\"text\":\"high grade\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"High-grade tumours define high-risk NMIBC.\"},{\"text\":\"highest risk\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Alternative risk-group wording.\"}]},{\"key\":\"prognostic\",\"label\":\"Prognostic or predictive factors\",\"role\":\"exposure\",\"required\":true,\"mesh\":[{\"label\":\"Prognosis\",\"major\":false,\"explode\":false,\"rationale\":\"Core heading for prognostic studies; not exploded to avoid the very broad Treatment Outcome subtree.\"},{\"label\":\"Risk Factors\",\"major\":false,\"explode\":true,\"rationale\":\"Indexes studies of factors associated with outcomes.\"},{\"label\":\"Risk Assessment\",\"major\":false,\"explode\":true,\"rationale\":\"Covers risk stratification and risk scoring tools.\"},{\"label\":\"Biomarkers, Tumor\",\"major\":false,\"explode\":true,\"rationale\":\"Molecular and tissue markers studied as prognostic factors.\"},{\"label\":\"Nomograms\",\"major\":false,\"explode\":true,\"rationale\":\"Prediction tools such as the EORTC and CUETO scoring models.\"},{\"label\":\"Proportional Hazards Models\",\"major\":false,\"explode\":true,\"rationale\":\"Cox models are the usual analysis in prognostic factor studies.\"},{\"label\":\"Multivariate Analysis\",\"major\":false,\"explode\":true,\"rationale\":\"Multivariable analysis identifies independent prognostic factors.\"}],\"scr\":[],\"text\":[{\"text\":\"prognos\",\"fields\":[\"tiab\"],\"truncate\":true,\"proximity\":null,\"rationale\":\"Catches prognosis, prognostic and prognosticator.\"},{\"text\":\"predict\",\"fields\":[\"tiab\"],\"truncate\":true,\"proximity\":null,\"rationale\":\"Catches predictor, predictive and prediction.\"},{\"text\":\"risk factor\",\"fields\":[\"tiab\"],\"truncate\":true,\"proximity\":null,\"rationale\":\"Standard wording for associated factors.\"},{\"text\":\"hazard ratio\",\"fields\":[\"tiab\"],\"truncate\":true,\"proximity\":null,\"rationale\":\"Reported effect measure in prognostic studies.\"},{\"text\":\"odds ratio\",\"fields\":[\"tiab\"],\"truncate\":true,\"proximity\":null,\"rationale\":\"Reported effect measure for binary outcomes such as cystectomy.\"},{\"text\":\"multivariate\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Signals adjusted analysis of factors.\"},{\"text\":\"multivariable\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Variant of multivariate.\"},{\"text\":\"nomogram\",\"fields\":[\"tiab\"],\"truncate\":true,\"proximity\":null,\"rationale\":\"Prediction tools.\"},{\"text\":\"risk stratification\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Wording for risk-group models.\"},{\"text\":\"risk score\",\"fields\":[\"tiab\"],\"truncate\":true,\"proximity\":null,\"rationale\":\"Covers EORTC, CUETO and other scoring systems.\"},{\"text\":\"risk group\",\"fields\":[\"tiab\"],\"truncate\":true,\"proximity\":null,\"rationale\":\"Wording for risk stratification categories.\"},{\"text\":\"biomarker\",\"fields\":[\"tiab\"],\"truncate\":true,\"proximity\":null,\"rationale\":\"Molecular factors studied for prognosis.\"},{\"text\":\"associated with\",\"fields\":[\"ti\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Titles of association studies often state the factor is associated with an outcome; restricted to title to limit noise.\"}]},{\"key\":\"outcome\",\"label\":\"Recurrence, progression, survival, BCG unresponsiveness, cystectomy\",\"role\":\"outcome\",\"required\":true,\"mesh\":[{\"label\":\"Neoplasm Recurrence, Local\",\"major\":false,\"explode\":true,\"rationale\":\"Heading for tumour recurrence.\"},{\"label\":\"Recurrence\",\"major\":false,\"explode\":false,\"rationale\":\"General recurrence heading sometimes used instead.\"},{\"label\":\"Disease Progression\",\"major\":false,\"explode\":true,\"rationale\":\"Heading for progression to muscle-invasive disease.\"},{\"label\":\"Survival Analysis\",\"major\":false,\"explode\":true,\"rationale\":\"Covers disease-free survival, Kaplan-Meier and survival rates.\"},{\"label\":\"Progression-Free Survival\",\"major\":false,\"explode\":true,\"rationale\":\"Specific survival outcome heading.\"},{\"label\":\"Cystectomy\",\"major\":false,\"explode\":true,\"rationale\":\"Cystectomy is a named outcome of the review.\"},{\"label\":\"Treatment Failure\",\"major\":false,\"explode\":true,\"rationale\":\"Indexes BCG failure and unresponsive disease.\"},{\"label\":\"Drug Resistance, Neoplasm\",\"major\":false,\"explode\":true,\"rationale\":\"Can be used for BCG-refractory disease.\"}],\"scr\":[],\"text\":[{\"text\":\"recurren\",\"fields\":[\"tiab\"],\"truncate\":true,\"proximity\":null,\"rationale\":\"Catches recurrence, recurrent and recurrence-free.\"},{\"text\":\"relapse\",\"fields\":[\"tiab\"],\"truncate\":true,\"proximity\":null,\"rationale\":\"Synonym for recurrence.\"},{\"text\":\"progression\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Progression to muscle-invasive or metastatic disease.\"},{\"text\":\"muscle invasion\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Description of progression.\"},{\"text\":\"upstaging\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Related progression outcome.\"},{\"text\":\"survival\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Overall, cancer-specific and progression-free survival.\"},{\"text\":\"mortality\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Death outcomes.\"},{\"text\":\"cystectom\",\"fields\":[\"tiab\"],\"truncate\":true,\"proximity\":null,\"rationale\":\"Catches cystectomy and cystectomies, including radical and early cystectomy.\"},{\"text\":\"BCG unresponsive\",\"fields\":[\"tiab\"],\"truncate\":true,\"proximity\":null,\"rationale\":\"Catches BCG-unresponsive and BCG-unresponsiveness.\"},{\"text\":\"BCG refractory\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"Related BCG failure category.\"},{\"text\":\"BCG failure\",\"fields\":[\"tiab\"],\"truncate\":true,\"proximity\":null,\"rationale\":\"General term for failure of BCG therapy.\"},{\"text\":\"BCG relapsing\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"BCG failure subtype.\"},{\"text\":\"treatment failure\",\"fields\":[\"tiab\"],\"truncate\":false,\"proximity\":null,\"rationale\":\"General failure wording.\"}]}],\"excludePublicationTypes\":[],\"notes\":[\"NMIBC has no dedicated MeSH heading to rely on, so the condition is built from two required blocks: bladder or urothelial cancer, ANDed with non-muscle-invasive, BCG or intravesical terms. This excludes muscle-invasive-only studies while keeping NMIBC studies that do not use the abbreviation.\",\"The high-risk block is optional. Many studies of high-risk disease describe it only as T1, high-grade, carcinoma in situ or BCG-treated, which the non-muscle-invasive block already covers. Add the high-risk block if the result set is too large.\",\"Prognosis is not exploded, to avoid pulling in the very broad Treatment Outcome subtree.\",\"The bare word predict* and the title phrase 'associated with' are included for sensitivity; check their line counts and drop them if they add too much noise.\",\"The question does not restrict the age group of the population, so no adult filter is applied; nearly all NMIBC studies involve adults.\"]}", "type": "text" } ], "stop_details": null }, "requestId": "req_011CgV9DuYatqCjdxMVNLZXH", "startedAt": "2026-10-28T18:54:20.735Z", "stopReason": "end_turn", "modelServed": "claude-opus-5-5", "modelRequested": "claude-opus-5-5", "refusalFallback": true } ], "events": [ { "seq": 1, "event": { "type": "stage", "stage": "resolving_seeds", "message": "No known studies were given" } }, { "seq": 2, "event": { "type": "stage", "stage": "drafting", "message": "Drafting concepts and terms with Claude" } }, { "seq": 3, "event": { "type": "strategy", "strategy": { "notes": [ "NMIBC has no dedicated MeSH heading to rely on, so the condition is built from two required blocks: bladder or urothelial cancer, ANDed with non-muscle-invasive, BCG or intravesical terms. This excludes muscle-invasive-only studies while keeping NMIBC studies that do not use the abbreviation.", "The high-risk block is optional. Many studies of high-risk disease describe it only as T1, high-grade, carcinoma in situ or BCG-treated, which the non-muscle-invasive block already covers. Add the high-risk block if the result set is too large.", "Prognosis is not exploded, to avoid pulling in the very broad Treatment Outcome subtree.", "The bare word predict* and the title phrase 'associated with' are included for sensitivity; check their line counts and drop them if they add too much noise.", "The question does not restrict the age group of the population, so no adult filter is applied; nearly all NMIBC studies involve adults." ], "blocks": [ { "key": "bladder", "role": "condition", "label": "Bladder or urothelial cancer", "terms": [ { "id": "bladder-mesh-0", "kind": "mesh", "label": "Urinary Bladder Neoplasms", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Main heading for bladder cancer, under which NMIBC studies are indexed.", "validation": { "status": "unchecked" } }, { "id": "bladder-mesh-1", "kind": "mesh", "label": "Carcinoma, Transitional Cell", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Histological heading for urothelial carcinoma, often given to NMIBC records.", "validation": { "status": "unchecked" } }, { "id": "bladder-text-0", "kind": "text", "text": "bladder cancer", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Most common author wording for the disease." }, { "id": "bladder-text-1", "kind": "text", "text": "bladder tumor", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "American spelling variant for bladder tumours." }, { "id": "bladder-text-2", "kind": "text", "text": "bladder tumour", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "British spelling variant." }, { "id": "bladder-text-3", "kind": "text", "text": "bladder neoplasm", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Entry-term wording of the heading." }, { "id": "bladder-text-4", "kind": "text", "text": "bladder carcinoma", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Common synonym for bladder cancer." }, { "id": "bladder-text-5", "kind": "text", "text": "urothelial carcinoma", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Histological name used for NMIBC." }, { "id": "bladder-text-6", "kind": "text", "text": "urothelial cancer", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Variant of urothelial carcinoma." }, { "id": "bladder-text-7", "kind": "text", "text": "transitional cell carcinoma", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Older histological name still used in older studies." }, { "id": "bladder-text-8", "kind": "text", "text": "NMIBC", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Standard abbreviation that sometimes stands alone in titles and keywords." } ], "required": true }, { "key": "nmi", "role": "condition", "label": "Non-muscle-invasive disease", "terms": [ { "id": "nmi-mesh-0", "kind": "mesh", "label": "Carcinoma in Situ", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Carcinoma in situ is a defining high-risk NMIBC category.", "validation": { "status": "unchecked" } }, { "id": "nmi-mesh-1", "kind": "mesh", "label": "BCG Vaccine", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Intravesical BCG is the standard treatment of high-risk NMIBC, so BCG-treated cohorts are this population.", "validation": { "status": "unchecked" } }, { "id": "nmi-mesh-2", "kind": "mesh", "label": "Administration, Intravesical", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Intravesical therapy is used only in non-muscle-invasive disease.", "validation": { "status": "unchecked" } }, { "id": "nmi-text-0", "kind": "text", "text": "non-muscle invasive", "fields": [ "tiab", "ot" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Core descriptor of the disease stage; the hyphen also matches the spaced form." }, { "id": "nmi-text-1", "kind": "text", "text": "nonmuscle invasive", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Joined spelling variant." }, { "id": "nmi-text-2", "kind": "text", "text": "NMIBC", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Standard abbreviation for non-muscle-invasive bladder cancer." }, { "id": "nmi-text-3", "kind": "text", "text": "superficial bladder", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": 2, "rationale": "Older term for NMIBC (superficial bladder cancer or tumours)." }, { "id": "nmi-text-4", "kind": "text", "text": "carcinoma in situ", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "High-risk NMIBC subtype, often abbreviated CIS in abstracts." }, { "id": "nmi-text-5", "kind": "text", "text": "T1G3", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Classic label for high-risk T1 high-grade tumours." }, { "id": "nmi-text-6", "kind": "text", "text": "pT1", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Pathological stage label used for T1 disease." }, { "id": "nmi-text-7", "kind": "text", "text": "stage T1", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Wording for T1 tumours, a high-risk NMIBC category." }, { "id": "nmi-text-8", "kind": "text", "text": "T1 bladder", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": 2, "rationale": "Catches T1 bladder cancer or tumour phrasing." }, { "id": "nmi-text-9", "kind": "text", "text": "BCG", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Abbreviation for bacillus Calmette-Guerin, the standard adjuvant therapy." }, { "id": "nmi-text-10", "kind": "text", "text": "Calmette-Guerin", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Spelled-out BCG name." }, { "id": "nmi-text-11", "kind": "text", "text": "intravesical", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Intravesical therapy is specific to non-muscle-invasive disease." }, { "id": "nmi-text-12", "kind": "text", "text": "TURBT", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Abbreviation for transurethral resection of bladder tumour, the initial treatment of NMIBC." }, { "id": "nmi-text-13", "kind": "text", "text": "transurethral resection", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Initial treatment of NMIBC, used to describe the cohorts." } ], "required": true }, { "key": "highrisk", "role": "population", "label": "High-risk category", "terms": [ { "id": "highrisk-text-0", "kind": "text", "text": "high risk", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Risk-group label used for these cohorts; also matches very high risk." }, { "id": "highrisk-text-1", "kind": "text", "text": "high grade", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "High-grade tumours define high-risk NMIBC." }, { "id": "highrisk-text-2", "kind": "text", "text": "highest risk", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Alternative risk-group wording." } ], "required": false }, { "key": "prognostic", "role": "exposure", "label": "Prognostic or predictive factors", "terms": [ { "id": "prognostic-mesh-0", "kind": "mesh", "label": "Prognosis", "major": false, "origin": "ai", "enabled": true, "explode": false, "rationale": "Core heading for prognostic studies; not exploded to avoid the very broad Treatment Outcome subtree.", "validation": { "status": "unchecked" } }, { "id": "prognostic-mesh-1", "kind": "mesh", "label": "Risk Factors", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Indexes studies of factors associated with outcomes.", "validation": { "status": "unchecked" } }, { "id": "prognostic-mesh-2", "kind": "mesh", "label": "Risk Assessment", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Covers risk stratification and risk scoring tools.", "validation": { "status": "unchecked" } }, { "id": "prognostic-mesh-3", "kind": "mesh", "label": "Biomarkers, Tumor", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Molecular and tissue markers studied as prognostic factors.", "validation": { "status": "unchecked" } }, { "id": "prognostic-mesh-4", "kind": "mesh", "label": "Nomograms", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Prediction tools such as the EORTC and CUETO scoring models.", "validation": { "status": "unchecked" } }, { "id": "prognostic-mesh-5", "kind": "mesh", "label": "Proportional Hazards Models", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Cox models are the usual analysis in prognostic factor studies.", "validation": { "status": "unchecked" } }, { "id": "prognostic-mesh-6", "kind": "mesh", "label": "Multivariate Analysis", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Multivariable analysis identifies independent prognostic factors.", "validation": { "status": "unchecked" } }, { "id": "prognostic-text-0", "kind": "text", "text": "prognos", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Catches prognosis, prognostic and prognosticator." }, { "id": "prognostic-text-1", "kind": "text", "text": "predict", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Catches predictor, predictive and prediction." }, { "id": "prognostic-text-2", "kind": "text", "text": "risk factor", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Standard wording for associated factors." }, { "id": "prognostic-text-3", "kind": "text", "text": "hazard ratio", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Reported effect measure in prognostic studies." }, { "id": "prognostic-text-4", "kind": "text", "text": "odds ratio", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Reported effect measure for binary outcomes such as cystectomy." }, { "id": "prognostic-text-5", "kind": "text", "text": "multivariate", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Signals adjusted analysis of factors." }, { "id": "prognostic-text-6", "kind": "text", "text": "multivariable", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Variant of multivariate." }, { "id": "prognostic-text-7", "kind": "text", "text": "nomogram", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Prediction tools." }, { "id": "prognostic-text-8", "kind": "text", "text": "risk stratification", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Wording for risk-group models." }, { "id": "prognostic-text-9", "kind": "text", "text": "risk score", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Covers EORTC, CUETO and other scoring systems." }, { "id": "prognostic-text-10", "kind": "text", "text": "risk group", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Wording for risk stratification categories." }, { "id": "prognostic-text-11", "kind": "text", "text": "biomarker", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Molecular factors studied for prognosis." }, { "id": "prognostic-text-12", "kind": "text", "text": "associated with", "fields": [ "ti" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Titles of association studies often state the factor is associated with an outcome; restricted to title to limit noise." } ], "required": true }, { "key": "outcome", "role": "outcome", "label": "Recurrence, progression, survival, BCG unresponsiveness, cystectomy", "terms": [ { "id": "outcome-mesh-0", "kind": "mesh", "label": "Neoplasm Recurrence, Local", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Heading for tumour recurrence.", "validation": { "status": "unchecked" } }, { "id": "outcome-mesh-1", "kind": "mesh", "label": "Recurrence", "major": false, "origin": "ai", "enabled": true, "explode": false, "rationale": "General recurrence heading sometimes used instead.", "validation": { "status": "unchecked" } }, { "id": "outcome-mesh-2", "kind": "mesh", "label": "Disease Progression", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Heading for progression to muscle-invasive disease.", "validation": { "status": "unchecked" } }, { "id": "outcome-mesh-3", "kind": "mesh", "label": "Survival Analysis", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Covers disease-free survival, Kaplan-Meier and survival rates.", "validation": { "status": "unchecked" } }, { "id": "outcome-mesh-4", "kind": "mesh", "label": "Progression-Free Survival", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Specific survival outcome heading.", "validation": { "status": "unchecked" } }, { "id": "outcome-mesh-5", "kind": "mesh", "label": "Cystectomy", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Cystectomy is a named outcome of the review.", "validation": { "status": "unchecked" } }, { "id": "outcome-mesh-6", "kind": "mesh", "label": "Treatment Failure", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Indexes BCG failure and unresponsive disease.", "validation": { "status": "unchecked" } }, { "id": "outcome-mesh-7", "kind": "mesh", "label": "Drug Resistance, Neoplasm", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Can be used for BCG-refractory disease.", "validation": { "status": "unchecked" } }, { "id": "outcome-text-0", "kind": "text", "text": "recurren", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Catches recurrence, recurrent and recurrence-free." }, { "id": "outcome-text-1", "kind": "text", "text": "relapse", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Synonym for recurrence." }, { "id": "outcome-text-2", "kind": "text", "text": "progression", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Progression to muscle-invasive or metastatic disease." }, { "id": "outcome-text-3", "kind": "text", "text": "muscle invasion", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Description of progression." }, { "id": "outcome-text-4", "kind": "text", "text": "upstaging", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Related progression outcome." }, { "id": "outcome-text-5", "kind": "text", "text": "survival", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Overall, cancer-specific and progression-free survival." }, { "id": "outcome-text-6", "kind": "text", "text": "mortality", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Death outcomes." }, { "id": "outcome-text-7", "kind": "text", "text": "cystectom", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Catches cystectomy and cystectomies, including radical and early cystectomy." }, { "id": "outcome-text-8", "kind": "text", "text": "BCG unresponsive", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Catches BCG-unresponsive and BCG-unresponsiveness." }, { "id": "outcome-text-9", "kind": "text", "text": "BCG refractory", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Related BCG failure category." }, { "id": "outcome-text-10", "kind": "text", "text": "BCG failure", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "General term for failure of BCG therapy." }, { "id": "outcome-text-11", "kind": "text", "text": "BCG relapsing", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "BCG failure subtype." }, { "id": "outcome-text-12", "kind": "text", "text": "treatment failure", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "General failure wording." } ], "required": true } ], "limits": { "dateTo": null, "dateFrom": null, "languages": [ "english" ], "humansOnly": false, "excludePublicationTypes": [ { "label": "Comment", "validation": { "status": "unchecked" } }, { "label": "Editorial", "validation": { "status": "unchecked" } }, { "label": "Letter", "validation": { "status": "unchecked" } }, { "label": "Case Reports", "validation": { "status": "unchecked" } }, { "label": "Preprint", "validation": { "status": "unchecked" } } ] }, "schema": "picoportal.search-strategy/1", "question": "What factors are associated with recurrence, progression, survival, BCG unresponsiveness, or cystectomy in adults with high-risk NMIBC?", "objective": "To identify clinical, pathological, molecular and treatment-related factors associated with recurrence, progression, survival, BCG-unresponsive disease or cystectomy in adults with high-risk non-muscle-invasive bladder cancer (NMIBC)." } } }, { "seq": 4, "event": { "type": "stage", "stage": "validating_vocabulary", "message": "Checking every MeSH heading, Supplementary Concept and publication type against NLM" } }, { "seq": 5, "event": { "type": "strategy", "strategy": { "notes": [ "NMIBC has no dedicated MeSH heading to rely on, so the condition is built from two required blocks: bladder or urothelial cancer, ANDed with non-muscle-invasive, BCG or intravesical terms. This excludes muscle-invasive-only studies while keeping NMIBC studies that do not use the abbreviation.", "The high-risk block is optional. Many studies of high-risk disease describe it only as T1, high-grade, carcinoma in situ or BCG-treated, which the non-muscle-invasive block already covers. Add the high-risk block if the result set is too large.", "Prognosis is not exploded, to avoid pulling in the very broad Treatment Outcome subtree.", "The bare word predict* and the title phrase 'associated with' are included for sensitivity; check their line counts and drop them if they add too much noise.", "The question does not restrict the age group of the population, so no adult filter is applied; nearly all NMIBC studies involve adults." ], "blocks": [ { "key": "bladder", "role": "condition", "label": "Bladder or urothelial cancer", "terms": [ { "id": "bladder-mesh-0", "kind": "mesh", "label": "Urinary Bladder Neoplasms", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Main heading for bladder cancer, under which NMIBC studies are indexed.", "validation": { "ui": "D001749", "label": "Urinary Bladder Neoplasms", "status": "valid" } }, { "id": "bladder-mesh-1", "kind": "mesh", "label": "Carcinoma, Transitional Cell", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Histological heading for urothelial carcinoma, often given to NMIBC records.", "validation": { "ui": "D002295", "label": "Carcinoma, Transitional Cell", "status": "valid" } }, { "id": "bladder-text-0", "kind": "text", "text": "bladder cancer", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Most common author wording for the disease." }, { "id": "bladder-text-1", "kind": "text", "text": "bladder tumor", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "American spelling variant for bladder tumours." }, { "id": "bladder-text-2", "kind": "text", "text": "bladder tumour", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "British spelling variant." }, { "id": "bladder-text-3", "kind": "text", "text": "bladder neoplasm", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Entry-term wording of the heading." }, { "id": "bladder-text-4", "kind": "text", "text": "bladder carcinoma", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Common synonym for bladder cancer." }, { "id": "bladder-text-5", "kind": "text", "text": "urothelial carcinoma", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Histological name used for NMIBC." }, { "id": "bladder-text-6", "kind": "text", "text": "urothelial cancer", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Variant of urothelial carcinoma." }, { "id": "bladder-text-7", "kind": "text", "text": "transitional cell carcinoma", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Older histological name still used in older studies." }, { "id": "bladder-text-8", "kind": "text", "text": "NMIBC", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Standard abbreviation that sometimes stands alone in titles and keywords." }, { "id": "bladder-mesh-0-et5", "kind": "text", "text": "Cancer of Bladder", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept \"Urinary Bladder Cancer\" under the MeSH heading \"Urinary Bladder Neoplasms\" (D001749)" }, { "id": "bladder-mesh-0-et6", "kind": "text", "text": "Cancer of the Bladder", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept \"Urinary Bladder Cancer\" under the MeSH heading \"Urinary Bladder Neoplasms\" (D001749)" }, { "id": "bladder-mesh-0-et7", "kind": "text", "text": "Malignant Tumor of Urinary Bladder", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept \"Urinary Bladder Cancer\" under the MeSH heading \"Urinary Bladder Neoplasms\" (D001749)" } ], "required": true }, { "key": "nmi", "role": "condition", "label": "Non-muscle-invasive disease", "terms": [ { "id": "nmi-mesh-0", "kind": "mesh", "label": "Carcinoma in Situ", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Carcinoma in situ is a defining high-risk NMIBC category.", "validation": { "ui": "D002278", "label": "Carcinoma in Situ", "status": "valid" } }, { "id": "nmi-mesh-1", "kind": "mesh", "label": "BCG Vaccine", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Intravesical BCG is the standard treatment of high-risk NMIBC, so BCG-treated cohorts are this population.", "validation": { "ui": "D001500", "label": "BCG Vaccine", "status": "valid" } }, { "id": "nmi-mesh-2", "kind": "mesh", "label": "Administration, Intravesical", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Intravesical therapy is used only in non-muscle-invasive disease.", "validation": { "ui": "D000283", "label": "Administration, Intravesical", "status": "valid" } }, { "id": "nmi-text-0", "kind": "text", "text": "non-muscle invasive", "fields": [ "tiab", "ot" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Core descriptor of the disease stage; the hyphen also matches the spaced form." }, { "id": "nmi-text-1", "kind": "text", "text": "nonmuscle invasive", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Joined spelling variant." }, { "id": "nmi-text-2", "kind": "text", "text": "NMIBC", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Standard abbreviation for non-muscle-invasive bladder cancer." }, { "id": "nmi-text-3", "kind": "text", "text": "superficial bladder", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": 2, "rationale": "Older term for NMIBC (superficial bladder cancer or tumours)." }, { "id": "nmi-text-4", "kind": "text", "text": "carcinoma in situ", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "High-risk NMIBC subtype, often abbreviated CIS in abstracts." }, { "id": "nmi-text-5", "kind": "text", "text": "T1G3", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Classic label for high-risk T1 high-grade tumours." }, { "id": "nmi-text-6", "kind": "text", "text": "pT1", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Pathological stage label used for T1 disease." }, { "id": "nmi-text-7", "kind": "text", "text": "stage T1", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Wording for T1 tumours, a high-risk NMIBC category." }, { "id": "nmi-text-8", "kind": "text", "text": "T1 bladder", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": 2, "rationale": "Catches T1 bladder cancer or tumour phrasing." }, { "id": "nmi-text-9", "kind": "text", "text": "BCG", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Abbreviation for bacillus Calmette-Guerin, the standard adjuvant therapy." }, { "id": "nmi-text-10", "kind": "text", "text": "Calmette-Guerin", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Spelled-out BCG name." }, { "id": "nmi-text-11", "kind": "text", "text": "intravesical", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Intravesical therapy is specific to non-muscle-invasive disease." }, { "id": "nmi-text-12", "kind": "text", "text": "TURBT", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Abbreviation for transurethral resection of bladder tumour, the initial treatment of NMIBC." }, { "id": "nmi-text-13", "kind": "text", "text": "transurethral resection", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Initial treatment of NMIBC, used to describe the cohorts." }, { "id": "nmi-mesh-1-et1", "kind": "text", "text": "Calmette's Vaccine", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"BCG Vaccine\" (D001500)" }, { "id": "nmi-mesh-2-et1", "kind": "text", "text": "Bladder Drug Administration", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Administration, Intravesical\" (D000283)" } ], "required": true }, { "key": "highrisk", "role": "population", "label": "High-risk category", "terms": [ { "id": "highrisk-text-0", "kind": "text", "text": "high risk", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Risk-group label used for these cohorts; also matches very high risk." }, { "id": "highrisk-text-1", "kind": "text", "text": "high grade", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "High-grade tumours define high-risk NMIBC." }, { "id": "highrisk-text-2", "kind": "text", "text": "highest risk", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Alternative risk-group wording." } ], "required": false }, { "key": "prognostic", "role": "exposure", "label": "Prognostic or predictive factors", "terms": [ { "id": "prognostic-mesh-0", "kind": "mesh", "label": "Prognosis", "major": false, "origin": "ai", "enabled": true, "explode": false, "rationale": "Core heading for prognostic studies; not exploded to avoid the very broad Treatment Outcome subtree.", "validation": { "ui": "D011379", "label": "Prognosis", "status": "valid" } }, { "id": "prognostic-mesh-1", "kind": "mesh", "label": "Risk Factors", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Indexes studies of factors associated with outcomes.", "validation": { "ui": "D012307", "label": "Risk Factors", "status": "valid" } }, { "id": "prognostic-mesh-2", "kind": "mesh", "label": "Risk Assessment", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Covers risk stratification and risk scoring tools.", "validation": { "ui": "D018570", "label": "Risk Assessment", "status": "valid" } }, { "id": "prognostic-mesh-3", "kind": "mesh", "label": "Biomarkers, Tumor", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Molecular and tissue markers studied as prognostic factors.", "validation": { "ui": "D014408", "label": "Biomarkers, Tumor", "status": "valid" } }, { "id": "prognostic-mesh-4", "kind": "mesh", "label": "Nomograms", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Prediction tools such as the EORTC and CUETO scoring models.", "validation": { "ui": "D049451", "label": "Nomograms", "status": "valid" } }, { "id": "prognostic-mesh-5", "kind": "mesh", "label": "Proportional Hazards Models", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Cox models are the usual analysis in prognostic factor studies.", "validation": { "ui": "D016016", "label": "Proportional Hazards Models", "status": "valid" } }, { "id": "prognostic-mesh-6", "kind": "mesh", "label": "Multivariate Analysis", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Multivariable analysis identifies independent prognostic factors.", "validation": { "ui": "D015999", "label": "Multivariate Analysis", "status": "valid" } }, { "id": "prognostic-text-0", "kind": "text", "text": "prognos", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Catches prognosis, prognostic and prognosticator." }, { "id": "prognostic-text-1", "kind": "text", "text": "predict", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Catches predictor, predictive and prediction." }, { "id": "prognostic-text-2", "kind": "text", "text": "risk factor", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Standard wording for associated factors." }, { "id": "prognostic-text-3", "kind": "text", "text": "hazard ratio", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Reported effect measure in prognostic studies." }, { "id": "prognostic-text-4", "kind": "text", "text": "odds ratio", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Reported effect measure for binary outcomes such as cystectomy." }, { "id": "prognostic-text-5", "kind": "text", "text": "multivariate", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Signals adjusted analysis of factors." }, { "id": "prognostic-text-6", "kind": "text", "text": "multivariable", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Variant of multivariate." }, { "id": "prognostic-text-7", "kind": "text", "text": "nomogram", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Prediction tools." }, { "id": "prognostic-text-8", "kind": "text", "text": "risk stratification", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Wording for risk-group models." }, { "id": "prognostic-text-9", "kind": "text", "text": "risk score", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Covers EORTC, CUETO and other scoring systems." }, { "id": "prognostic-text-10", "kind": "text", "text": "risk group", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Wording for risk stratification categories." }, { "id": "prognostic-text-11", "kind": "text", "text": "biomarker", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Molecular factors studied for prognosis." }, { "id": "prognostic-text-12", "kind": "text", "text": "associated with", "fields": [ "ti" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Titles of association studies often state the factor is associated with an outcome; restricted to title to limit noise." }, { "id": "prognostic-mesh-1-et2", "kind": "text", "text": "Population at Risk", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept under the MeSH heading \"Risk Factors\" (D012307)" }, { "id": "prognostic-mesh-1-et3", "kind": "text", "text": "Health Correlates", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept under the MeSH heading \"Risk Factors\" (D012307)" }, { "id": "prognostic-mesh-1-et4", "kind": "text", "text": "Populations at Risk", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept \"Population at Risk\" under the MeSH heading \"Risk Factors\" (D012307)" }, { "id": "prognostic-mesh-2-et1", "kind": "text", "text": "Health Risk Assessment", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Risk Assessment\" (D018570)" }, { "id": "prognostic-mesh-2-et2", "kind": "text", "text": "Benefit-Risk Assessment", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept under the MeSH heading \"Risk Assessment\" (D018570)" }, { "id": "prognostic-mesh-2-et3", "kind": "text", "text": "Risk-Benefit Assessment", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept \"Benefit-Risk Assessment\" under the MeSH heading \"Risk Assessment\" (D018570)" }, { "id": "prognostic-mesh-3-et2", "kind": "text", "text": "Carcinogen Markers", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Biomarkers, Tumor\" (D014408)" }, { "id": "prognostic-mesh-3-et3", "kind": "text", "text": "Biological Tumor Marker", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Biomarkers, Tumor\" (D014408)" }, { "id": "prognostic-mesh-3-et4", "kind": "text", "text": "Tumor Metabolite Marker", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Biomarkers, Tumor\" (D014408)" }, { "id": "prognostic-mesh-3-et5", "kind": "text", "text": "Biochemical Tumor Marker", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Biomarkers, Tumor\" (D014408)" }, { "id": "prognostic-mesh-3-et6", "kind": "text", "text": "Biological Tumor Markers", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Biomarkers, Tumor\" (D014408)" }, { "id": "prognostic-mesh-3-et7", "kind": "text", "text": "Biochemical Tumor Markers", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Biomarkers, Tumor\" (D014408)" }, { "id": "prognostic-mesh-4-et1", "kind": "text", "text": "Partin Tables", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept under the MeSH heading \"Nomograms\" (D049451)" }, { "id": "prognostic-mesh-5-et1", "kind": "text", "text": "Proportional Hazard Model", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Proportional Hazards Models\" (D016016)" }, { "id": "prognostic-mesh-5-et2", "kind": "text", "text": "Proportional Hazard Models", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Proportional Hazards Models\" (D016016)" }, { "id": "prognostic-mesh-5-et3", "kind": "text", "text": "Proportional Hazards Model", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Proportional Hazards Models\" (D016016)" }, { "id": "prognostic-mesh-5-et4", "kind": "text", "text": "Cox Proportional Hazards Models", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept under the MeSH heading \"Proportional Hazards Models\" (D016016)" }, { "id": "prognostic-mesh-5-et5", "kind": "text", "text": "Cox Models", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept under the MeSH heading \"Proportional Hazards Models\" (D016016)" }, { "id": "prognostic-mesh-5-et6", "kind": "text", "text": "Cox Proportional Hazards Model", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept \"Cox Proportional Hazards Models\" under the MeSH heading \"Proportional Hazards Models\" (D016016)" } ], "required": true }, { "key": "outcome", "role": "outcome", "label": "Recurrence, progression, survival, BCG unresponsiveness, cystectomy", "terms": [ { "id": "outcome-mesh-0", "kind": "mesh", "label": "Neoplasm Recurrence, Local", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Heading for tumour recurrence.", "validation": { "ui": "D009364", "label": "Neoplasm Recurrence, Local", "status": "valid" } }, { "id": "outcome-mesh-1", "kind": "mesh", "label": "Recurrence", "major": false, "origin": "ai", "enabled": true, "explode": false, "rationale": "General recurrence heading sometimes used instead.", "validation": { "ui": "D012008", "label": "Recurrence", "status": "valid" } }, { "id": "outcome-mesh-2", "kind": "mesh", "label": "Disease Progression", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Heading for progression to muscle-invasive disease.", "validation": { "ui": "D018450", "label": "Disease Progression", "status": "valid" } }, { "id": "outcome-mesh-3", "kind": "mesh", "label": "Survival Analysis", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Covers disease-free survival, Kaplan-Meier and survival rates.", "validation": { "ui": "D016019", "label": "Survival Analysis", "status": "valid" } }, { "id": "outcome-mesh-4", "kind": "mesh", "label": "Progression-Free Survival", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Specific survival outcome heading.", "validation": { "ui": "D000077982", "label": "Progression-Free Survival", "status": "valid" } }, { "id": "outcome-mesh-5", "kind": "mesh", "label": "Cystectomy", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Cystectomy is a named outcome of the review.", "validation": { "ui": "D015653", "label": "Cystectomy", "status": "valid" } }, { "id": "outcome-mesh-6", "kind": "mesh", "label": "Treatment Failure", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Indexes BCG failure and unresponsive disease.", "validation": { "ui": "D017211", "label": "Treatment Failure", "status": "valid" } }, { "id": "outcome-mesh-7", "kind": "mesh", "label": "Drug Resistance, Neoplasm", "major": false, "origin": "ai", "enabled": true, "explode": true, "rationale": "Can be used for BCG-refractory disease.", "validation": { "ui": "D019008", "label": "Drug Resistance, Neoplasm", "status": "valid" } }, { "id": "outcome-text-0", "kind": "text", "text": "recurren", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Catches recurrence, recurrent and recurrence-free." }, { "id": "outcome-text-1", "kind": "text", "text": "relapse", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Synonym for recurrence." }, { "id": "outcome-text-2", "kind": "text", "text": "progression", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Progression to muscle-invasive or metastatic disease." }, { "id": "outcome-text-3", "kind": "text", "text": "muscle invasion", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Description of progression." }, { "id": "outcome-text-4", "kind": "text", "text": "upstaging", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Related progression outcome." }, { "id": "outcome-text-5", "kind": "text", "text": "survival", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Overall, cancer-specific and progression-free survival." }, { "id": "outcome-text-6", "kind": "text", "text": "mortality", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Death outcomes." }, { "id": "outcome-text-7", "kind": "text", "text": "cystectom", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Catches cystectomy and cystectomies, including radical and early cystectomy." }, { "id": "outcome-text-8", "kind": "text", "text": "BCG unresponsive", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "Catches BCG-unresponsive and BCG-unresponsiveness." }, { "id": "outcome-text-9", "kind": "text", "text": "BCG refractory", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "Related BCG failure category." }, { "id": "outcome-text-10", "kind": "text", "text": "BCG failure", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": true, "proximity": null, "rationale": "General term for failure of BCG therapy." }, { "id": "outcome-text-11", "kind": "text", "text": "BCG relapsing", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "BCG failure subtype." }, { "id": "outcome-text-12", "kind": "text", "text": "treatment failure", "fields": [ "tiab" ], "origin": "ai", "enabled": true, "truncate": false, "proximity": null, "rationale": "General failure wording." }, { "id": "outcome-mesh-1-et2", "kind": "text", "text": "Recrudescence", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Narrower concept under the MeSH heading \"Recurrence\" (D012008)" }, { "id": "outcome-mesh-7-et1", "kind": "text", "text": "Neoplasm Drug Resistance", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Drug Resistance, Neoplasm\" (D019008)" }, { "id": "outcome-mesh-7-et2", "kind": "text", "text": "Antineoplastic Drug Resistance", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Drug Resistance, Neoplasm\" (D019008)" }, { "id": "outcome-mesh-7-et3", "kind": "text", "text": "Antineoplastic Agent Resistance", "fields": [ "tiab" ], "origin": "mesh_entry_term", "enabled": false, "truncate": false, "proximity": null, "rationale": "Synonym of the MeSH heading \"Drug Resistance, Neoplasm\" (D019008)" } ], "required": true } ], "limits": { "dateTo": null, "dateFrom": null, "languages": [ "english" ], "humansOnly": false, "excludePublicationTypes": [ { "label": "Comment", "validation": { "ui": "D016420", "label": "Comment", "status": "valid" } }, { "label": "Editorial", "validation": { "ui": "D016421", "label": "Editorial", "status": "valid" } }, { "label": "Letter", "validation": { "ui": "D016422", "label": "Letter", "status": "valid" } }, { "label": "Case Reports", "validation": { "ui": "D002363", "label": "Case Reports", "status": "valid" } }, { "label": "Preprint", "validation": { "ui": "D000076942", "label": "Preprint", "status": "valid" } } ] }, "schema": "picoportal.search-strategy/1", "question": "What factors are associated with recurrence, progression, survival, BCG unresponsiveness, or cystectomy in adults with high-risk NMIBC?", "objective": "To identify clinical, pathological, molecular and treatment-related factors associated with recurrence, progression, survival, BCG-unresponsive disease or cystectomy in adults with high-risk non-muscle-invasive bladder cancer (NMIBC)." } } }, { "seq": 6, "event": { "type": "stage", "stage": "counting", "message": "Running 19 lines on PubMed" } }, { "seq": 7, "event": { "done": 1, "type": "progress", "total": 19, "message": "Line 4: 54,049 records" } }, { "seq": 8, "event": { "done": 2, "type": "progress", "total": 19, "message": "Line 2: 85,737 records" } }, { "seq": 9, "event": { "done": 3, "type": "progress", "total": 19, "message": "Line 3: 103,654 records" } }, { "seq": 10, "event": { "done": 4, "type": "progress", "total": 19, "message": "Line 5: 85,031 records" } }, { "seq": 11, "event": { "done": 5, "type": "progress", "total": 19, "message": "Line 6: 1,499 records" } }, { "seq": 12, "event": { "done": 6, "type": "progress", "total": 19, "message": "Line 7: 108,908 records" } }, { "seq": 13, "event": { "done": 7, "type": "progress", "total": 19, "message": "Line 9: 531,268 records" } }, { "seq": 14, "event": { "done": 8, "type": "progress", "total": 19, "message": "Line 10: 5,161,509 records" } }, { "seq": 15, "event": { "done": 9, "type": "progress", "total": 19, "message": "Line 11: 6,455,728 records" } }, { "seq": 16, "event": { "done": 10, "type": "progress", "total": 19, "message": "Line 1: 76,110 records" } }, { "seq": 17, "event": { "done": 11, "type": "progress", "total": 19, "message": "Line 12: 1,007,392 records" } }, { "seq": 18, "event": { "done": 12, "type": "progress", "total": 19, "message": "Line 14: 4,250,666 records" } }, { "seq": 19, "event": { "done": 13, "type": "progress", "total": 19, "message": "Line 16: 4,884,955 records" } }, { "seq": 20, "event": { "done": 14, "type": "progress", "total": 19, "message": "Line 15: 7,885 records" } }, { "seq": 21, "event": { "done": 15, "type": "progress", "total": 19, "message": "Line 8: 2,283,845 records" } }, { "seq": 22, "event": { "done": 16, "type": "progress", "total": 19, "message": "Line 18: 6,907 records" } }, { "seq": 23, "event": { "done": 17, "type": "progress", "total": 19, "message": "Line 19: 593,438 records" } }, { "seq": 24, "event": { "done": 18, "type": "progress", "total": 19, "message": "Line 13: 3,941,252 records" } }, { "seq": 25, "event": { "done": 19, "type": "progress", "total": 19, "message": "Line 17: 7,458 records" } }, { "seq": 26, "event": { "type": "lines", "lines": [ { "no": 1, "kind": "terms", "refs": [], "count": 76110, "query": "\"Urinary Bladder Neoplasms\"[Mesh] OR \"Carcinoma, Transitional Cell\"[Mesh]", "issues": [], "display": "\"Urinary Bladder Neoplasms\"[Mesh] OR \"Carcinoma, Transitional Cell\"[Mesh]", "termIds": [ "bladder-mesh-0", "bladder-mesh-1" ], "blockKey": "bladder", "countedAt": "2026-10-28T18:55:46.498Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"Urinary Bladder Neoplasms\"[MeSH Terms] OR \"carcinoma, transitional cell\"[MeSH Terms]", "quotedPhrasesNotFound": [] } }, { "no": 2, "kind": "terms", "refs": [], "count": 85737, "query": "\"bladder cancer*\"[tiab] OR \"bladder tumor*\"[tiab] OR \"bladder tumour*\"[tiab] OR \"bladder neoplasm*\"[tiab] OR \"bladder carcinoma*\"[tiab] OR \"urothelial carcinoma*\"[tiab] OR \"urothelial cancer*\"[tiab] OR \"transitional cell carcinoma*\"[tiab] OR NMIBC[tiab]", "issues": [], "display": "\"bladder cancer*\"[tiab] OR \"bladder tumor*\"[tiab] OR \"bladder tumour*\"[tiab] OR \"bladder neoplasm*\"[tiab] OR \"bladder carcinoma*\"[tiab] OR \"urothelial carcinoma*\"[tiab] OR \"urothelial cancer*\"[tiab] OR \"transitional cell carcinoma*\"[tiab] OR NMIBC[tiab]", "termIds": [ "bladder-text-0", "bladder-text-1", "bladder-text-2", "bladder-text-3", "bladder-text-4", "bladder-text-5", "bladder-text-6", "bladder-text-7", "bladder-text-8" ], "blockKey": "bladder", "countedAt": "2026-10-28T18:55:43.164Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"bladder cancer*\"[Title/Abstract] OR \"bladder tumor*\"[Title/Abstract] OR \"bladder tumour*\"[Title/Abstract] OR \"bladder neoplasm*\"[Title/Abstract] OR \"bladder carcinoma*\"[Title/Abstract] OR \"urothelial carcinoma*\"[Title/Abstract] OR \"urothelial cancer*\"[Title/Abstract] OR \"transitional cell carcinoma*\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract]", "quotedPhrasesNotFound": [] } }, { "no": 3, "kind": "block", "refs": [ 1, 2 ], "count": 103654, "query": "(\"Urinary Bladder Neoplasms\"[Mesh] OR \"Carcinoma, Transitional Cell\"[Mesh]) OR (\"bladder cancer*\"[tiab] OR \"bladder tumor*\"[tiab] OR \"bladder tumour*\"[tiab] OR \"bladder neoplasm*\"[tiab] OR \"bladder carcinoma*\"[tiab] OR \"urothelial carcinoma*\"[tiab] OR \"urothelial cancer*\"[tiab] OR \"transitional cell carcinoma*\"[tiab] OR NMIBC[tiab])", "issues": [], "display": "1 OR 2", "blockKey": "bladder", "countedAt": "2026-10-28T18:55:43.566Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"Urinary Bladder Neoplasms\"[MeSH Terms] OR \"carcinoma, transitional cell\"[MeSH Terms] OR \"bladder cancer*\"[Title/Abstract] OR \"bladder tumor*\"[Title/Abstract] OR \"bladder tumour*\"[Title/Abstract] OR \"bladder neoplasm*\"[Title/Abstract] OR \"bladder carcinoma*\"[Title/Abstract] OR \"urothelial carcinoma*\"[Title/Abstract] OR \"urothelial cancer*\"[Title/Abstract] OR \"transitional cell carcinoma*\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract]", "quotedPhrasesNotFound": [] } }, { "no": 4, "kind": "terms", "refs": [], "count": 54049, "query": "\"Carcinoma in Situ\"[Mesh] OR \"BCG Vaccine\"[Mesh] OR \"Administration, Intravesical\"[Mesh]", "issues": [], "display": "\"Carcinoma in Situ\"[Mesh] OR \"BCG Vaccine\"[Mesh] OR \"Administration, Intravesical\"[Mesh]", "termIds": [ "nmi-mesh-0", "nmi-mesh-1", "nmi-mesh-2" ], "blockKey": "nmi", "countedAt": "2026-10-28T18:55:42.841Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"Carcinoma in Situ\"[MeSH Terms] OR \"BCG Vaccine\"[MeSH Terms] OR \"administration, intravesical\"[MeSH Terms]", "quotedPhrasesNotFound": [] } }, { "no": 5, "kind": "terms", "refs": [], "count": 85031, "query": "\"non-muscle invasive\"[tiab] OR \"nonmuscle invasive\"[tiab] OR NMIBC[tiab] OR \"superficial bladder\"[tiab:~2] OR \"carcinoma in situ\"[tiab] OR T1G3[tiab] OR pT1[tiab] OR \"stage T1\"[tiab] OR \"T1 bladder\"[tiab:~2] OR BCG[tiab] OR \"Calmette-Guerin\"[tiab] OR intravesical[tiab] OR TURBT[tiab] OR \"transurethral resection\"[tiab]", "issues": [ { "code": "field_subsumed", "level": "info", "termId": "nmi-text-0", "message": "\"non-muscle invasive\"[ot] adds almost nothing to \"non-muscle invasive\"[tiab], which already searches the title, the abstract and the keywords.", "blockKey": "nmi" } ], "display": "\"non-muscle invasive\"[tiab] OR \"nonmuscle invasive\"[tiab] OR NMIBC[tiab] OR \"superficial bladder\"[tiab:~2] OR \"carcinoma in situ\"[tiab] OR T1G3[tiab] OR pT1[tiab] OR \"stage T1\"[tiab] OR \"T1 bladder\"[tiab:~2] OR BCG[tiab] OR \"Calmette-Guerin\"[tiab] OR intravesical[tiab] OR TURBT[tiab] OR \"transurethral resection\"[tiab]", "termIds": [ "nmi-text-0", "nmi-text-1", "nmi-text-2", "nmi-text-3", "nmi-text-4", "nmi-text-5", "nmi-text-6", "nmi-text-7", "nmi-text-8", "nmi-text-9", "nmi-text-10", "nmi-text-11", "nmi-text-12", "nmi-text-13" ], "blockKey": "nmi", "countedAt": "2026-10-28T18:55:44.386Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"non-muscle invasive\"[Title/Abstract] OR \"nonmuscle invasive\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract] OR \"superficial bladder\"[Title/Abstract:~2] OR \"carcinoma in situ\"[Title/Abstract] OR \"T1G3\"[Title/Abstract] OR \"pT1\"[Title/Abstract] OR \"stage T1\"[Title/Abstract] OR \"T1 bladder\"[Title/Abstract:~2] OR \"BCG\"[Title/Abstract] OR \"Calmette-Guerin\"[Title/Abstract] OR \"intravesical\"[Title/Abstract] OR \"TURBT\"[Title/Abstract] OR \"transurethral resection\"[Title/Abstract]", "quotedPhrasesNotFound": [] } }, { "no": 6, "kind": "terms", "refs": [], "count": 1499, "query": "\"non-muscle invasive\"[ot]", "issues": [ { "code": "field_subsumed", "level": "info", "termId": "nmi-text-0", "message": "\"non-muscle invasive\"[ot] adds almost nothing to \"non-muscle invasive\"[tiab], which already searches the title, the abstract and the keywords.", "blockKey": "nmi" } ], "display": "\"non-muscle invasive\"[ot]", "termIds": [ "nmi-text-0" ], "blockKey": "nmi", "countedAt": "2026-10-28T18:55:44.493Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"non-muscle invasive\"[Other Term]", "quotedPhrasesNotFound": [] } }, { "no": 7, "kind": "block", "refs": [ 4, 5, 6 ], "count": 108908, "query": "(\"Carcinoma in Situ\"[Mesh] OR \"BCG Vaccine\"[Mesh] OR \"Administration, Intravesical\"[Mesh]) OR (\"non-muscle invasive\"[tiab] OR \"nonmuscle invasive\"[tiab] OR NMIBC[tiab] OR \"superficial bladder\"[tiab:~2] OR \"carcinoma in situ\"[tiab] OR T1G3[tiab] OR pT1[tiab] OR \"stage T1\"[tiab] OR \"T1 bladder\"[tiab:~2] OR BCG[tiab] OR \"Calmette-Guerin\"[tiab] OR intravesical[tiab] OR TURBT[tiab] OR \"transurethral resection\"[tiab]) OR (\"non-muscle invasive\"[ot])", "issues": [], "display": "4 OR 5 OR 6", "blockKey": "nmi", "countedAt": "2026-10-28T18:55:44.854Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"Carcinoma in Situ\"[MeSH Terms] OR \"BCG Vaccine\"[MeSH Terms] OR \"administration, intravesical\"[MeSH Terms] OR \"non-muscle invasive\"[Title/Abstract] OR \"nonmuscle invasive\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract] OR \"superficial bladder\"[Title/Abstract:~2] OR \"Carcinoma in Situ\"[Title/Abstract] OR \"T1G3\"[Title/Abstract] OR \"pT1\"[Title/Abstract] OR \"stage T1\"[Title/Abstract] OR \"T1 bladder\"[Title/Abstract:~2] OR \"BCG\"[Title/Abstract] OR \"Calmette-Guerin\"[Title/Abstract] OR \"intravesical\"[Title/Abstract] OR \"TURBT\"[Title/Abstract] OR \"transurethral resection\"[Title/Abstract] OR \"non-muscle invasive\"[Other Term]", "quotedPhrasesNotFound": [] } }, { "no": 8, "kind": "terms", "refs": [], "count": 2283845, "query": "\"Prognosis\"[Mesh:NoExp] OR \"Risk Factors\"[Mesh] OR \"Risk Assessment\"[Mesh] OR \"Biomarkers, Tumor\"[Mesh] OR \"Nomograms\"[Mesh] OR \"Proportional Hazards Models\"[Mesh] OR \"Multivariate Analysis\"[Mesh]", "issues": [], "display": "\"Prognosis\"[Mesh:NoExp] OR \"Risk Factors\"[Mesh] OR \"Risk Assessment\"[Mesh] OR \"Biomarkers, Tumor\"[Mesh] OR \"Nomograms\"[Mesh] OR \"Proportional Hazards Models\"[Mesh] OR \"Multivariate Analysis\"[Mesh]", "termIds": [ "prognostic-mesh-0", "prognostic-mesh-1", "prognostic-mesh-2", "prognostic-mesh-3", "prognostic-mesh-4", "prognostic-mesh-5", "prognostic-mesh-6" ], "blockKey": "prognostic", "countedAt": "2026-10-28T18:55:48.198Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"Prognosis\"[MeSH Terms:noexp] OR \"Risk Factors\"[MeSH Terms] OR \"Risk Assessment\"[MeSH Terms] OR \"biomarkers, tumor\"[MeSH Terms] OR \"Nomograms\"[MeSH Terms] OR \"Proportional Hazards Models\"[MeSH Terms] OR \"Multivariate Analysis\"[MeSH Terms]", "quotedPhrasesNotFound": [] } }, { "no": 9, "kind": "terms", "refs": [], "count": 531268, "query": "\"associated with\"[ti]", "issues": [], "display": "\"associated with\"[ti]", "termIds": [ "prognostic-text-12" ], "blockKey": "prognostic", "countedAt": "2026-10-28T18:55:45.494Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"associated with\"[Title]", "quotedPhrasesNotFound": [] } }, { "no": 10, "kind": "terms", "refs": [], "count": 5161509, "query": "prognos*[tiab] OR predict*[tiab] OR \"risk factor*\"[tiab] OR \"hazard ratio*\"[tiab] OR \"odds ratio*\"[tiab] OR multivariate[tiab] OR multivariable[tiab] OR nomogram*[tiab] OR \"risk stratification\"[tiab] OR \"risk score*\"[tiab] OR \"risk group*\"[tiab] OR biomarker*[tiab]", "issues": [], "display": "prognos*[tiab] OR predict*[tiab] OR \"risk factor*\"[tiab] OR \"hazard ratio*\"[tiab] OR \"odds ratio*\"[tiab] OR multivariate[tiab] OR multivariable[tiab] OR nomogram*[tiab] OR \"risk stratification\"[tiab] OR \"risk score*\"[tiab] OR \"risk group*\"[tiab] OR biomarker*[tiab]", "termIds": [ "prognostic-text-0", "prognostic-text-1", "prognostic-text-2", "prognostic-text-3", "prognostic-text-4", "prognostic-text-5", "prognostic-text-6", "prognostic-text-7", "prognostic-text-8", "prognostic-text-9", "prognostic-text-10", "prognostic-text-11" ], "blockKey": "prognostic", "countedAt": "2026-10-28T18:55:45.936Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"prognos*\"[Title/Abstract] OR \"predict*\"[Title/Abstract] OR \"risk factor*\"[Title/Abstract] OR \"hazard ratio*\"[Title/Abstract] OR \"odds ratio*\"[Title/Abstract] OR \"multivariate\"[Title/Abstract] OR \"multivariable\"[Title/Abstract] OR \"nomogram*\"[Title/Abstract] OR \"risk stratification\"[Title/Abstract] OR \"risk score*\"[Title/Abstract] OR \"risk group*\"[Title/Abstract] OR \"biomarker*\"[Title/Abstract]", "quotedPhrasesNotFound": [] } }, { "no": 11, "kind": "block", "refs": [ 8, 9, 10 ], "count": 6455728, "query": "(\"Prognosis\"[Mesh:NoExp] OR \"Risk Factors\"[Mesh] OR \"Risk Assessment\"[Mesh] OR \"Biomarkers, Tumor\"[Mesh] OR \"Nomograms\"[Mesh] OR \"Proportional Hazards Models\"[Mesh] OR \"Multivariate Analysis\"[Mesh]) OR (\"associated with\"[ti]) OR (prognos*[tiab] OR predict*[tiab] OR \"risk factor*\"[tiab] OR \"hazard ratio*\"[tiab] OR \"odds ratio*\"[tiab] OR multivariate[tiab] OR multivariable[tiab] OR nomogram*[tiab] OR \"risk stratification\"[tiab] OR \"risk score*\"[tiab] OR \"risk group*\"[tiab] OR biomarker*[tiab])", "issues": [], "display": "8 OR 9 OR 10", "blockKey": "prognostic", "countedAt": "2026-10-28T18:55:46.298Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"Prognosis\"[MeSH Terms:noexp] OR \"Risk Factors\"[MeSH Terms] OR \"Risk Assessment\"[MeSH Terms] OR \"biomarkers, tumor\"[MeSH Terms] OR \"Nomograms\"[MeSH Terms] OR \"Proportional Hazards Models\"[MeSH Terms] OR \"Multivariate Analysis\"[MeSH Terms] OR \"associated with\"[Title] OR \"prognos*\"[Title/Abstract] OR \"predict*\"[Title/Abstract] OR \"risk factor*\"[Title/Abstract] OR \"hazard ratio*\"[Title/Abstract] OR \"odds ratio*\"[Title/Abstract] OR \"multivariate\"[Title/Abstract] OR \"multivariable\"[Title/Abstract] OR \"nomogram*\"[Title/Abstract] OR \"risk stratification\"[Title/Abstract] OR \"risk score*\"[Title/Abstract] OR \"risk group*\"[Title/Abstract] OR \"biomarker*\"[Title/Abstract]", "quotedPhrasesNotFound": [] } }, { "no": 12, "kind": "terms", "refs": [], "count": 1007392, "query": "\"Neoplasm Recurrence, Local\"[Mesh] OR \"Recurrence\"[Mesh:NoExp] OR \"Disease Progression\"[Mesh] OR \"Survival Analysis\"[Mesh] OR \"Progression-Free Survival\"[Mesh] OR \"Cystectomy\"[Mesh] OR \"Treatment Failure\"[Mesh] OR \"Drug Resistance, Neoplasm\"[Mesh]", "issues": [], "display": "\"Neoplasm Recurrence, Local\"[Mesh] OR \"Recurrence\"[Mesh:NoExp] OR \"Disease Progression\"[Mesh] OR \"Survival Analysis\"[Mesh] OR \"Progression-Free Survival\"[Mesh] OR \"Cystectomy\"[Mesh] OR \"Treatment Failure\"[Mesh] OR \"Drug Resistance, Neoplasm\"[Mesh]", "termIds": [ "outcome-mesh-0", "outcome-mesh-1", "outcome-mesh-2", "outcome-mesh-3", "outcome-mesh-4", "outcome-mesh-5", "outcome-mesh-6", "outcome-mesh-7" ], "blockKey": "outcome", "countedAt": "2026-10-28T18:55:46.863Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"neoplasm recurrence, local\"[MeSH Terms] OR \"Recurrence\"[MeSH Terms:noexp] OR \"Disease Progression\"[MeSH Terms] OR \"Survival Analysis\"[MeSH Terms] OR \"Progression-Free Survival\"[MeSH Terms] OR \"Cystectomy\"[MeSH Terms] OR \"Treatment Failure\"[MeSH Terms] OR \"drug resistance, neoplasm\"[MeSH Terms]", "quotedPhrasesNotFound": [] } }, { "no": 13, "kind": "terms", "refs": [], "count": 3941252, "query": "recurren*[tiab] OR relapse*[tiab] OR progression[tiab] OR \"muscle invasion\"[tiab] OR upstaging[tiab] OR survival[tiab] OR mortality[tiab] OR cystectom*[tiab] OR \"BCG unresponsive*\"[tiab] OR \"BCG refractory\"[tiab] OR \"BCG failure*\"[tiab] OR \"BCG relapsing\"[tiab] OR \"treatment failure\"[tiab]", "issues": [], "display": "recurren*[tiab] OR relapse*[tiab] OR progression[tiab] OR \"muscle invasion\"[tiab] OR upstaging[tiab] OR survival[tiab] OR mortality[tiab] OR cystectom*[tiab] OR \"BCG unresponsive*\"[tiab] OR \"BCG refractory\"[tiab] OR \"BCG failure*\"[tiab] OR \"BCG relapsing\"[tiab] OR \"treatment failure\"[tiab]", "termIds": [ "outcome-text-0", "outcome-text-1", "outcome-text-2", "outcome-text-3", "outcome-text-4", "outcome-text-5", "outcome-text-6", "outcome-text-7", "outcome-text-8", "outcome-text-9", "outcome-text-10", "outcome-text-11", "outcome-text-12" ], "blockKey": "outcome", "countedAt": "2026-10-28T18:55:49.591Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"recurren*\"[Title/Abstract] OR \"relapse*\"[Title/Abstract] OR \"progression\"[Title/Abstract] OR \"muscle invasion\"[Title/Abstract] OR \"upstaging\"[Title/Abstract] OR \"survival\"[Title/Abstract] OR \"mortality\"[Title/Abstract] OR \"cystectom*\"[Title/Abstract] OR \"bcg unresponsive*\"[Title/Abstract] OR \"BCG refractory\"[Title/Abstract] OR \"bcg failure*\"[Title/Abstract] OR \"BCG relapsing\"[Title/Abstract] OR \"treatment failure\"[Title/Abstract]", "quotedPhrasesNotFound": [] } }, { "no": 14, "kind": "block", "refs": [ 12, 13 ], "count": 4250666, "query": "(\"Neoplasm Recurrence, Local\"[Mesh] OR \"Recurrence\"[Mesh:NoExp] OR \"Disease Progression\"[Mesh] OR \"Survival Analysis\"[Mesh] OR \"Progression-Free Survival\"[Mesh] OR \"Cystectomy\"[Mesh] OR \"Treatment Failure\"[Mesh] OR \"Drug Resistance, Neoplasm\"[Mesh]) OR (recurren*[tiab] OR relapse*[tiab] OR progression[tiab] OR \"muscle invasion\"[tiab] OR upstaging[tiab] OR survival[tiab] OR mortality[tiab] OR cystectom*[tiab] OR \"BCG unresponsive*\"[tiab] OR \"BCG refractory\"[tiab] OR \"BCG failure*\"[tiab] OR \"BCG relapsing\"[tiab] OR \"treatment failure\"[tiab])", "issues": [], "display": "12 OR 13", "blockKey": "outcome", "countedAt": "2026-10-28T18:55:47.590Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"neoplasm recurrence, local\"[MeSH Terms] OR \"Recurrence\"[MeSH Terms:noexp] OR \"Disease Progression\"[MeSH Terms] OR \"Survival Analysis\"[MeSH Terms] OR \"Progression-Free Survival\"[MeSH Terms] OR \"Cystectomy\"[MeSH Terms] OR \"Treatment Failure\"[MeSH Terms] OR \"drug resistance, neoplasm\"[MeSH Terms] OR \"recurren*\"[Title/Abstract] OR \"relapse*\"[Title/Abstract] OR \"progression\"[Title/Abstract] OR \"muscle invasion\"[Title/Abstract] OR \"upstaging\"[Title/Abstract] OR \"survival\"[Title/Abstract] OR \"mortality\"[Title/Abstract] OR \"cystectom*\"[Title/Abstract] OR \"bcg unresponsive*\"[Title/Abstract] OR \"BCG refractory\"[Title/Abstract] OR \"bcg failure*\"[Title/Abstract] OR \"BCG relapsing\"[Title/Abstract] OR \"Treatment Failure\"[Title/Abstract]", "quotedPhrasesNotFound": [] } }, { "no": 15, "kind": "combine", "refs": [ 3, 7, 11, 14 ], "count": 7885, "query": "((\"Urinary Bladder Neoplasms\"[Mesh] OR \"Carcinoma, Transitional Cell\"[Mesh]) OR (\"bladder cancer*\"[tiab] OR \"bladder tumor*\"[tiab] OR \"bladder tumour*\"[tiab] OR \"bladder neoplasm*\"[tiab] OR \"bladder carcinoma*\"[tiab] OR \"urothelial carcinoma*\"[tiab] OR \"urothelial cancer*\"[tiab] OR \"transitional cell carcinoma*\"[tiab] OR NMIBC[tiab])) AND ((\"Carcinoma in Situ\"[Mesh] OR \"BCG Vaccine\"[Mesh] OR \"Administration, Intravesical\"[Mesh]) OR (\"non-muscle invasive\"[tiab] OR \"nonmuscle invasive\"[tiab] OR NMIBC[tiab] OR \"superficial bladder\"[tiab:~2] OR \"carcinoma in situ\"[tiab] OR T1G3[tiab] OR pT1[tiab] OR \"stage T1\"[tiab] OR \"T1 bladder\"[tiab:~2] OR BCG[tiab] OR \"Calmette-Guerin\"[tiab] OR intravesical[tiab] OR TURBT[tiab] OR \"transurethral resection\"[tiab]) OR (\"non-muscle invasive\"[ot])) AND ((\"Prognosis\"[Mesh:NoExp] OR \"Risk Factors\"[Mesh] OR \"Risk Assessment\"[Mesh] OR \"Biomarkers, Tumor\"[Mesh] OR \"Nomograms\"[Mesh] OR \"Proportional Hazards Models\"[Mesh] OR \"Multivariate Analysis\"[Mesh]) OR (\"associated with\"[ti]) OR (prognos*[tiab] OR predict*[tiab] OR \"risk factor*\"[tiab] OR \"hazard ratio*\"[tiab] OR \"odds ratio*\"[tiab] OR multivariate[tiab] OR multivariable[tiab] OR nomogram*[tiab] OR \"risk stratification\"[tiab] OR \"risk score*\"[tiab] OR \"risk group*\"[tiab] OR biomarker*[tiab])) AND ((\"Neoplasm Recurrence, Local\"[Mesh] OR \"Recurrence\"[Mesh:NoExp] OR \"Disease Progression\"[Mesh] OR \"Survival Analysis\"[Mesh] OR \"Progression-Free Survival\"[Mesh] OR \"Cystectomy\"[Mesh] OR \"Treatment Failure\"[Mesh] OR \"Drug Resistance, Neoplasm\"[Mesh]) OR (recurren*[tiab] OR relapse*[tiab] OR progression[tiab] OR \"muscle invasion\"[tiab] OR upstaging[tiab] OR survival[tiab] OR mortality[tiab] OR cystectom*[tiab] OR \"BCG unresponsive*\"[tiab] OR \"BCG refractory\"[tiab] OR \"BCG failure*\"[tiab] OR \"BCG relapsing\"[tiab] OR \"treatment failure\"[tiab]))", "issues": [], "display": "3 AND 7 AND 11 AND 14", "countedAt": "2026-10-28T18:55:48.037Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "(\"Urinary Bladder Neoplasms\"[MeSH Terms] OR \"carcinoma, transitional cell\"[MeSH Terms] OR (\"bladder cancer*\"[Title/Abstract] OR \"bladder tumor*\"[Title/Abstract] OR \"bladder tumour*\"[Title/Abstract] OR \"bladder neoplasm*\"[Title/Abstract] OR \"bladder carcinoma*\"[Title/Abstract] OR \"urothelial carcinoma*\"[Title/Abstract] OR \"urothelial cancer*\"[Title/Abstract] OR \"transitional cell carcinoma*\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract])) AND (\"Carcinoma in Situ\"[MeSH Terms] OR \"BCG Vaccine\"[MeSH Terms] OR \"administration, intravesical\"[MeSH Terms] OR (\"non-muscle invasive\"[Title/Abstract] OR \"nonmuscle invasive\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract] OR \"superficial bladder\"[Title/Abstract:~2] OR \"Carcinoma in Situ\"[Title/Abstract] OR \"T1G3\"[Title/Abstract] OR \"pT1\"[Title/Abstract] OR \"stage T1\"[Title/Abstract] OR \"T1 bladder\"[Title/Abstract:~2] OR \"BCG\"[Title/Abstract] OR \"Calmette-Guerin\"[Title/Abstract] OR \"intravesical\"[Title/Abstract] OR \"TURBT\"[Title/Abstract] OR \"transurethral resection\"[Title/Abstract]) OR \"non-muscle invasive\"[Other Term]) AND (\"Prognosis\"[MeSH Terms:noexp] OR \"Risk Factors\"[MeSH Terms] OR \"Risk Assessment\"[MeSH Terms] OR \"biomarkers, tumor\"[MeSH Terms] OR \"Nomograms\"[MeSH Terms] OR \"Proportional Hazards Models\"[MeSH Terms] OR \"Multivariate Analysis\"[MeSH Terms] OR \"associated with\"[Title] OR (\"prognos*\"[Title/Abstract] OR \"predict*\"[Title/Abstract] OR \"risk factor*\"[Title/Abstract] OR \"hazard ratio*\"[Title/Abstract] OR \"odds ratio*\"[Title/Abstract] OR \"multivariate\"[Title/Abstract] OR \"multivariable\"[Title/Abstract] OR \"nomogram*\"[Title/Abstract] OR \"risk stratification\"[Title/Abstract] OR \"risk score*\"[Title/Abstract] OR \"risk group*\"[Title/Abstract] OR \"biomarker*\"[Title/Abstract])) AND (\"neoplasm recurrence, local\"[MeSH Terms] OR \"Recurrence\"[MeSH Terms:noexp] OR \"Disease Progression\"[MeSH Terms] OR \"Survival Analysis\"[MeSH Terms] OR \"Progression-Free Survival\"[MeSH Terms] OR \"Cystectomy\"[MeSH Terms] OR \"Treatment Failure\"[MeSH Terms] OR \"drug resistance, neoplasm\"[MeSH Terms] OR (\"recurren*\"[Title/Abstract] OR \"relapse*\"[Title/Abstract] OR \"progression\"[Title/Abstract] OR \"muscle invasion\"[Title/Abstract] OR \"upstaging\"[Title/Abstract] OR \"survival\"[Title/Abstract] OR \"mortality\"[Title/Abstract] OR \"cystectom*\"[Title/Abstract] OR \"bcg unresponsive*\"[Title/Abstract] OR \"BCG refractory\"[Title/Abstract] OR \"bcg failure*\"[Title/Abstract] OR \"BCG relapsing\"[Title/Abstract] OR \"Treatment Failure\"[Title/Abstract]))", "quotedPhrasesNotFound": [] } }, { "no": 16, "kind": "exclude", "refs": [], "count": 4884955, "query": "\"Comment\"[Publication Type] OR \"Editorial\"[Publication Type] OR \"Letter\"[Publication Type] OR \"Case Reports\"[Publication Type] OR \"Preprint\"[Publication Type]", "issues": [], "display": "\"Comment\"[Publication Type] OR \"Editorial\"[Publication Type] OR \"Letter\"[Publication Type] OR \"Case Reports\"[Publication Type] OR \"Preprint\"[Publication Type]", "countedAt": "2026-10-28T18:00:07.644Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"Comment\"[Publication Type] OR \"Editorial\"[Publication Type] OR \"Letter\"[Publication Type] OR \"Case Reports\"[Publication Type] OR \"Preprint\"[Publication Type]", "quotedPhrasesNotFound": [] } }, { "no": 17, "kind": "not", "refs": [ 15, 16 ], "count": 7458, "query": "(((\"Urinary Bladder Neoplasms\"[Mesh] OR \"Carcinoma, Transitional Cell\"[Mesh]) OR (\"bladder cancer*\"[tiab] OR \"bladder tumor*\"[tiab] OR \"bladder tumour*\"[tiab] OR \"bladder neoplasm*\"[tiab] OR \"bladder carcinoma*\"[tiab] OR \"urothelial carcinoma*\"[tiab] OR \"urothelial cancer*\"[tiab] OR \"transitional cell carcinoma*\"[tiab] OR NMIBC[tiab])) AND ((\"Carcinoma in Situ\"[Mesh] OR \"BCG Vaccine\"[Mesh] OR \"Administration, Intravesical\"[Mesh]) OR (\"non-muscle invasive\"[tiab] OR \"nonmuscle invasive\"[tiab] OR NMIBC[tiab] OR \"superficial bladder\"[tiab:~2] OR \"carcinoma in situ\"[tiab] OR T1G3[tiab] OR pT1[tiab] OR \"stage T1\"[tiab] OR \"T1 bladder\"[tiab:~2] OR BCG[tiab] OR \"Calmette-Guerin\"[tiab] OR intravesical[tiab] OR TURBT[tiab] OR \"transurethral resection\"[tiab]) OR (\"non-muscle invasive\"[ot])) AND ((\"Prognosis\"[Mesh:NoExp] OR \"Risk Factors\"[Mesh] OR \"Risk Assessment\"[Mesh] OR \"Biomarkers, Tumor\"[Mesh] OR \"Nomograms\"[Mesh] OR \"Proportional Hazards Models\"[Mesh] OR \"Multivariate Analysis\"[Mesh]) OR (\"associated with\"[ti]) OR (prognos*[tiab] OR predict*[tiab] OR \"risk factor*\"[tiab] OR \"hazard ratio*\"[tiab] OR \"odds ratio*\"[tiab] OR multivariate[tiab] OR multivariable[tiab] OR nomogram*[tiab] OR \"risk stratification\"[tiab] OR \"risk score*\"[tiab] OR \"risk group*\"[tiab] OR biomarker*[tiab])) AND ((\"Neoplasm Recurrence, Local\"[Mesh] OR \"Recurrence\"[Mesh:NoExp] OR \"Disease Progression\"[Mesh] OR \"Survival Analysis\"[Mesh] OR \"Progression-Free Survival\"[Mesh] OR \"Cystectomy\"[Mesh] OR \"Treatment Failure\"[Mesh] OR \"Drug Resistance, Neoplasm\"[Mesh]) OR (recurren*[tiab] OR relapse*[tiab] OR progression[tiab] OR \"muscle invasion\"[tiab] OR upstaging[tiab] OR survival[tiab] OR mortality[tiab] OR cystectom*[tiab] OR \"BCG unresponsive*\"[tiab] OR \"BCG refractory\"[tiab] OR \"BCG failure*\"[tiab] OR \"BCG relapsing\"[tiab] OR \"treatment failure\"[tiab]))) NOT (\"Comment\"[Publication Type] OR \"Editorial\"[Publication Type] OR \"Letter\"[Publication Type] OR \"Case Reports\"[Publication Type] OR \"Preprint\"[Publication Type])", "issues": [], "display": "15 NOT 16", "countedAt": "2026-10-28T18:55:50.709Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "((\"Urinary Bladder Neoplasms\"[MeSH Terms] OR \"carcinoma, transitional cell\"[MeSH Terms] OR (\"bladder cancer*\"[Title/Abstract] OR \"bladder tumor*\"[Title/Abstract] OR \"bladder tumour*\"[Title/Abstract] OR \"bladder neoplasm*\"[Title/Abstract] OR \"bladder carcinoma*\"[Title/Abstract] OR \"urothelial carcinoma*\"[Title/Abstract] OR \"urothelial cancer*\"[Title/Abstract] OR \"transitional cell carcinoma*\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract])) AND (\"Carcinoma in Situ\"[MeSH Terms] OR \"BCG Vaccine\"[MeSH Terms] OR \"administration, intravesical\"[MeSH Terms] OR (\"non-muscle invasive\"[Title/Abstract] OR \"nonmuscle invasive\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract] OR \"superficial bladder\"[Title/Abstract:~2] OR \"Carcinoma in Situ\"[Title/Abstract] OR \"T1G3\"[Title/Abstract] OR \"pT1\"[Title/Abstract] OR \"stage T1\"[Title/Abstract] OR \"T1 bladder\"[Title/Abstract:~2] OR \"BCG\"[Title/Abstract] OR \"Calmette-Guerin\"[Title/Abstract] OR \"intravesical\"[Title/Abstract] OR \"TURBT\"[Title/Abstract] OR \"transurethral resection\"[Title/Abstract]) OR \"non-muscle invasive\"[Other Term]) AND (\"Prognosis\"[MeSH Terms:noexp] OR \"Risk Factors\"[MeSH Terms] OR \"Risk Assessment\"[MeSH Terms] OR \"biomarkers, tumor\"[MeSH Terms] OR \"Nomograms\"[MeSH Terms] OR \"Proportional Hazards Models\"[MeSH Terms] OR \"Multivariate Analysis\"[MeSH Terms] OR \"associated with\"[Title] OR (\"prognos*\"[Title/Abstract] OR \"predict*\"[Title/Abstract] OR \"risk factor*\"[Title/Abstract] OR \"hazard ratio*\"[Title/Abstract] OR \"odds ratio*\"[Title/Abstract] OR \"multivariate\"[Title/Abstract] OR \"multivariable\"[Title/Abstract] OR \"nomogram*\"[Title/Abstract] OR \"risk stratification\"[Title/Abstract] OR \"risk score*\"[Title/Abstract] OR \"risk group*\"[Title/Abstract] OR \"biomarker*\"[Title/Abstract])) AND (\"neoplasm recurrence, local\"[MeSH Terms] OR \"Recurrence\"[MeSH Terms:noexp] OR \"Disease Progression\"[MeSH Terms] OR \"Survival Analysis\"[MeSH Terms] OR \"Progression-Free Survival\"[MeSH Terms] OR \"Cystectomy\"[MeSH Terms] OR \"Treatment Failure\"[MeSH Terms] OR \"drug resistance, neoplasm\"[MeSH Terms] OR (\"recurren*\"[Title/Abstract] OR \"relapse*\"[Title/Abstract] OR \"progression\"[Title/Abstract] OR \"muscle invasion\"[Title/Abstract] OR \"upstaging\"[Title/Abstract] OR \"survival\"[Title/Abstract] OR \"mortality\"[Title/Abstract] OR \"cystectom*\"[Title/Abstract] OR \"bcg unresponsive*\"[Title/Abstract] OR \"BCG refractory\"[Title/Abstract] OR \"bcg failure*\"[Title/Abstract] OR \"BCG relapsing\"[Title/Abstract] OR \"Treatment Failure\"[Title/Abstract]))) NOT (\"Comment\"[Publication Type] OR \"Editorial\"[Publication Type] OR \"Letter\"[Publication Type] OR \"Case Reports\"[Publication Type] OR \"Preprint\"[Publication Type])", "quotedPhrasesNotFound": [] } }, { "no": 18, "kind": "limits", "refs": [ 17 ], "count": 6907, "query": "((((\"Urinary Bladder Neoplasms\"[Mesh] OR \"Carcinoma, Transitional Cell\"[Mesh]) OR (\"bladder cancer*\"[tiab] OR \"bladder tumor*\"[tiab] OR \"bladder tumour*\"[tiab] OR \"bladder neoplasm*\"[tiab] OR \"bladder carcinoma*\"[tiab] OR \"urothelial carcinoma*\"[tiab] OR \"urothelial cancer*\"[tiab] OR \"transitional cell carcinoma*\"[tiab] OR NMIBC[tiab])) AND ((\"Carcinoma in Situ\"[Mesh] OR \"BCG Vaccine\"[Mesh] OR \"Administration, Intravesical\"[Mesh]) OR (\"non-muscle invasive\"[tiab] OR \"nonmuscle invasive\"[tiab] OR NMIBC[tiab] OR \"superficial bladder\"[tiab:~2] OR \"carcinoma in situ\"[tiab] OR T1G3[tiab] OR pT1[tiab] OR \"stage T1\"[tiab] OR \"T1 bladder\"[tiab:~2] OR BCG[tiab] OR \"Calmette-Guerin\"[tiab] OR intravesical[tiab] OR TURBT[tiab] OR \"transurethral resection\"[tiab]) OR (\"non-muscle invasive\"[ot])) AND ((\"Prognosis\"[Mesh:NoExp] OR \"Risk Factors\"[Mesh] OR \"Risk Assessment\"[Mesh] OR \"Biomarkers, Tumor\"[Mesh] OR \"Nomograms\"[Mesh] OR \"Proportional Hazards Models\"[Mesh] OR \"Multivariate Analysis\"[Mesh]) OR (\"associated with\"[ti]) OR (prognos*[tiab] OR predict*[tiab] OR \"risk factor*\"[tiab] OR \"hazard ratio*\"[tiab] OR \"odds ratio*\"[tiab] OR multivariate[tiab] OR multivariable[tiab] OR nomogram*[tiab] OR \"risk stratification\"[tiab] OR \"risk score*\"[tiab] OR \"risk group*\"[tiab] OR biomarker*[tiab])) AND ((\"Neoplasm Recurrence, Local\"[Mesh] OR \"Recurrence\"[Mesh:NoExp] OR \"Disease Progression\"[Mesh] OR \"Survival Analysis\"[Mesh] OR \"Progression-Free Survival\"[Mesh] OR \"Cystectomy\"[Mesh] OR \"Treatment Failure\"[Mesh] OR \"Drug Resistance, Neoplasm\"[Mesh]) OR (recurren*[tiab] OR relapse*[tiab] OR progression[tiab] OR \"muscle invasion\"[tiab] OR upstaging[tiab] OR survival[tiab] OR mortality[tiab] OR cystectom*[tiab] OR \"BCG unresponsive*\"[tiab] OR \"BCG refractory\"[tiab] OR \"BCG failure*\"[tiab] OR \"BCG relapsing\"[tiab] OR \"treatment failure\"[tiab]))) NOT (\"Comment\"[Publication Type] OR \"Editorial\"[Publication Type] OR \"Letter\"[Publication Type] OR \"Case Reports\"[Publication Type] OR \"Preprint\"[Publication Type])) AND english[la]", "issues": [], "display": "17 AND english[la]", "countedAt": "2026-10-28T18:55:49.070Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "(((\"Urinary Bladder Neoplasms\"[MeSH Terms] OR \"carcinoma, transitional cell\"[MeSH Terms] OR (\"bladder cancer*\"[Title/Abstract] OR \"bladder tumor*\"[Title/Abstract] OR \"bladder tumour*\"[Title/Abstract] OR \"bladder neoplasm*\"[Title/Abstract] OR \"bladder carcinoma*\"[Title/Abstract] OR \"urothelial carcinoma*\"[Title/Abstract] OR \"urothelial cancer*\"[Title/Abstract] OR \"transitional cell carcinoma*\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract])) AND (\"Carcinoma in Situ\"[MeSH Terms] OR \"BCG Vaccine\"[MeSH Terms] OR \"administration, intravesical\"[MeSH Terms] OR (\"non-muscle invasive\"[Title/Abstract] OR \"nonmuscle invasive\"[Title/Abstract] OR \"NMIBC\"[Title/Abstract] OR \"superficial bladder\"[Title/Abstract:~2] OR \"Carcinoma in Situ\"[Title/Abstract] OR \"T1G3\"[Title/Abstract] OR \"pT1\"[Title/Abstract] OR \"stage T1\"[Title/Abstract] OR \"T1 bladder\"[Title/Abstract:~2] OR \"BCG\"[Title/Abstract] OR \"Calmette-Guerin\"[Title/Abstract] OR \"intravesical\"[Title/Abstract] OR \"TURBT\"[Title/Abstract] OR \"transurethral resection\"[Title/Abstract]) OR \"non-muscle invasive\"[Other Term]) AND (\"Prognosis\"[MeSH Terms:noexp] OR \"Risk Factors\"[MeSH Terms] OR \"Risk Assessment\"[MeSH Terms] OR \"biomarkers, tumor\"[MeSH Terms] OR \"Nomograms\"[MeSH Terms] OR \"Proportional Hazards Models\"[MeSH Terms] OR \"Multivariate Analysis\"[MeSH Terms] OR \"associated with\"[Title] OR (\"prognos*\"[Title/Abstract] OR \"predict*\"[Title/Abstract] OR \"risk factor*\"[Title/Abstract] OR \"hazard ratio*\"[Title/Abstract] OR \"odds ratio*\"[Title/Abstract] OR \"multivariate\"[Title/Abstract] OR \"multivariable\"[Title/Abstract] OR \"nomogram*\"[Title/Abstract] OR \"risk stratification\"[Title/Abstract] OR \"risk score*\"[Title/Abstract] OR \"risk group*\"[Title/Abstract] OR \"biomarker*\"[Title/Abstract])) AND (\"neoplasm recurrence, local\"[MeSH Terms] OR \"Recurrence\"[MeSH Terms:noexp] OR \"Disease Progression\"[MeSH Terms] OR \"Survival Analysis\"[MeSH Terms] OR \"Progression-Free Survival\"[MeSH Terms] OR \"Cystectomy\"[MeSH Terms] OR \"Treatment Failure\"[MeSH Terms] OR \"drug resistance, neoplasm\"[MeSH Terms] OR (\"recurren*\"[Title/Abstract] OR \"relapse*\"[Title/Abstract] OR \"progression\"[Title/Abstract] OR \"muscle invasion\"[Title/Abstract] OR \"upstaging\"[Title/Abstract] OR \"survival\"[Title/Abstract] OR \"mortality\"[Title/Abstract] OR \"cystectom*\"[Title/Abstract] OR \"bcg unresponsive*\"[Title/Abstract] OR \"BCG refractory\"[Title/Abstract] OR \"bcg failure*\"[Title/Abstract] OR \"BCG relapsing\"[Title/Abstract] OR \"Treatment Failure\"[Title/Abstract]))) NOT (\"Comment\"[Publication Type] OR \"Editorial\"[Publication Type] OR \"Letter\"[Publication Type] OR \"Case Reports\"[Publication Type] OR \"Preprint\"[Publication Type])) AND \"english\"[Language]", "quotedPhrasesNotFound": [] } }, { "no": 19, "kind": "terms", "refs": [], "count": 593438, "query": "\"high risk\"[tiab] OR \"high grade\"[tiab] OR \"highest risk\"[tiab]", "issues": [], "display": "\"high risk\"[tiab] OR \"high grade\"[tiab] OR \"highest risk\"[tiab]", "termIds": [ "highrisk-text-0", "highrisk-text-1", "highrisk-text-2" ], "blockKey": "highrisk", "countedAt": "2026-10-28T18:55:49.174Z", "diagnostics": { "fieldsNotFound": [], "outputMessages": [], "phrasesIgnored": [], "translationSet": [], "phrasesNotFound": [], "queryTranslation": "\"high risk\"[Title/Abstract] OR \"high grade\"[Title/Abstract] OR \"highest risk\"[Title/Abstract]", "quotedPhrasesNotFound": [] } } ] } }, { "seq": 27, "event": { "type": "stage", "stage": "fetching_records", "message": "Fetching the first 20 records" } }, { "seq": 28, "event": { "type": "records", "total": 6907, "records": [ { "pmid": "42946445", "year": "2026", "title": "High Ubiquitin-like Protein 3 Expression Is Associated With Prolonged Recurrence-free Survival in Non-muscle-invasive Bladder Cancer.", "authors": "Sano A, Tamura K, Sakai Y et al.", "journal": "Anticancer research", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42927820", "year": "2026", "title": "Elevated GANAB fuels PD-1/PD-L1 checkpoint-mediated immune escape by maintaining PD-L1 stability in bladder cancer.", "authors": "Jin X, Xu Y, Ling K et al.", "journal": "Cellular signalling", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42923499", "year": "2026", "title": "Assessment of muscularis propria invasion in urothelial bladder carcinoma using continuous-time random walk and stretched-exponential models: Comparison with VI-RADS and apparent diffusion coefficient.", "authors": "Wu Y, Zhu X, Zhou X et al.", "journal": "Experimental and therapeutic medicine", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42923287", "year": "2026", "title": "Research progress and clinical translation prospects of multiple urinary biomarkers in non-invasive diagnosis of urothelial carcinoma.", "authors": "Li S, Wang L, Gao B", "journal": "Frontiers in oncology", "publicationTypes": [ "Journal Article", "Review" ] }, { "pmid": "42910392", "year": "2026", "title": "Deciphering the clinical significance of Beclin-1 and Bcl-2 in urothelial carcinoma of bladder.", "authors": "Niharika, Tripathi S, Singhai A et al.", "journal": "Indian journal of urology : IJU : journal of the Urological Society of India", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42909595", "year": "2026", "title": "Timing of FDA-Defined Adequate BCG Therapy and Oncologic Outcomes in High-Risk Non-Muscle-Invasive Bladder Cancer.", "authors": "Abou Chakra M, Myers AA, Duquesne I et al.", "journal": "Urology practice", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42908741", "year": "2026", "title": "Population-specific molecular features and clinical significance of urinary tumor DNA mutations in Chinese patients with newly diagnosed non-muscle-invasive bladder cancer.", "authors": "Sun Z, Xie R, Pan J et al.", "journal": "Frontiers in oncology", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42903929", "year": "2026", "title": "FGFR3 mRNA expression in urothelial bladder cancer: Associations with tumor phenotype without prognostic impact.", "authors": "Pakovski K, Markova M, Janchulev J et al.", "journal": "Central European journal of urology", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42903705", "year": "2026", "title": "Reprogramming innate immune memory in bladder cancer: the proposed bone marrow-bladder axis and next-generation BCG-based immunotherapies.", "authors": "Yang M, Guo Y, Shen YZ et al.", "journal": "Frontiers in immunology", "publicationTypes": [ "Journal Article", "Review", "Research Support, Non-U.S. Gov't" ] }, { "pmid": "42901828", "year": "2026", "title": "Clinical Outcomes of Bladder-sparing Management Versus Early Radical Cystectomy in cT1 Micropapillary Bladder Cancer: A Systematic Review and Meta-analysis.", "authors": "Patel SR, Rauf M, Geng Y et al.", "journal": "European urology oncology", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42898355", "year": "2026", "title": "Prognosis and tumor grading in bladder urothelial carcinomas with intratumoral grade heterogeneity.", "authors": "Alkan GV, Doğan K, Türk Alkan M et al.", "journal": "Pathology oncology research : POR", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42891336", "year": "2026", "title": "Microbiome-urothelium crosstalk in bladder cancer: From dysbiosis to clinical translation.", "authors": "Xu H, Li Z, Yang L et al.", "journal": "iMetaOmics", "publicationTypes": [ "Journal Article", "Review" ] }, { "pmid": "42889172", "year": "2026", "title": "NEITHER study: NICE versus EAU inconsistent triage, expenses and reliability in non-high-risk non-muscle invasive bladder cancer surveillance.", "authors": "Ibrahim Y, Ribeiro L, Heelan M et al.", "journal": "BJUI compass", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42889117", "year": "2026", "title": "Risk factors for recurrence after initial transurethral resection of bladder tumor in patients with non-muscle-invasive bladder cancer.", "authors": "Yuan F, Li X, Zhang J et al.", "journal": "Frontiers in oncology", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42885914", "year": "2026", "title": "Enhanced detection of bladder cancer using machine learning analysis of routine urinary sediment data.", "authors": "Okuyama R, Horiuchi H, Nakamura M et al.", "journal": "Clinical chemistry and laboratory medicine", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42881413", "year": "2026", "title": "Bladder cancer organoids in precision medicine: bridging basic science, clinical therapeutics and drug development.", "authors": "Zhong X, Wang G, Zhang H et al.", "journal": "Cancer cell international", "publicationTypes": [ "Journal Article", "Review" ] }, { "pmid": "42880421", "year": "2026", "title": "Diet quality and prognosis in patients with non-muscle invasive bladder cancer: the Be-Well Study.", "authors": "Ergas IJ, Zimbalist A, Haque R et al.", "journal": "Urology", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42869744", "year": "2026", "title": "Contemporary Oncological and Patient-reported Outcomes of Intravesical Gemcitabine/Docetaxel in BCG-unresponsive Non-muscle-invasive Bladder Cancer: A Multi-institutional Prospective Cohort Study.", "authors": "Tan YG, Dudinec J, Kamat AM et al.", "journal": "European urology focus", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42866931", "year": "2026", "title": "Urinary Extracellular Vesicle-Associated EphA2 Predicts Intravesical Recurrence in Bladder Cancer.", "authors": "Hashimoto M, Tomiyama E, Inoki L et al.", "journal": "International journal of urology : official journal of the Japanese Urological Association", "publicationTypes": [ "Journal Article" ] }, { "pmid": "42866795", "year": "2026", "title": "An interpretable LASSO-Boruta nomogram for non-muscle-invasive bladder cancer recurrence after intravesical instillation.", "authors": "Li B, Ji G, Wang W et al.", "journal": "Translational andrology and urology", "publicationTypes": [ "Journal Article" ] } ] } }, { "seq": 29, "event": { "type": "stage", "stage": "saving", "message": "Saving the run" } }, { "seq": 30, "event": { "type": "done", "finalCount": 6907 } } ] }